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Abstract
A series of chiral di-, tri- and tetra amine ligands were synthesised from
enantiomerically pure 1,2-cyclohexanediamine and 1,2-diphenylethanediamine and,
in combination with Ru(II) or Fe(II), employed as asymmetric catalysts in the
epoxidation of aromatic alkenes, hydrosilylation of acetophenone, nitro-aldol
reaction and asymmetric transfer hydrogenation (ATH) of different ketones.
A novel class of tridentate ruthenium catalysts of general structure 239 below were
developed. Specifically, a novel class of tridentate ligand was synthesised and a
derivative of (R,R)-N-tosyl-1,2-diphenyl-1,2-ethylenediamine ((R,R)-TsDPEN) and
was found to provide the best activity and selectivity in reduction reactions with
Ru3(CO)12.
Reaction conditions were optimised using 239 for the ruthenium-catalysed ATH of a
number of ketones. In particular, it was found that the presence of meta-methoxy
substituent on the aromatic ring of the substrate yields optimal results under the ATH
conditions employed for 48 h (98% conv., 94% ee). Also, aryl ketones substituted at
the ortho position were reduced in almost quantitative yield, with enantiomeric
excesses greater than 90% in some cases.
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1. Introduction
1.1. Chirality
Chirality: A molecule that is non-superimposable upon its mirror image is considered
to be chiral.
Chirality has extremely important connotations in chemistry; any molecule that
possesses an element of chirality can exist in two distinct mirror image forms,
known as enantiomers. The physical and chemical properties of two enantiomers of a
compound are identical in the absence of an external chiral source.1 One notable
characteristic of an enantiomeric pair is their equal and opposite rotation (clockwise
(+) and anticlockwise (-)) of plane-polarised light. This has been extremely useful as
a directly observable property in assigning stereochemistry to chiral molecules. A
simple compound that exhibits this enantiomeric property is
chlorofluorobromomethane, which can be resolved into two enantiomeric forms
(Figure 1).
Figure 1: The two optical isomers of chlorofluorobromomethane.
The two enantiomers will rotate plane-polarised light by the same amount but in
opposite directions. This leads to one way of labelling enantiomers; enantiomers that
rotate plane-polarised light to the right are called dextro isomers and are given the
label (d) or (+), and enantiomers that rotate plane-polarised light to the left are called
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levo isomers and are given the label (l) or (-). Due to this effect on light, enantiomers
are often referred to as optical isomers.2 The Cahn-Ingold-Prelog3 system was
devised to specify the absolute configuration at any sterogenic centre. Figure 2
shows how the configuration is worked out. First of all the atoms directly attached to
the asymmetric centre and their atomic numbers are identified. Next the attached
atoms are given a priority based on their atomic numbers. If there are two carbon
atoms, and hence the same atomic numbers, attached to the centre then they cannot
be given a priority. In this instance move to the next atoms along for each carbon and
identify which has the highest atomic number. This substituent takes priority over
the other. If the priority order of the groups decreases clockwise, then the stereogenic
centre is called rectus and given the label (R), If the priority decreases anticlockwise,
then the stereogenic centre is called sinister and given the label (S). In the case below
the priority rules order the groups in decreasing atomic mass in a clockwise direction
and the stereocentre has an (R) configuration.
Figure 2: Assigning priorities to substituents of an asymmetric centre.
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1.1.1. Chiral resolution
This is a process for the separation of racemic compounds into their enantiomers. A
common way of separating enantiomers is the conversion of the enantiomers into
diastereomers that are not mirror images of each other. 1,1-Bi-2-naphthol4 can be
resolved in various ways. Here, the diol is first converted into a diester. Cholesterol
esterase is then used to hydrolyse the (S)-enantiomer of the ester, which then
precipitates from solution. The (R)-enantiomer can be obtained after the workup of
the mother liquors (Scheme 1).
OH
OH
Cl
O
TEA, Ethyl ether
O
O
O
O
O
O
O
O
OH
OH
OH
OH
Crystallization
CH3OH
CH3ONa
H2O
2
3
4
5
6
4
cholesterol
esterase
Scheme1: Separation of enantiomers of 1,1-bi-2-naphthol by resolution.
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1.1.2. Chiral auxiliary
An auxiliary is a chiral agent that is introduced to a molecule in order to create
internal asymmetric induction in a subsequent reaction, and can then be removed and
recycled. Chiral auxiliaries were introduced by E. J. Corey in 1978 with chiral 8-
phenylmenthol5 and by B. M. Trost in 1980 with chiral mandelic acid.6 An example
of a chiral auxiliary is the use of Evans auxiliaries, such as oxazolidinone 7, which
when coupled to propanyl chloride 8 to form compound 9, which can then undergo a
stereoselective aldol reaction with aldehyde7 (Scheme 2).
Scheme 2: Diastereoselective aldol condensation using chiral auxiliary 7.
Pseudoephedrine 12 can also be used as a chiral auxiliary in stereoselective
nucleophilic addition to an amide.8 The reaction between pseudoephedrine 12 and
propanoyl chloride 8 forms compound 13, which when added to benzyl bromide 14
forms 15 with high enantioselectivity. Removal of the chiral auxiliary by different
methods gives the products 16- 18 (Scheme 3).
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NH2
OH
CH3 Cl
O
N
HOH
CH3 O
Br
LDA, LiCl, THF, 0 °C
N
HOH
CH3 O
O
HO
O
H
HO
H2SO4, dioxane
LiAlH(OEt)3
N
BH3-Li+
8
14
15(R)-16
(R)-18
(R)-17
99 % ee
93 % ee
97 % ee
12 13
Scheme 3: The use of pseudoephedrine 12 in the stereoselective alkylation
of an amide.
1.2. Catalytic methods
1.2.1. Organocatalysis
Organocatalysis is a form of catalysis whereby the rate of a chemical reaction is
increased by an organic compound referred to as an organocatalyst, normally
consisting of carbon, hydrogen, sulfur and other non-metal elements.
Regular achiral organocatalysts are based on nitrogen such as piperidine as used in
the Knoevenagel condensation,9 4-dimethylaminopyridine (DMAP) used in
Introduction
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esterfications and 1,4-diazabicyclo[2.2.2]octane (DABCO) used in the Baylis-
Hillman reaction. Current interest in organocatalysis is focused on asymmetric
catalysis with chiral catalysts and this particular branch is generally referred to as
asymmetric organocatalysis or enantioselective organocatalysis. In the 1970s, the
Hajos–Parrish–Eder–Sauer–Wiechert reaction was developed (Scheme 4).
O
O
O
HN
CO2H
DMF
O
O
Me
OH
21 (93% ee)
19
20
Scheme 4: L-Proline-catalysed Hajos-Parrish-Eder-Sauer-Wiechert reaction.
In this reaction proline, a naturally occurring chiral amino acid, is the chiral catalyst
in an aldol reaction. The starting material 19 is an achiral triketone and it requires
just 3% of proline to obtain the product 21 in 93% enantiomeric excess.
A particular class of imidazolidinone compounds are suitable catalysts for many
asymmetric reactions such as asymmetric Diels-Alder reactions. These are very
useful reaction for synthesising bicyclic derivatives and can be used to synthesise
chiral building blocks. This reaction is a fundamental C-C bond forming reaction and
during this process,10-12 cyclic rings are constructed with a number of stereocenters.11
(Scheme 5).
Scheme 5: Asymmetric organocatalysis of an asymmetric Diels-Alder reactions.
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The original representative of the imidazolidinone class of compounds was derived
from phenylalanine in two chemical steps (amidation with methylamine followed by
condensation reaction with acetone) which leave the chirality intact (Scheme 6).13
Scheme 6: Synthesis of (5S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one.
1.2.2. Biocatalysis
Biocatalysis involves the use of enzymes to perform chemical transformations on
organic compounds. Most classes of enzymes can be employed as biocatalysts.14-16
Enzymes display three major types of selectivity:
Chemoselectivity; since the purpose of an enzyme is to act on a single type of
functional group.
Regioselectivity and diastereoselectivity; due to their complex three-dimensional
structure enzymes may distinguish between functional groups which are chemically
situated in different regions of the substrate molecule.
Enantioselectivity; since almost all enzymes are made from L-amino acids, enzymes
are chiral catalysts. As a consequence, any type of chirality present in a substrate
molecule is recognized upon the formation of the enzyme substrate complex. Thus a
prochiral substrate may be transformed into an optically active product and each
enantiomer of a racemic substrate may react at different rates.
In asymmetric biocatalysis the methods by which enantiopure compounds are
obtained can be divided into two different methods:
Introduction
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1. Kinetic resolution of a racemic mixture; the enzyme converts one of the
enantiomers into product at a greater reaction rate than the other enantiomer (Scheme
7).
Scheme 7: Kinetic resolution of a racemic mixture by a chiral enzyme.
2. Biocatalysed asymmetric synthesis: a non-chiral unit becomes chiral in such a way
that the different possible enantiomers are formed in different quantities. The
chirality is introduced into the substrate through the influence of an enzyme which is
enantiomerically pure (Scheme 8).
Scheme 8: Asymmetric synthesis using an enzyme contained in yeat.
1.3. Metal catalysed reactions
1.3.1. Iron catalysed epoxidation of alkenes
Beller has reported extensively on the development of iron catalysts for the oxidation
of alkenes17 and has recently published details of an asymmetric system which
employs hydrogen peroxide as the oxidant and a simple catalyst consisting of ferric
Introduction
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chloride hexahydrate (FeCl3.6H2O), pyridine-2,6-dicarboxilic acid (H2pydic), and a
carefully chosen chiral N-sulfonated ethylene diamine derivative.18,19 For the initial
investigation, trans-stilbene was used as a model substrate because of its
nonvolatility and the stability of the epoxide product. A series of chiral pyrrolidine
derivatives were used as ligands (Table 1).
Scheme 9: Epoxidation of trans-stilbene.
A closer look at the effect of different chiral pyrrolidine derivatives 32a-f as ligands
revealed a relationship between the type and size of substituents adjacent to the
chiral centre and the ee values achieved. The diphenyl-substituted 32d led to product
formation in 10% ee (Table 1, entry 4). Replacing the hydroxyl group in 32d with a
fluoride led to a much more active catalyst and increased the ee value from 10 to
17% (Table 1, entries 5 and 6). This suggested the importance of H-bonding in
addition to steric factors in the enantioselectivity-determining step. Chiral N-
sulfonated diamine derivatives ligands 34-37 were synthesized by monosulfonation
of C2-symmetrical 1,2-diamines with p-toluenesulfonyl chloride in the presence of a
base such as diisopropyl ethylamine (DIPEA). Where necessary, reductive N-
alkylation of the resulting products was carried out in the presence of a suitable
aldehyde and sodium borohydride (NaBH4), (Scheme 10).
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Table 1: Iron-catalyzed asymmetric epoxidation of trans-stilbene 30 using ligands
32a-f.
Entry Ligand,
abs. config.
R R t[h] % Conv.a % Yielda % ee b
abs. config.c
1 32a, (S) H OH 1 95 73 0
2 32b, (S) H NH2 36 60 58 1, (-)-(2S,3S)
3 32c, (S) Ph H 60 61 45 0
4 32d, (S) Ph OH 36 78 53 10, (+)-(2R,3R)
5 32e, (R) Ph F 1 100 90 16, (-)-(2S,3S)
6d 32e, (R) Ph F 14 100 98 17, (-)-(2S,3S)
7 32f, (S) F F 1 100 93 2, ( +)-(2R,3R)
a Determined by G.C using dodecane as the internal standard. bDetermined by chiral HPLC.
cDetermined by the sign of optical rotation of isolated product . dReaction at 0 C.
The influence of various ligands on the conversion and enantioselectivity of the
reaction is summarized in Table 2.
Scheme 10: General synthesis of the chiral ligands. a) R1SO2Cl, DIPEA, 0 C to r.t;
b) PhCHO, EtOH, reflux; c) NaBH4, EtOH, r.t.
Ligand 36b gave trans-stilbene oxide (-)-(2S,3S) 31 in 28% ee under the standard
reaction conditions (Table 2, entry 2).
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Table 2: Iron-catalyzed asymmetric epoxidation of trans-stilbene using ligands
36a-b and 37a-b.a
Entry Ligand % Convb % Yieldc % eed
1 100 88 26 (-)-(2S,3S)
2 100 86 28 (-)-(2S,3S)
3 100 98 36 (+)-(2R,3R)
4 100 92 41 (-)-(2S,3S)
5 100 87 42 (+)-(2R,3R)
6e (S,S)-37b
100 97 47 (+)-(2R,3R)
aSubstrate (0.5 mmol), H2O2 (1mmol), FeCl3.6H2O (5 mol%), H2pydic (5 mol%), ligand (12 mol%),
2-methylbutane-2-ol, r.t., 1h. bDetermined by G.C using dodecane as the internal standard.
cDetermined by chiral HPLC. dDetermined by the sign of optical rotation of isolated product and
chiral HPLC. eReaction at -8 to -10 C, 24 h.
Benzylation of the remaining amino group in the ligand generally resulted in further
enhancement of the product ee value. Among these N-benzyl-substituted (S,S)-37b
led to the most significant increase in ee value, giving (+)-(2R,3R) 31 in 42% ee
(Table 2, entry 5) at room temperature which improved to 47% ee when the
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temperature was lowered to -8 C (Table 2, entry 6). Interestingly, the absolute
configuration reversed upon changing from the ligand 36 series to the N-benzylated
37 ligand series.
This result suggested the existence of several catalytic species, the importance of the
specific spatial orientation of the chiral ligand imposed by a rigid aromatic system,
and the possible role of - interactions and hydrogen bonding in controlling
enantioselectivities.
To explore the scope of the reaction, a series of aromatic olefins were epoxidized in
the presence of (S,S)-37b, which was the best ligand in the model reaction in terms
of costs, selectivity, and product yields (Table 3). Among trans-stilbene derivatives,
the substrates with substituents in the para position were more reactive than the
analogous ortho or meta-substituted compounds, probably because of steric effects
(Table 3 entries 2, 3, 4 and 6). The enantioselectivities of small alkenes, such as the
styrenes, are lower than those achieved with large alkenes. The highest
enantioselectivities were obtained using sterically bulky 4,4-dialkyl-substituted
trans-stilbenes such as (E)-2-(4-tert-butylstyryl)naphthalene (38h) which gave a
product of 91% ee (Table 3, entry 8), which could be enhanced to 97% ee when the
reaction temperature was lowered to 10 C.
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Table 3: Iron-catalyzed asymmetric epoxidation of different aromatic alkenes.a
Entry Alkene % Conv.b % Yieldc % eed, abs. config.
1 100 94 28, (+)-(2R,3R)
2 100 92 64, (+)-(2R,3R)
3
100 82 81, (+)-(2R,3R)
4 60 57 55 (+)-(2S,3S)
5 100 49 48 (-)-(2S,3S)
6 95 88 27 (+)-(2R,3R)
7 91 62 14 (+)-(2R,3R)
8e
100 46 91 (+)-(2R,3R)
9f 100 40 97 (+)-(2R,3R)
aSubstrate (0.5 mmol), H2O2 (1mmol), FeCl3.6H2O (5 mol%), H2pydic (5 mol%), ligand (12 mol%),
2-methylbutane-2-ol, r.t., 1h. bDetermined by G.C using dodecane as the internal standard.
cDetermined by chiral HPLC. dDetermined by the sign of optical rotation of isolated product and
chiral HPLC. e Determined after 24h. f 10 oC, equiv H2O2, 10 mol% H2pydic, 10 mol% FeCl3. 6H2O,
24 mol% (S,S)-37b.
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1.3.2. Iron-catalyzed asymmetric epoxidation of enones
An asymmetric epoxidation of ,-disubstituted enones has been achieved using an
iron-catalysed approach. In this process, the combination of a chiral bipyridine
derivative complexed to Fe(OTf)2 directs the reaction of a peracid with enones
achieving ees of up to 91% ee in preliminary studies (Scheme 11).20 In this process
the formation of a very hindered (2:1) complex between the ligand and the iron(II)
was isolated and characterised by X-ray crystallography. This creates a bulky
catalyst with a well-defined chiral environment, however the means by which
asymmetric induction is achieved still remains unclear and is the subject of ongoing
investigations. Intriguingly, even a non-activated alkene could be epoxidised; trans-
-methylstilbene was converted to the epoxide in 50% yield and 87% ee.
Following on from a series of papers related to non-chiral alkene oxidation using
biomimetic iron/amine complexes,21 Que et al. reported in 2008 the use of a series of
C2-symmetric tetradonor ligands containing a combination of pyridyl and tertiary
amine donors.22 A difference with this system, however, was the preference for diol
products over epoxides. Of the series of five ligands tested, in combination with
Fe(II), complex 46 gave the best result for cis-dihydroxylation of trans-2-heptene
(Scheme 12). An X-ray crystallographic structure solution on complex 46 confirmed
a C2-symmetric environment around the metal, created by the tetradentate ligand. A
good result (96% ee, diol:epoxide 13:1) was achieved with trans-4-octene, whilst 1-
octene was dihydroxylated in 76% ee with a 64:1 diol:epoxide ratio. Ethyl trans-
crotonate gave a diol of 78% ee, and dimethyl fumarate a diol of just 23% ee,
indicating the loss of enantioselectivity related to electron-withdrawing groups on
the substrate.
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Scheme 11: Enantioselective epoxidation of enones.
Scheme 12: Enantioselective alkene epoxidation using a mixed pyridyl/tertiary
amine ligand.
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Other alkenes tested included allyl chloride (70% ee) and tert-butyl acrylate (68%
ee). Compounds 41-44, are epoxidised from corresponding alkenes using same
procedure.
1.3.3. Sharpless epoxidation reaction
In the last decades a great number of new catalytic asymmetric reactions have been
discovered. A good example is the asymmetric epoxidation of allylic alcohols or
Sharpless asymmetric epoxidation (SAE) or Sharpless-Katsuki epoxidation. This
was a breakthrough in asymmetric synthesis at the beginning of the 1980s (Scheme
13).23 The reaction has a wide scope and is characterized by simplicity, high
selectivity and versatility. The obtained epoxides are useful intermediates in
asymmetric synthesis.
Scheme 13: Sharpless asymmetric epoxidation of allylic alcohols.
The oxidizing agent in the above reaction is tert-butyl hydroperoxide 49 (TBHP).
Enantioselectivity is achieved by a catalyst formed from titanium tetra(isopropoxide)
and diethyl tartrate (DET). Only 5-10 mol% of the catalyst in the presence of 3Å
molecular sieves (3Å MS) is required24 for reaction of the allylic alcohol with TBHP
49 in the presence of Ti(OiPr)4 and DET to form an epoxy alcohol of high
enantiomeric purity. A typical trans-disubstituted allylic alcohol (Table 4, entries 1
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and 2) can be epoxidized at –20 C in at least 94% conversion with just 5% Ti(OiPr)4
and 6-7.5% tartarate. The reactions are quite rapid, generally reaching completion in
2-3 h. However, cis-disubstituted allylic alcohols (Table 4, entries 3 and 4) require
longer reaction times (1-2 days).
Table 4: Asymmetric epoxidation of allylic alcohols (Scheme 13).a
Entry Product Ti % Tartarate % C Time
(h)
%Yieldb %eec
1 5 (+) DET
(6.0)
-20 2.5 85 94
2 5 (+) DIPT
(7.5)
-20 3 89 98
3 10 (+) DET
(14)
-10 29 74 86
4 5 (+) DIPT
(7.4)
-12 42 63 80
5 4.7 (+) DET
(5.9)
-12 11 91 96
6 5 (+) DIPT
(7.5)
-35 2 79 98
7 5 (+) DIPT
(6.0)
0 5 65 90
8 5 (+) DIPT
(6.0)
-20 2 70 91
aAll reaction were carried out with TBHP. bYields reported are isolated yields. c Determined by GC
analysis.
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It was found that such slow-reacting substrates require more catalyst (10%) and a
slightly higher temperature than in case of trans-disubstituted allylic alcohol in order
to achieve complete reaction with minimal loss of selectivity. The unsymmetrical
disubstituted allylic alcohol (Table 4, entry 5) was amongst the best substrates, both
in terms of yield and enantioselectivity. Tri-disubstituted allylic alcohol (Table 4,
entry 6) tend to react very rapidly under these catalytic conditions. Also low
molecular weight allylic alcohols (Table 4, entries 7 and 8) at -20 to 0 C in 2-5 h
give slightly lower conversion (65-70%) but high enantioselectivity ( 90%).
1.4. BINAP/diamine-Ru enantioselective transfer hydrogenation of aromatic
ketones
Although BINAP-Ru(II) complexes such as [BINAP=2,2-
bis(diphenylphosphino)1,1-binaphthyl] have proved extremely efficient as catalyst
for asymmetric hydrogenation of functionalized ketones,25,26 they are unable to
hydrogenate simple ketones that lack heteroatoms to anchor the Ru metal. Noyori et
al27 developed a catalytic system that can hydrogenate simple aromatic ketones
(Scheme 14), this asymmetric synthesis has proven to be efficient compared to other
catalytic enantioselective reductions.28-30
Scheme 14: Hydrogenation of aromatic ketones by BINAP/diamine-Ru catalyst.
Phosphine-Ru(II) complexes are normally not very active as catalysts for
hydrogenation of acetophenone.31 In this case however, the activity of
RuCl2[P(C6H5)3]3 was remarkably enhanced with the addition of 1 equivalent of
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diamine and 2.8 mM of KOH in 2-propanol. The hydrogenation of 1-
acetonaphthone with a catalyst system consisting of RuCl-[(S)-binap](dmf)n,32 (S,S)-
1,2-diphenylethylenediamine [(S,S)-33], and KOH (1:1:2 mole ratio) in 2-propanol
(S/C=500, 4 atm of H2, 28 C, 6 h) afforded (R)-1-(1-naphthyl)ethanol in 97% ee and
99% yield. The high enantioselectivity obtained is a result of synergetistic effects
of diphosphine and diamine, which exhibit a matched asymmetric directing effect.
Replacenent of S,S diamine by the R,R enantiomer under the same conditions gave
the R alcohol in only 14% ee. A combination of the (S)-BINAP-Ru complex and
achiral ethylenediamine or achiral RuCl2[P(C6H5)3]3 and (S,S)-33 provided the R
product in 57% and 75% ee, respectively.
Figure 3: Reduction of aromatic ketones by BINAP/diamine-Ru catalyst
Using the BINAP-Ru(II)-diamine-inorganic base combined catalytic system a
variety of aromatic ketones were reduced. Diamines 33 and 54-5633-34 are the most
effective chiral controllers (Table 5). The enantioselectivity appears to be influenced
(S)-52: Ar=C6H5 (BINAP)
(S)-53: Ar=p-CH3C6H4
NH2
NH2
(S,S)-33
NH2R
NH2
(S)-54: R=CH3
(S)-55: R=(CH3)2CHCH2
(S)-56: R=(CH3)2CHO
R
57a: R=CH3
57b: R=n-C4H9
57c: R=(CH3)2CH
57d: R=(CH3)3C
O
Me
58a: R=CH3
58b: R=(CH3)3C
58c: R=CH3O
58d: R=Cl
R
PAr2
PAr2
OCH3
H3CO
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by the structure of the diamine auxiliaries as well as the substituents in the
substrates. In the reaction of alkyl/aryl ketones 57a-c, the enantioselectivity was
noticeably increased by increasing the bulkiness of the alkyl group from methyl to
primary alkyl to isopropyl. Alkyl, methoxy or chloro substituents at the meta or para
position of acetophenone increase the enantioselectivities.
Table 5: Enantioselective transfer hydrogenation of aromatic ketones catalysed by a
BINAP-Ru(II) complex-chiral diamine-KOH system.a
Entry Substrate
Chiral element Conditions Alcohol product
Phos-
phine
diamine H2
atm
Time
(h)
% yieldc % eed
abs. config.e
1 57a (S)-52 (S)-55 4 3 99 87(R)
2 57b (S)-52 (S)-54 4 3 99 90(R)
3 57c (S)-52 (S)-56 8 6 99 95(R)
4 o-58a (S)-52 (S,S)-53 4 5 99 94(R)
5 o-58d (S)-53 (S,S)-33 50 3 99 94(R)
6 m-58c (R)-52 (R)-56 8 3 99 88(S)
7 m-58d (S)-53 (S)-56 8 1 96 90(R)
8 p-58a (R)-52 (R)-56 4 3 99 91(S)
9 p-58b (S)-53 (S,S)-33 4 1.5 99 96(R)
10 p-58c (R)-52 (R)-56 4 3 99 92(S)
11 p-58d (S)-52 (S)-56 8 16 99 94(R)
12 1-NpAc (S)-53 (S,S)-33 4 16 99 97(R)
Conditions: 1.4 M of substrate (5mmol) in 2-propanol. Substrate:Ru:diamine:KOH=500:1:1:2, 11-30
C. bNp= naphthyl. cDetermined by chiral GC and 1H NMR analysis. dDetermined by HPLC analysis
using a DAICEL CHIRAL CEL OB column (eluent, 10:90 2-propanol:hexane; flow rate, 0.5
cm3/min). eDetermined by sign of optical rotation.
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The hydrogenation of ortho-methylated and chlorinated acetophenones, o-58a and o-
58d, proceeded with high stereoselectivity. The ketones m-58c-d and p-58a-d were
reduced with higher enantioselectivity than unsubstituted acetophenone 57a
highlighting the effect of the electronic properties of the substituents. In conclusion a
BINAP-Ru(II) complex-chiral diamine-KOH system acts as a very practical catalyst
for enantioselective hydrogenation of simple aromatic ketones.
1.5. Asymmetric transfer hydrogenation (ATH) of ketones by Ir(III) camphor
modified diamine ligand
Catalysis in water is a field of increasing interest in modern chemistry, as its
environmental and economic gains are potentially significant.35 Among many
reactions using water as the solvent or cosolvent which have been reported,
asymmetric transfer hydrogenation (ATH) has recently attracted a great deal of
attention.36-37 ATH provides a powerful alternative to asymmetric hydrogenation for
the catalytic reduction of ketones and imines because of its combined versatility and
practical simplicity.38-41 Among the various chiral catalysts reported for ATH
reactions, the most notable is the Ru-TsDPEN [TsDPEN =(1R,2R)-N-(p-
toluenesulfonyl)-1,2-diphenyl ethylenediamine] complex developed by Noyori,
Ikariya, Hashiguchi and co-workers.41 Xiao et al. recently reported that the ATH of
the aromatic ketones with the Ru-(R,R)-TsDPEN catalyst37a or its polymer analogue
Ru-PTsDPEN37b can be greatly accelerated using water as the solvent. Also they
reported that a camphor modified 1,2-diphenylethylenediamine ligand forms an
excellent catalyst with iridium for the ATH of ketones in neat water42 (Figure 4).
Camphorsulfonyl (Cs) has also been used as a chiral auxiliary in amine and amino
alcohol ligands to promote reactions such as enantioselective addition to aldehydes
and ketones upon coordination with copper or titanium species.43-44
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Initially the ATH was carried out at a S/C ratio of 100. Table 6 summarises the
results obtained with Ru-, Rh- and Ir-CsDPEN complexes. The reactions were nearly
complete within 0.7 h with Rh- and Ir-(R,R,R)CsDPEN (Table 6, entry 1). Using the
opposite configuration M-(S,S,S)CsDPEN complexes gave the product of opposite
configuration (Table 6, entry 2), indicating that the enantioselective reduction is
determined by the chelating amino component of the ligand.
Figure 4: Camphor modified 1,2-diphenylethylenediamine ligand.
By increasing the S/C ratio to 1000, the Ir-CsDPEN is the most effective catalyst for
the reduction of acetophenone as the reaction reaches near completion in about 2.5 h,
whereas with the other two Rh and Ru catalysts the reaction was not complete even
after 20 h. However the enantioselectivities for the three catalysts all remain as high
as when a S/C ratio of 100 is used. The Ir-(R,R,R)CsDPEN catalyst was extended to
a range of different ketones under the same conditions at a S/C ratio of 1000. Table 7
shows a summary of the results obtained.
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Table 6: ATH of acetophenone with M-(R,R,R)CsDPEN in water.a
Entry S/C Rh (III) Ru (II) Ir (III)
Time
(h)
Conv.b
%
eeb
%
Time
(h)
Conv.b
%
eeb
%
Time
(h)
Conv.b
%
eeb
%
1 100 0.7 99 99 2 99 97 0.7 98 97
2c 100 0.7 97 98 2 99 96 0.7 99 96
3 1000 20 89 99 20 95 96 2.5 97 98
aConditions: 40 C, acetophenone (1 mmol), HCOONa (5 equiv.), S/C=100, in 2 cm3, HCOONa (5
equiv.), S/C=1000, in 8 cm3. bDetermined by GC. cUsing (S,S,S)CsDPEN as a ligand, the
configuration of the product was S, whereas using (R,R,R)CsDPEN, the configuration was R.
It is noteworthy that the ATH of 1-(benzofuran-2-yl)ethanone was nearly complete
in about 45 min. with 94% ee (Table 7, entry 4), also for substrates containing
electron withdrawing substituents full conversions were achieved within a few hours.
Steric effects may play a role; ATH of 4-chloroacetophenone gave 96% ee, (Table
7, entry1), however a lower enantioselectivity of 88% ee (Table 7, entry 2) was
obtained for the ATH of 2-chloroacetophenone. Although the reactions were
performed under nitrogen no significant decrease in conversion or enantioselectivity
was observed in the ATH of 4-chloroacetophenone without nitrogen. In the case of
ATH for the electron-donating substituents, the reaction was slower in most cases,
thus for the 2- and 4-methyl substituted acetophenone, the reaction requires longer
times for completion (Table 7, entries 5 and 6).
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Table 7: ATH of aryl ketones substituents by with Ir-(R,R,R)CsDPEN in water.a
Entry Ketone Time (h) % Conv.b % eeb
1 2 50 96
2 3 98 88
3 3.1 99 96
4 0.75 99 94
5 29 84 93
6 8.5 94 92
7 21 99 85
8 22 94 97
9 50 78 86
aConditions: 40 C, acetophenone (1 mmol), HCOONa (5 equiv.), S/C=1000, in 8 cm3. bDetermined
by GC. cUsing (R,R,R)CsDPEN as a ligand, the configuration of the product was R.
Introduction
25
The 2- and 4-methoxy substituted acetophenone (Table 7, entries 7 and 8) also
required longer reaction times. The ATH of 4-methylpropiophenone was slowest,
giving only 78% conversion after a reaction time of 50 h (Table 7, entry 9).
1.6. Hydrosilylation of ketones
Asymmetric hydrosilylation represents an alternative method for the generation of
enantiomerically enriched alcohols from ketones. Iron-catalysed hydrosilylation has
been achieved using a number of catalysts45 with examples dating from 1990.
Nishiyama has published a number of findings in this area. In early work the
catalysis of ketone hydrosilylation with iron complexes of bis(oxazolinyl)pyridine
ligands was disclosed, including several asymmetric applications (Scheme 15).46 In
further extended studies on the more promising N-bridged bisoxazoline ligands such
as 67 to 70 (Scheme 15, Figure 5), the derivative 70 derived from the
diphenylmethyl-substituted amino alcohol (Bopa-dpm) proved to be the most
enantioselective when used in conjunction with iron diacetate.47 Products of up to
80% ee were formed with conversions as high as 99% in many cases (Figure 5).
Scheme 15: Asymmetric hydrosilylation of ketones using bis(oxazoline) complexes
of iron.
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The suggested mechanism involves the formation of a metal hydride and transfer of
the hydride to the ketone substrate via a complex in which the ketone is co-ordinated
to the iron.
Figure 5: Asymmetric reduction of ketones by Fe(OAc)2/BPA-dpm complexes.
1.7. Henry reaction
The Henry (nitroaldol) reaction is an efficient C-C bond forming reaction. This
reaction allows a stereogenic centre to be generated at the β-position to the nitro 
functionality. The resulting β-nitro alcohol products can be converted to α-hydroxy 
ketones. Both products are very useful as chiral building blocks for natural products.
Due to the recent development of asymmetric organocatalysis, research groups have
focused on asymmetric versions of the Henry reaction. In earlier work, metal
complexes have been combined with different chiral ligands.48 Recently chiral
ligands with Cu salts have been found to be very promising in this application
(Scheme 16).49-50
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Scheme 16: Chiral ligands developed for Henry reactions.
1.8. Asymmetric transfer hydrogenation
Asymmetric transfer hydrogenation (ATH) can be defined as the reduction of
prochiral compounds with a hydrogen donor other than hydrogen gas in the presence
of a chiral catalyst (Scheme 17).51 It is generally regarded as a safer and more
practical alternative to hydrogenation since high pressures of hydrogen gas are not
required.
DH2 +
R R
X
R R
XH
D +
Catalyst
Scheme 17: A transfer hydrogenation reaction where X = O, NR or CR2,
DH2 = hydrogen donor.
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1.8.1. The Meerwein-Ponndorf-Verley reduction
The first reported example of a transfer hydrogenation reaction was the Meerwein-
Ponndorf-Verley (MPV) reduction which was independently reported by Meerwein
and Schmidt,52 Ponndorf53 and Verley54 in the mid 1920s. It was found that a
stoichiometric amount of an aluminium alkoxide reagent would facilitate the transfer
of hydrogen from 2-propanol to aldehydes and ketones to give the corresponding
primary and secondary alcohols selectively. Over a decade later, Oppenauer reported
the reverse reaction, where alcohols were oxidised to aldehyde and ketones by
aluminium tert-butoxide using acetone as the hydrogen acceptor (Scheme 18).55
Scheme 18: The MPV reduction and Oppenauer oxidation reaction.
The reaction is thought to proceed through a six-membered cyclic transition state
in which the hydrogen donor is coordinated to the aluminium centre as an alkoxide
and the hydrogen acceptor is coordinated by a Lewis acidic interaction. Direct
hydride transfer from the donor to the acceptor takes place to give an alkoxide
product which is released from the metal by an alcoholysis reaction with the bulk
solvent (Figure 6).
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Figure 6: Mechanism of the MPV reduction.
1.8.2. Ligand used in ATH
The chiral catalysts used in this reaction most often consist of a transition metal ion
in combination with chiral ligands.56 However in recent years simple organic chiral
catalysts have also been used for this particular transformation.57
Figure 7: Chiral ligands used in ATH reaction.
Among the most active and selective catalysts reported so far are those containing
the ligands diphosphonite 88,58 pyridine derivative 89,59 amino alcohol 9060 and aza-
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norbornyl alcohol 91,61 as well as complexes 9262 and 93,63 which are based on
monotosylated diamine ligands.
Bidentate phosphorus donor ligands generally work better in enantioselective
hydrogenation reactions than in asymmetric hydrogen transfer reactions. An
exception is ligand 88, which has a large bite angle and generates a highly efficient
and selective catalyst for ketone reductions under transfer hydrogenation conditions
when used together with [Ru(p-cymene)Cl2]2.58,64
The pyridine-derived ligand 89 binds in a pincer-type fashion when coordinated to
[RuCl2(PPh3)3]. When this complex is combined with a chiral diphosphine ligand,
the catalyst formed shows astonishingly high turnover frequencies at loadings as low
as 0.005 mol%.59
Amino alcohols and monotosylated diamine ligands are normally used together with
Ru, Rh or Ir complexes to form bifunctional catalysts.56 In a bifunctional catalyst,
besides inducing enantioselectivity, the chiral ligand accepts and donates a proton
with its basic nitrogen, whereas the hydride is received and delivered by the
transition metal, as illustrated in Scheme 19.65
Figure 8: Chiral ligands derived from TsDPEN used in ATH reaction.
Complex 92, developed and thoroughly studied by Noyori, is perhaps the most well
known and successful catalyst for asymmetric transfer hydrogenation.66 The tethered
version of this catalyst 93, shows enhanced activity and selectivity in several cases
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over the untethered diamine due to the locked conformation of the arene providing
by the tether.63
Scheme 19: Formation of the complex hydride.
The class of substrates that can be highly selectively reduced by catalysts containing
Ru, Rh or Ir complexes is limited to aryl alkyl ketones. The high selectivity
associated with these reactions is attributed to a stabilizing dipolar interaction
between the arene-CH of the catalyst (e.g. p-cymene) and the π-system of the 
substrate. 67 When reducing dialkyl ketones in hydrogen transfer reactions, the
resulting enantioselectivities have so far been rather moderate. The only exceptions
are the ruthenium catalysts based on either a β-cyclodextrin coupled amino alcohol 
ligand presented by Woggon and co-workers,68 or ligand 88 developed by Reetz,
which have shown promising selectivities for this transformation.58,64
1.8.3. Hydrogen donors in ATH
Isopropanol (IPA) and formic acid (FA)/triethylamine (TEA) are by far the most
commonly used sources of hydrogen in transfer hydrogenation. During the process,
IPA is oxidized to acetone (Scheme 20).
Scheme 20: Transfer hydrogenation using isopropanol as source of hydrogen.
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This makes the reduction of ketones by IPA a reversible process. To shift the
equilibrium towards the desired product IPA is most frequently used as the solvent
of the reaction as the life-time of many metal catalysts in IPA solution is usually
reasonably long even at reflux temperature to allow most reactions to be driven to
high conversions. When IPA is the hydrogen donor a base is usually required for the
activation of the starting complex for catalysis. Sodium or potassium carbonates,
hydroxides or alkoxides at various concentrations have been employed for this
purpose. Quite few catalytic precursors do not require any base (Shvo catalyst,
Figure 9)69 or need just two equivalents for metal atom (Noyori’s and similar
catalysts).70
Although IPA is environmentally friendly and easy to handle, the reversibility of the
reaction remains a major drawback in asymmetric hydride transfer. At low
conversions the reaction is kinetically controlled and the stereoselectivity may be
high. As the conversion increases, the rate of the reverse reaction becomes higher
and the ratio of enantiomers falls under thermodynamic control with gradual loss of
the enantiomeric purity of the product. This limitation can be overcome by
continuously distilling off the acetone as soon as it is formed or by operating in
dilute solution.
Figure 9: Shvo catalyst.
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Formic acid and its salts are better suited hydrogen donors than IPA because their
dehydrogenation in open systems is substantially irreversible due to the evolution of
CO2 (Scheme 21).71
Scheme 21: Transfer hydrogenation using formic acid as source of hydrogen.
An azeotropic 5:2 mixture of FA and TEA is most frequently employed as the
reducing agent. This gives a single phase at room temperature; it is miscible with
many solvents at 20–60 C; it allows for high substrate concentrations to give high
conversions without back-reaction and racemization. There are however some
restrictions to the use of FA/TEA; several complexes undergo fast decomposition on
attempted dissolution in formic acid and some other ones lose their catalytic activity
completely probably because the acid inhibits one of the steps of the activation
process promoted by the base.
1.8.4. Factors affecting Enantioselectivity in ATH
In asymmetric transfer hydrogenation the stable complex 92 has been used, which
can be easily prepared in situ or isolated by reaction of [Ru(arene)Cl2]2 with chiral
ligands such as TsDPEN.
Figure 10: Complex 92 and intermediates formed during catalytic cycle.
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Complex 92 is a precatalyst, as during the reaction it is converted into the 16 electron
species 94 by reaction with KOH in toluene. The 16 electron species reacts with IPA
to give the hydride form of the catalyst 95.69 The enantioselectivity may arise due to
a stereodetermining transition state with electronic influences around the metal
centre and also via space interactions between the catalyst and substrate. The
transition state structure was studied by hybrid density functional theory (DFT)-
based calculations for compound 95. This study has revealed that enantioselectivity
originates not only from the well-defined cyclic transition state but also through a
CH/π interaction of η6-arene of the complex and the aryl group of the substrate as
shown in Figure 11.73-74
Andersson et al. also reported the DFT calculation for three different mechanistic
models for the asymmetric transfer hydrogenation with Ru(arene)-aminoalcohol, (A)
direct transfer of hydrogen of an alcohol to the carbonyl carbon of a ketone, (B)
migratory insertion (MI) of a coordinated ketone into a metal hydride bond, or (C) a
concerted mechanism where a proton and a hydride are transferred simultaneously to
the ketone (Figure 12).75 The computational data has shown that the six membered
transition state has a strong preference for planarity.
Figure 11: CH/π interaction in asymmetric transfer hydrogenation of ketones.  
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The planarity of the transition state is also dependent on the conformational behavior
of the O,N-linkage of the amino alcohol ligand.75 In 2004, Brandt, Roth and
Andersson reported more experiments which provide an insight into the asymmetric
transfer hydrogenation of ketones.76 They reported asymmetric transfer
hydrogenation of different substituted aliphatic and aromatic ketones and used the
data for DFT calculations.
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Figure 12: Possible model for transfer hydrogenation between metal hydride and
ketones.
Both experimental and computational data were found which provided additional
support for the interaction between the substrate phenyl ring and metal arene ring,
which is in contrast to aliphatic ketones. At the same time, enantioselectivity in
transfer hydrogenation of ketones is also influenced by steric, electrostatic,
dispersion and solvent effects.76 As a result excellent enantiomeric excesses are
observed for substrates containing a combination of aryl and alkyl substituents on
the carbonyl group. For substrates not fitting this model, enantioselectivities are
frequently lower and unpredictable, although there are examples of alternative
asymmetric transfer hydrogenation catalysts which have a broad substrate range.76
Noyori also investigated the effects of having electron-donating/withdrawing groups
on the aryl substituent of the substrate, and its effects on the enantioselectivity. It
was discovered that electron-donating substituents on the aryl group increase the
enantioselectivity due to an enhanced CH accepting ability by the electron rich
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aromatic ring, while electron withdrawing substituents reduce the
enantioselectivity.77-79 Wills and co-workers80 had investigated the anti-orientation,
and the importance of 1,2-disubstitution pattern of phenyl groups in TsDPEN on the
rate and the stereo-outcome of Ru(II) catalysed ATH reactions. It was discovered
that ligand 36b was the best ligand for Ru(II) catalysed transfer hydrogenation
reduction in-terms of rate and enantioselectivity in comparison to ligands 98-100,
giving 57a in 100% conv., 98% ee (R) at 28 °C in 22 h. Identifying the importance
of having matching stereogenic centres and trans orientation of the phenyl groups,
provides an extra element of stereo control and rate enhancement (Scheme 22).
Scheme 22: ATH reduction of 57a, using ligands 36b, 98-100 in conjunction with
Ru(p-cymene)Cl2]2 (S/C = 200).
1.8.5. Mechanistic studies
Noyori proposed the metal ligand bifunctional catalytic mechanism shown in Figure
13, which functions through a concerted transfer of a hydride and proton. It is
sometimes referred to as the “outer sphere” mechanism because of the substrate
having no direct contact with the metal centre.
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Figure 13: ATH reduction mechanism of ketones using catalyst 92.
The process is initiated by the elimination of HCl from the 18 electron “precatalyst”
complex 9281 upon treatment with an appropriate base (KOH in IPA, TEA if formic
acid is used as hydrogen donor). This results in the formation of the active 16
electron species 94 , that gains two hydrogens from the hydrogen donor (IPA or
formic acid) to give the 18 electron species 95 and acetone or CO2 as a side product.
The kinetic isotope effect for the dehydrogenation of isopropanol was investigated
by Casey et al,82 showing that hydride and proton transfer takes place
simultaneously, which is in agreement with what Noyori has shown. In a concerted
process the hydride and the proton are then transferred to the ketone asymmetrically
via a six-membered transition state giving the product and also regenerating the
active 16 electron species 94 to complete the cycle. In contrast to the bifunctional
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TsDPEN-Ru catalysts developed by Noyori, the orientation of approach may be
dominated by a favourable π/π interaction between the arene group in the ligand and 
the aromatic substituent on the respective ketone.
Noyori et al isolated and characterised the three key intermediates (92, 94 and 95)
using X-ray crystallography. They also proved that the role of the base is only to
generate the active 16 electron species from 92,81 as after isolation 94 and 95 were
both tested for the reduction of ketones, giving results comparable to the in situ
formed complex. This also eliminated the possibility of the direct hydrogen transfer
mechanism, as this would require the participation of the ruthenium isopropoxide
intermediate. Further investigation carried out by Noyori83 and Andersson84
confirmed this.
1.8.6. Substrates scope for transfer hydrogenation
Substrates for transfer hydrogenations are typically carbon-carbon double bonds,85
carbon-oxygen double bonds in ketones and aldehydes85, and carbon-nitrogen double
bonds in imines.85
1.8.6.1. Aryl alkyl ketones
Aromatic ketones are the most commonly used substrates in asymmetric transfer
hydrogenation reduction, especially using monotosylated diamines or -amino
alcohol ligands. A variety of aromatic ketones were reduced using catalyst (S,S)-
105.86 ATH reactions were carried out using 2M solution of substrate in a 5:2
FA/TEA azeotrope. A range of aromatic ketones can be reduced to the secondary
alcohols with a high yield and satisfactory enantioselectivity (S/C=200), in FA/TEA
at 28 C, giving the resulting secondary alcohols with the excellent yields and
enantioselectivities (Scheme 23, Table 8).
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Scheme 23: A range of aryl ketones were reduced using (S,S)-105.
Table 8: A range of aryl ketones were reduced using (S,S)-105a
Entry Substrate Catalyst 105 Time/h % yieldb % eec abs. config.d
1 57a S,S 20 99 98 S
2 m-58d S,S 21 99 97 S
3 p-58d S,S 24 99 95 S
4 p-102 S,S 14 99 90 S
5 m-58c S,S 50 99 98 S
6 p-58c S,S 60 99 97 S
7 103 S,S 60 96 97 S
8 104 S,S 90 99 95 S
aThe reaction was carried out at 28 C using a ketone (5.0 mmol) in FA/TEA mixture (5:2, 2.5 cm3),
S/C = 200. bDetermined by GC or 400 MHz 1H NMR analysis. cDetermined by chiral HPLC.
dDetermined by the sign of optical rotation of the isolated product.
The justification for why the reductions proceed with excellent enantioselectivities,
is due to the CH/ interaction between the Ru-arene ring and the aryl group on the
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ketone, along with the favourable diastereomeric transition state extracted by the
monotosylated diamine ligand.
The pyridine bridged compounds 106-111 were employed for enantioselective
reduction of ketones using Sn(OTf)2 and polymethylhydrosiloxane (PMHS) as the
reducing agent, This process is related to the hydrosilylation of ketones.
Figure 14: Hydrosilylation of ketones by pyridine ligands.
Table 9: Reduction of acetophenone to 1-phenylethanol with tin(II) triflate (10
mol%)/106-111 (10 mol%), and PMHS (200 mol%).
Entry Ligand % Conversion % ee Config.
1 106 95 58 R
2 107 78 54 S
3 108 50 13 S
4 109 30 44 R
5 110 50 58 R
6 111 82 0 -
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Among these ligands compound 106 gave a good conversion (95%) over a period of
12-14 h, but enantioselectivity was quite low (58% ee) for reduction of acetophenone
(Table 9).87
Recently Zhengkun88 et al reported versatile unsymmetrical pyridyl-based NNN
ligands and their active Ru(II) complexes 112-115 for the ATH of ketones. Results
of ATH for acetophenone, 3-bromoacetophenone and 3-chloroacetophenone in
presence of the iPrOK base in 2-propanol using these ligands are summarised in
Table 10.
Figure 15: ATH of ketones by pyridyl-based NNN ligands.
Acetophenone was reduced to the corresponding alcohol at 40 C in 98% yield and
36% ee within 60 min by using 0.5 mol% 112 as the catalyst, whereas 113 exhibited
a much lower catalytic activity (Table 10, entry 1 and 2). Complex 114 showed
higher catalytic activity, reaching 93-96% yields and 90-93% ee over a period of 8-
10 min at 30-40 C (Table 10, entry 3 and 4). Although complex 115 also exhibited
good catalytic activity, the desired product was only formed with poor enantiopurity
(23% ee). These results suggest that the convertible NH group in the ligand has a
remarkable enhancing effect on the catalyst activity (Table 10, entry 1-5). Complex
114 gave better catalyst activity, this may be because it could be easily converted
into the coordinatively unsaturated 16-electron complex in situ under the basic
conditions,89-90 which were then transformed into the catalytically active RuH species
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and thus facilitated the catalytic reaction. Next the ATH of various aromatic ketones
was explored under optimal reaction conditions, 30-40 C, with 0.3-0.4 mol% 114 as
the catalyst (Table 11). At 40 C and with 0.3 mol% 114 as the catalyst,
propiophenone, 3-methylacetophenone, and 2-bromoacetophenone were reduced to
the corresponding alcohols in 95-99% yields with 90-97% ee within 5-45 min,
reaching final TOFs of up to 3960 h1 (Table 11, entries 1, 3 and 4).
Table 10: ATH of ketones catalysed by complexes 112-115.a
Entry Ketone Catalyst
(mol%)
T (C) t (min) %Conv.b %
eeb
abs.
Config.c
1 57a 112 (0.5) 40 60 98 36 R
2 57a 113 (1.0) 40 120 94 27 R
3 57a 114 (0.3) 40 8 96 93 S
4 57a 114 (0.4) 30 10 93 90 S
5 57a 115 (0.4) 30 15 97 23 R
6 116 114 (0.3) 40 5 99 84 S
7 116 114 (0.4) 30 10 98 85 S
8 m-58d 114 (0.4) 30 20 97 84 S
aConditions: ketone (2.0 mmol); 0.1 M in 20 cm3 iPrOH, iPrOK/cat. = 20:1; N2 (0.1 MPa).
bDetermined by GC analysis using a chiral column -DEX 225. cDetermined by the sign of optical
rotation of isolated product.
2-Methylacetophenone and chloro, bromo-substituted acetophenone reached 97-
98% yield with 73-98% ee for their reduction over a period of 5-20 min (Table 11,
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entries 2 and 5-7). Surprisingly 2-trifluoromethylacetophenone gave the desired
product in 99% yield and 99% ee (Table 11, entry 8).
Table 11: ATH of ketones catalysed by complex 114.a
Entry Ketone t (min) %Conv.b % eeb Final TOF
1 40 96 93 480
2 5 97 98 2910
3 45 95c 90 423
4 5 99d 97 3960
5 10 98 85 1470
6 20 98 96 735
7 20 97 84 728
8 10 99e 99 743
9 20 99 77 743
aKetone (2 mol%; 0.1 M in 20 cm3 iPrOH), iPrOK/cat. = 10:1; N2(0.1 MPa), 30 C.
bDetermined by chiral GC. c114 (0.3 mol%), 40 C, d114 (0.6 mol%. e114 (0.8 mol%). All the
configuration are S.
1.8.6.2. Dialkyl ketones
Dialkyl ketones have proven to be more difficult substrates for transfer
hydrogenation due to the loss of the directing effect of the -face interaction between
aryl groups on the substrate and the catalyst.91 Selective hydrogenation can be
performed however, if there is a large difference between the steric bulk on one side
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of the ketone compared to the other.91 The steric interaction between the aryl ring on
the catalyst and a bulky alkyl group on the substrate can be enough to create
selectivity in the reaction. The product of this type of directing interaction is of the
opposite configuration compared to the product of a -face interaction, due to steric
interaction pushing the bulky alkyl group away from the aryl ring, whilst the -face
interaction pulls the aryl group towards the phenyl ring.91
A successful example of the reduction of dialkyl ketones by ATH has been reported
by Zhang92,93 and Hidi94, in which reduction of dialkyl ketones 117 and 118 was
carried out using ferrocene based complex [Ru(PPh3)(oxazolinyl
ferrocenylphosphine)Cl2] 119 and sodium isopropoxide in isopropanol at 50 C. This
gave 117 in 99% ee and 81% conv., in 16 h, and 118 in 98% ee and 78% conv., in 3
h (Scheme 24).94
Scheme 24: ATH reduction of dialkyl ketone 117 and 118 using complex 119.
1.8.6.3. Cyclic α,β-unsaturated ketones  
The reduction of -phenyl substituted cyclohex-2-en-1-one 120, catalysed by
complex (S,S)-123 gave the allylic alcohol 120 in a modest yield and
enantioselectivity (Scheme 25, Table 12, entry 1).95 Excellent enantioselectivities
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were obtained for the reduction of cyclic enones 121 and 122, which were reduced to
the allylic alcohols 121 and 122 with enantioselectivities of 99%, and reasonable
yields (Table 12, entries 2 and 3).95
Scheme 25: ATH of cyclic α,β-unsaturated ketones. 
Table 12. ATH of cyclic α,β-unsaturated ketones catalysed by complex (S,S)-123.
Entry Ketone % Yield % ee
1 120 47 72 (R)
2 121 78 99 (R)
3 122 54 99 (R)
1.8.6.4. , -Acetylenic ketones
Asymmetric reduction of ,-acetylenic ketones has also been shown to demonstrate
high reactivity and enantioselectivity in ATH catalysed by complex 123. The phenyl
substituted acetylenic ketone 124 was reduced by (S,S)-123 to afford alcohols (S)-
124 in 97% ee and 99% yield using isopropanol as a hydrogen donor (Scheme 26).
However, when the FA/TEA system was used as a hydrogen source in the same
reduction, the reactivity of the catalyst diminished with (S)-124 obtained in 91% ee
but only 55% yield with a 20 h reaction time.96
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Scheme 26: ATH of 124 catalysed by (S,S)-123.
Other acetylenic ketones which contained a pre-existing stereogenic centre such as
125 may also be employed as a substrate in ATH. Both diastereomers of 125 can be
accessed by using (R,R)- or (S,S)-123 giving (3S,4S)-125 in 99% ee and 97% yield
when (R,R)-123 is employed. Similary when (S,S)-123 is used as the catalyst,
(3R,4S)- 125 is achieved in 99% ee and 97% yield (Scheme 27).96
Scheme 27: ATH of ,-acetylenic ketones containing a stereogenic centre.
1.8.6.5. Heterocyclic ketones
Chiral heterocyclic alcohols are useful intermediates for the synthesis of biologically
active molecules, novel chiral ligands and natural products (Scheme 28). In 2000,
Ikariya reported the reduction of 2-pyridyl alkyl ketone 126 using compound 92 with
a high yield of up to 97% and high enantioselectivity of up to 95% ee using
FA:TEA.97 Interesting results were also obtained for compound 128 which converted
to alcohol 129.
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Scheme 28: Asymmetric transfer hydrogenation of heterocyclic ketones.
1.8.6.6. Imines
The synthesis of chiral amines in pharmaceuticals and agrochemical substances is
highly demanding, and requires efficient catalytic asymmetric reduction of imines.
Noyori reported the first highly efficient asymmetric reduction of a range of imines,
using suitably designed chiral Ru(II) complexes 141-144 in FA/TEA (5:2) mixture
under mild conditions. The reactions worked best in aprotic solvents including
MeCN, DMF, DMSO and CH2Cl2, but not in ethereal or alcoholic media, and neat
FA/TEA due to slow reaction rate. The structure of the aryl group and the
substitution pattern of η6-arene ligand on the Ru complex were fine-tuned depending
on the substrates used. The ATH of imine 130 was most successful, using (S,S)-141
(S/C = 200) in FA/TEA (5:2) and acetonitrile at 28 °C, giving salsolidine 130 (R) in
95% ee and >99% yield in 3 h. Various other cyclic imine derivatives 131-134 were
reduced giving excellent conversions (up to >99%) and enantioselectivities (up to
95%). This method was further applied to the reduction of indoles 135-136, giving
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good yields (up to 89%) and excellent enantioselectivities (up to 97%), and the
reduction of acyclic imines 137-140, which gave good conversions (up to 90%) but
were less stereoselective (ees of up to 89%) (Scheme 29, Table 13).98
Scheme 29: ATH reduction of imine derivatives using catalysts 141-144.
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Table 13: ATH reduction of imine derivatives using catalysts 141-144.a
Imine Catalyst S/C Solvent Time(h) %Yieldb %eeb Config.c
130 (S,S)-141 200 CH3CN 3 99 95 R
130 (S,S)-141 1000 CH3CN 12 97 94 R
131 (R,R)-142 200 DMF 7 90 95 S
132 (R,R)-142 200 CH2Cl2 12 99 92 S
133 (S,S)-144 200 CH2Cl2 8 99 84 R
134 (R,R)-144 100 CH2Cl2 12 99 84 S
135 (S,S)-141 200 DMF 5 86 97 R
135 (S,S)-141 1000 DMF 12 89 93 R
136 (S,S)-141 200 DMF 5 83 96 R
137 (S,S)-143 200 CH2Cl2 36 72 77 S
138 (S,S)-144 100 CH2Cl2 6 90 89 S
139 (S,S)-144 100 CH3CN 12 82 85 S
140 (S,S)-144 100 CH3CN 5 84 88 S
a(S/C = 200) in FA/TEA (5:2) and acetonitrile at 28 °C. bDetermined by chiral GC. cDetermined by
the sign of optical rotation of isolated product and chiral HPLC.
1.8.7. Tethered complxes for transfer hydrogenation
One of the most successful modifications to the Noyori TsDPEN in recent years has
been the synthesis of tethered ligands.99-101 These complexes contain connecting
carbon linker between the chiral ligand and the phenyl ring. This linkage creates a
tridentate ligand, where previously a bidentate and a monodentate ligands was used.
This tridentate ligand improves the stability and longevity of the catalyst and
subsequently the activity and enantioselectivity of the reaction.99-101 The tethered
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complexes (R,S)-145, (R,R)-146 and (R,R)-93 have all been synthesised and used for
the ATH of ketones.
Figure 16: Tethered complexes for ATH.
Investigations have indicated that the length of the carbon tether between the chiral
portion of the ligand and the phenyl ring has a large effect on the selectivity of the
catalyst.99 If the tether is too short then the phenyl group cannot sit on the top of the
metal centre and the complex does not form. Conversely, if the tether is too long, the
activity of the catalyst is also decreased.99
1.9. Summary
Various methods for epoxidation of different substrates, including alkenes, enones
and allylic alcohols have been outlined, high conversions and enantioselectivities
were obtained.
Chiral ligands and metal complexes developed for asymmetric transfer
hydrogenation of ketones and imines have been discussed. Of these, 1,2-
monotosylated diamine and -amino alcohol ligands were found to be the most
effective for this process when incorporated with a metal (arene) system as
developed by Noyori. Mechanistic studies revealed that the ATH by such system
operate via the metal ligand bifunctional catalysis mechanism through a concerted
transfer of a hydride and a proton with no direct coordination of the substrate to the
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metal centre of the catalyst. Theoretical and experimental data found that the origin
of the enantioselectivity for the reduction of aryl/alkyl ketones by these systems is
due to the CH/ attractive interaction that exist between the arene ligand on the
metal of the catalyst and the aryl substituent on the substrate which afford highly
optical active product. Asymmetric transfer hydrogenation using η6-arene-Ru-
complexes was found to be highly efficient and selective for a range of substrates
such as aryl alkyl ketones, heterocyclic ketones, ,-acetylenic  ketones, cyclic α,β-
unsaturated ketones and imines.
1.10. Aims and Objectives
The aim of this project is the synthesis of novel chiral di-, tri- and tetra amine
ligands, together with their ruthenium and iron metal complexes and the subsequent
investigation of their application as asymmetric catalysts.
Specifically, a series of chiral di-, tri- and tetra amines ligands based on a
combination of camphor compounds and diamines (such as 175 and 187), a
combination of 2-formylbenzenesulfonic chloride and diamines (such as 196 and
204) were synthesised and, in conjunction with Ru(II) or Fe(II), employed as
asymmetric catalysts. The synthesized ligands were studied for optimization of
reaction conditions and stereoselectivity for a range of different asymmetric
reactions including as epoxidation, hydrosilylation and asymmetric transfer
hydrogenation.
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Also a novel class of tridentate ruthenium catalysts of general structure below were
developed and employed as asymmetric catalysts in different applications including
ATH of a number of ketones.
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2. Results and discussion
2.1. Iron-catalyzed asymmetric epoxidation of aromatic alkenes using hydrogen
peroxide.
Among commonly available oxidants, hydrogen peroxide is one of the most practical
reagents in terms of cost and atom efficiency. In this respect the work of Beller et
al.,102 who developed a convenient catalyst consisting of ferric chloride hexahydrate
(FeCl3.6H2O), pyridine-2,6-dicarboxylic acid (H2pydic), and organic base, for
epoxidation of aromatic alkenes, is most notable. In order to gain experience in
asymmetric processes using iron catalysts, this reaction was selected for further
investigation. New ligands and additives were applied to the reaction in order to
identify the ideal features required in a good catalytic system.
2.1.1 Synthesis of (R,R)-N-(2-benzylamino-1,2-diphenyl-ethyl)-4-
methylbenzenesulfonamide 37b
For initial tests, the reported asymmetric epoxidation reported by Beller was selected
for investigation. The key ligand required was prepared by reacting (R,R)-TsDPEN
36b with benzaldehyde 147 in methanol. The imine formed was then reduced by
NaBH3 CN to give N-BnTsDPEN 37b (Scheme 30).
Scheme 30: Reaction scheme illustrating the synthesis of compound 37b.
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2.1.1.1 Optimisation of the reaction conditions for epoxidation
To optimise the reaction conditions, the epoxidation of trans-stilbene to trans-
stilbene oxide under published conditions was repeated and the product isolated in
88% yield (100% conversion) with 40.6% ee (2S,3S) (Scheme 31, Table 14). This
closely matched the reported results.
Scheme 31: The asymmetric epoxidation of trans-stilbene.
In the asymmetric epoxidation reaction of trans-stilbene to trans-stilbene oxide,
reducing the amount of ligand to 6 mol% resulted in 62% conversion to product
(Table 14, entry 2) and no epoxide was formed without adding H2pydic (Table 14,
entry 3). Usually, 1 mmol of aqueous (30%) H2O2 dissolved in 2-methyl butan-2-ol
was added to the reaction mixture over one hour using a syringe pump. In some
cases (Table 14, entry 4) the reactants were dissolved in the total amount of the
solvent (2-methyl-butan-2-ol), stirred for 30 min., then 1 mmol of H2O2 was added in
one portion. After completing the reaction, essentially the same conversion and ee
value (~50% ee) was obtained. Many solvents were examined in the epoxidation
reaction and gave products with the following conversions; dichloromethane (0%),
2-propanol (78%), ethanol (20%), 1-butanol (27%) and 2-butanol (77%). Their
conversion efficiency followed the order: 2-methyl-2-butanoltert-butanol
acetonitrile2-propanol. H2pydic is crucial for the reaction to occur and at least 10%
of the ligand 37b is needed to obtain full conversion (Table 14).
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Table 14: Epoxidation of trans-stilbene.a
Entry H2pydic
(xmol%)
Solvent (%) Conv.b (%) eec Remarks
1 5 2-Methyl-2-butanol 100 41 (S,S)
2 5 2-Methyl-2-butanol 62 n/od 6 % ligand
3 0 2-Methyl-2-butanol 0 -
4 5 2-Methyl-2-butanol 100 50 (S,S) H2O2 added
together
5 5 Dichloromethane 0 n/od
6 6 2-Propanol 78 34 (S,S)
7 5 Ethanol 20 n/od
8 5 1-Butanol 27 n/od
9 5 2-Butanol 67 n/od
10 5 tert-butanol 92 44 (S,S)
11 6 Acetonitrile 91 39 (S,S)
a30 (0.5 mmol), H2O2 (1mmol), H2pydic (x mol%), FeCl3 6H2O (5 mol%), ligand (12 mol%), solvent
(10 cm3), r.t., 1 h.bDetermined by H1 NMR. cDetermined by HPLC on a chiral column. dNot obtained.
To identify alternative additives and substrates for the asymmetric epoxidation
reaction, several additives (in place of the H2pydic) and varying conditions (Table
15) were examined including pyridine, benzoic acid, pyridine-3-carboxaldehyde, 2-
picolinic acid, isonicotinic acid, nicotinic acid, L-proline and 2,6-pyridine dicarbonyl
dichloride.
These additives were selected in order to establish which groups were essential for
promotion of the reaction. Most of the compounds gave products in low conversion;
only pyridine compounds with a carboxylic acid group substitution in the ortho
position (2-picolinic acid) gave encouraging results that enhanced with increasing
concentration (88%, but low %ee, Table 15, entry 9). This suggests that the
carboxylic acid may be coordinating to the metal in some way, possibly chelating
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with the pyridine group adjacent to it. Figure 17 shows the structures of the additives
used in the epoxidation reaction.
Table 15: Comparison of some additives used in the epoxidation of trans-stilbene .a
Entry Additive (x) x( mol%) (%)Conv.b (%) eec
1 Pyridine (149) 5 12 n/od
2 Benzoic acid (150) 5 6 -
3 Pyridine-3-carboxaldehyde (151) 5 13 -
4 2-Picolinic acid (152) 5 44 -
5 Nicotinic acid (153) 5 7 -
6 Isonicotinic acid (154) 5 6 -
7 L-proline (155) 5 0 -
8 2-Picolinic acid (152) 8 71 -
9 2-Picolinic acid (152) 12 88 2 (S,S)
10 2,6-Pyridine dicarbonyl dichloride
(156)
5 15 n/od
a30 (0.5 mmol), H2O2 (1mmol), Additive (x mol%), FeCl3 6H2O (5 mol%), ligand (12 mol%),
2-methyl-2-butanol (10 cm3), r.t., 1 h.b Determined by H1 NMR, cDetermined by HPLC on a chiral
column. dNot obtained.
Figure 17: Structure of some additives used for the epoxidation of trans-stilbene.
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2.1.1.2. Other ligands investigated for epoxidation reaction
Investigations into the epoxidation of trans-stilbene to trans-stilbene oxide by using
30% H2O2 as the oxidant were carried out. The catalyst system consisting of an iron
salt (FeCl3 6H2O) and H2pydic was extended using chiral ligands derived from N-
sulfonated diamines. The ligands were synthesized by monosulfonation of C2-
symmetrical 1,2-diamines with p-toluenesulfonyl chloride in the presence of a base
such as triethylamine (TEA).
Figure 18: Structure of ligands used for the epoxidation of trans-stilbene.
Where necessary, reductive N-alkylation of the resulting products was carried out in
the presence of a suitable aldehyde and sodium borohydride (157, 158, 159, 160,
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161, 162, 163 and 167). Monobenzylation of N-(2-amino-1,2-diphenyl)-4-methoxy-
benzenesulfonamide was also carried out to give 164. The combination of (R,R)-
TsDPEN and 1,2-dibromoethane was used to form 165. Reaction of (R,R)-TsDPEN
and 2,6-pyridinedicarbonyl dichloride gave 166, dibenzylation of DPEN gave 168
and tosylation of (R,R)-(−)-N-p-tosyl-1,2-cyclohexanediamine gave 169.
Table16: Comparison of ligand efficiency used in the epoxidation of trans-stilbene .a
Entry Ligand % Conv.b % eec
1 157 100% 31% (S,S)
2 158 100% 50% (S,S)
3 159 42% n/od
4 160 18% -
5 161 23% -
6 162 41% 7% (S,S)
7 163 89% 36% (R,R)
8 164 95% 44% (R,R)
9 165 14% n/od
10 166 38% -
11 167 100% 9% (R,R)
12 168 71% 38% (S,S)
13 169 94% 16% (R,R)
a30 (0.5 mmol), H2O2 (1mmol), H2pydic (5 mol %), FeCl3 6H2O (5 mol %), ligand (12 mol %), 2-
methyl-2-butanol (10 cm3), r.t., 1 h.bDetermined by H1 NMR. cDetermined by HPLC on a chiral
column. dNot obtained.
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Figure 18 shows the structure of ligands used for the epoxidation of trans-stilbene,
the influence of various ligands on the epoxidation reaction is summarized in Table
16. It is obvious that among these compounds, ligands 158, 164, 168, 163 and 157
gave the highest conversion and highest ee (50, 44, 38, 36 and 31% respectively). In
most cases these are the ligands which most resemble the ‘initial’ ligand.
Tetradentate ligands 159 and 165 gave poor results indicating that it may either be
too hindered or that four groups of attachment may destroy the catalytic potential of
the iron centre. Ligands, which were very hindered appeared to give poor results, as
did those lacking a basic nitrogen atom (e.g. 166 and 169). The number and position
of the methyl group (donating group) on the benzyl attached to a basic nitrogen is
important in controlling the reaction. 3,5-Dimethyl phenyl derivatives (158) gave full
conversion and led to the most significant increase in ee (50%) , 4-Methyl phenyl
derivatives (157) gave full conversion and 31% ee while 2,4,6-trimethyl phenyl
derivatives (161) gave poor conversion. Bromo substituted (163) (electron
withdrawing group) also gave good conversion and 36% ee. N-Benzylsubstituted
derivatives led to the highest ee compared to other ligands.
2.2. Nonlinear effects in asymmetrical stereoselective reactions.103-105
In many asymmetric syntheses, the enantiomeric excess of the product (eeprod) is
not always proportional to enantiomeric excess of the auxiliary (eeaux). A positive
non-linear effect (+)-NLE is obtained with amplified enantioselectivity if eeprod is
higher than eeaux. Conversely, if eeprod is lower than eeaux, (-)-NLE is obtained
with depleted enantioselectivity. There are several advantages of NLE investigations
with partially resolved chiral ligands. The first advantage is that NLEs which arise
from the association of the chiral auxiliaries in solution can be used to understand
subtle diastereomeric interactions between enantiomers. Secondly, NLEs can be
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useful in understanding the species involved in the catalytic cycle and their
behaviour in solution. Thirdly, NLEs can be used to generate products with high ees
from enantiomerically impure chiral auxiliaries.
Using the epoxidation reaction described above to study the effect of the
combination of RR and SS configuration ligands on the ee value, a series of solutions
of substrates were prepared, then the solutions we mixed together to make the
required percentage for both ligands configuration (Table 17).
Scheme 32: Investigation into nonlinear effects using RR and SS ligand enantiomers.
Procedure: Trans stilbene (0.449 g, 2.5 mmol), H2pydic (0.021g, 0.125 mmol) and
FeCl3.6H2O (0.034g, 0.125 mmol) were mixed in 40 cm3 of 2-methyl-2-butanol to
make solution 1.
(R,R)-Ligand (0.115g, 0.25 mmol) was dissolved in 10 cm3 of 2-methyl-2-butanol to
make solution 2.
(S, S)-Ligand (0.115 g, 0.25 mmol) was dissolved in 10 cm3 of 2-methyl-2-butanol to
make solution 3. The required formulation in each entry was prepared by combining
the reagents as mentioned in Table 17.
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Table 17: RR and SS ligands configurations percentage.
Substrates 90% RR,
10% SS
80% RR,
20% SS
70% RR,
30% SS
60% RR,
40% SS
50% RR,
50% SS
Solution 1 4 cm3 4 cm3 4 cm3 4 cm3 4 cm3
Solution 2 0.9 cm3 0.8 cm3 0.7 cm3 0.6 cm3 0.5 cm3
Solution 3 0.1 cm3 0.2 cm3 0.3 cm3 0.4 cm3 0.5 cm3
Table 18: Ligand and product ees.
Entry Ligands % Ligand ee % product ee %
1 100% RR 100 (R) 41 (R)
2 90% RR, 10% SS 80 (R) 35 (R)
3 80% RR, 20% SS 60 (R) 26 (R)
4 70% RR, 30% SS 40 (R) 17 (R)
5 60% RR, 40% SS 20 (R) 9 (R)
6 50% RR, 50% SS 0.0 0.1 (R)
Figure 19. Product ees vs ligand ees.
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Plotting the ligand ees against the product ees from the experiments shows no non-
linear effect, suggesting that there is no interaction between the ligands of each
configuration (RR and SS). Although it cannot be confirmed definitively using this
test, the evidence suggests the formation of a 1:1 ligand:metal complex in the
formation of diastereoisomeric compounds with different properties.
2.3. Synthesis of camphor-derived ligands.
The next series of studies involved the use of chiral compounds based on the
combination of diamine and a camphor compound. Such ligands have been
synthesised and evaluated as chiral ligands in the epoxidation, hydrosilylation and
ATH. The results are summarised (section 2.7, Table 24, entries 1, 4, 5 and 8) for
hydrosilylation, nitroaldol reaction (section 2.6, Table 23, entries 1, 5 and 6) and
ATH (section 2.5.1.1, Table 19, entries 1, 2, 3, 4 and 8, section 2.5.1.2, Table 20,
entries 1, 2, 3, 4 and 8, section 2.5.2, Table 21 and section 2.5.3, Table 22). In the
first attempt to synthesise camphor derived bidentate ligands, (1S)-(+)-camphor
sulfonyl chloride was reacted with (R,R)-TsDPEN and TEA in DCM to give
compound 171 (61% yield).
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Scheme 33: Synthesis of compounds 171-174.
Compound 172 was prepared using compound (R,R)-(−)-N-p-tosyl-1,2-
cyclohexanediamine and 1 equiv. of compound 170 (74% yield),106 Compound 173
was prepared using compound111 (R,R)-DPEN and 1 equiv. of compound 170 (62%
yield),107-111 while compound 174 was prepared using compound (R,R)-1,2-
diaminocyclohexane and 2 equiv. of compound 170 (69% yield), Scheme 33.
Reaction of compound 173 with benzaldehyde in methanol, then reduction of the
imine formed by NaBH3CN gave N-(2-benzylamino-1,2-diphenyl-ethyl)-C-(7,7-
dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-methanesulfonamide 175 (78% yield,
Scheme 34).
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Scheme 34: Synthesis of compound 175.
Epoxidation of trans-stilbene by the Beller epoxidation reaction method using
compound 175 gave the epoxide in 91% conv., 36% ee (S,S), (Scheme 35) .
Scheme 35: Epoxidation of trans-stilbene by compound 175.
In order to form tetradentate ligands, the formation of oxime compounds was
followed by reducing the oxime to an amine which could then be functionalised
further. This was considered to be a practical approach. In order to test this approach,
(1R,4S)-(-)-camphor oxime 178 (85% yield),112 was made by combination of (1R)-
(+)-camphor 176 (1mmol), hydroxylamine hydrochloride 177 and pyridine under
reflux in EtOH (Scheme 36).
Scheme 36: Synthesis of compound 178.
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By applying the same protocol compound 179 (91% yield) and compound 180 ( 62%
yield) were prepared (Scheme 37).
Scheme 37: Synthesis of compounds 179 and 180.
Epoxidation of trans-stilbene by Beller epoxidation reaction method using
compound 179 gave a product in only 12% conversion (Scheme 38).
Scheme 38: Epoxidation of trans-stilbene by compound 179.
Compound 178 was reduced by NaBH4 and NiCl2 in anhydrous MeOH at -60 C to
afford exo-(-)-bornylamine 181 as a foamy white solid (38% yield, Scheme 39).113-
114
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Scheme 39: Synthesis of compound 181.
Attempts to reduce compound 179 by NaBH4 and NiCl2 in anhydrous MeOH were
unsuccessful, as only starting materials were recovered (Scheme 40).
Scheme 40: Attempts to reduce compound 179.
In another approach (1R,4S)-(-)-camphor nitrimine112 183 was made by dissolving
compound 178 in glacial AcOH, treated with 5% aqueous NaNO2 to give the
product 183 in 35% yield (Scheme 41).
Scheme 41: Synthesis of compound 183.
Addition of norephedrine 184 to (1R,4S)-(-)-camphor nitrimine 183 in 1,2-
dichloroethane afforded (1R,1'R,2S,4'R)-1-phenyl-2-(1,7,7-
Results and discussions
67
trimethylbicyclo[2.2.1]hept-2-ylideneamino)propan-1-ol 185 as colourless crystals
(71% yield, Scheme 42).115
Scheme 42: Synthesis of compound 185.
In contrast, addition of (R,R)-TsDPEN 36b to (1R,4S)-(-)-camphor nitrimine 183 in
the same condition gave no reaction (Scheme 43). As a result, no attempt was made
to use a camphor nirimine product to make a tetradentate ligands.
Sheme 43: Addition of (R,R)-TsDPEN 36b to compound 183.
Different classes of compound were made by reduction of compounds116 173, 175
and 171 to afford N-(2-amino-1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-
bicyclo[2.2.1]hept-1-yl)-methanesulfonamide 187 (91% yield), N-(2-benzylamino-
1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-yl)-
methanesulfonamide 188 (85% yield) and N-[2-(2-hydroxy-7,7-dimethyl-
bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-1,2-diphenyl-ethyl]-4-methyl-
benzenesulfonamide 189 ( 62% yield), Scheme 44.
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Scheme 44: Synthesis of compounds 187-189.
2.4. Synthesis of chiral amine ligands derived from 2-formylbenzenesulfonyl
chloride
As formation of tetradentate ligands based on the combination of diamine and (1S)-
(+)-camphorsulfonyl chloride compound were not possible, the next target was
formation of tetradentate ligands using 2-formylbenzenesulfonyl chloride and
diamine compounds. The new novel compounds were evaluated as chiral ligands in
the epoxidation, hydrosilylation and ATH. The results are summarised in section 2.7,
Table 24, entries 2, 3 and 7 for hydrosilylation, nitroaldol reaction section 2.6, Table
23, entries 2, 3, 4, 7, 8 and 9 and ATH section 2.5.1.1, Table 19, entries 5, 6 and 7
and section 2.5.1.2, Table 20, entries 5, 6 and 7.
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Synthesis of 2-formyl benzene sulfonyl chloride
Chlorination of 2-formylbenzenesulfonic acid sodium salt 190 with SOCl2 191 in the
presence of catalytic amount of N,N-dimethylformamide (DMF) gave the relatively
unstable 2-formylbenzenesulfonyl chloride 192 (28% yield, Scheme 45).117-118
Scheme 45: Synthesis of compound 192.
Synthesis of N-tosyl-N-((2-methyl(o-(p-tosyl-1,2-diphenylethyl)-
aminophenyl)sulfonyl)-1,2-diphenyl-1,2-diaminoethane
Sulfonyl chloride 192 reacted with N-tosyl-1,2-diphenylethanediamine (TsDPEN) in
the presence of TEA to give the imine, which was then reduced by LiAlH4 to afford
N-tosyl-N-((2-methyl(o-(p-tosyl-1,2-diphenylethyl)-aminophenyl)sulfonyl)-1,2-
diphenyl-1,2-diaminoethane 193 (52% yield, Scheme 46).119
Compound 194 was prepared using 2 equiv. of (R,R)-toluene sulfonyl-1,2-
diaminocyclohexane and 1 equiv. of compound 192 (64% yield). Compound 195
was prepared using 2 equiv. of benzyl amine and 1 equiv. of compound 192 (76%
yield) while compound 196 was prepared using 2 equiv. of R-(+)-α-methylbenzyl 
amine and 1 equiv. of compound 192 (61% yield).
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Scheme 46: Synthesis of compound 193-196.
Epoxidation of trans-stilbene by Beller epoxidation reaction method using different
compounds (193-196) gave moderate to good conversion (30-90%) but low ee
(Scheme 47).
Scheme 47: Epoxidation of trans-stilbene using compounds 193-196.
Synthesis of (R,R)-acetic acid acetoxy-[2-(2-benzylamino-1,2-diphenyl-
ethylsulfamoyl)-phenyl]-methyl ester
Sulfonyl chloride 192 was treated with acetic anhydride 197 in the presence of a
catalytic amount of H2SO4 to give acetic acid acetoxy-(2-chlorosulfonyl-phenyl)-
methyl ester 198, which then reacted with 1,2-diphenylethanediamine 33 (DPEN),
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TEA in DCM to give (R,R)-acetic acid acetoxy-[2-(2-amino-1,2-diphenyl-
ethylsulfamoyl)-phenyl]-methyl ester 199 (86% yield). This was added to
benzaldehyde 147 and refluxed in benzene, then reduced by NaBH3CN to afford
(R,R)-acetic acid acetoxy-[2-(2-benzylamino-1,2-diphenyl-ethylsulfamoyl)-phenyl]-
methyl ester 200 (56% yield, Scheme 48).120 This compound was tested as a chiral
ligand in ATH of acetophenone using a FA:TEA mixture. The results are shown in
section 2.5.1.1, Table 19, entry 5).
Scheme 48: Synthesis of compound 200.
Synthesis of N-(2-hydroxy-1-methyl-2-phenyl-ethyl)-2-[(2-hydroxy-1-methyl-2-
phenyl-ethylamino)-methyl]-benzenesulfonamide
L-(-)-norephedrine 184 and imidazole 201 were mixed together in DCM, then was
added under nitrogen tert-butyl(chloro)dimethylsilane 202 (TBSCl) to give 2-(tert-
butyl-dimethyl-silanyloxy)-1-methyl-2-phenyl-ethylamine 203 (79% yield).121
Sulfonyl chloride 192 was dissolved in DCM, then compound 203 was added
followed by TEA. The unisolated intermediate was then reduced by LiAlH4 to
afford N-(2-hydroxy-1-methyl-2-phenyl-ethyl)-2-[(2-hydroxy-1-methyl-2-phenyl-
ethylamino)-methyl]-benzenesulfonamide 204 (71% yield, Scheme 49). This
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compound was tested as chiral ligand in ATH of acetophenone using a formic acid-
triethylamine 5:2 mixture. The results are shown in section 2.5.1.1, Table 19, entry
6) Scheme 49.
Scheme 49: Synthesis of compound 204.
Synthesis of 4-methyl-N-((R,R)-2{[(4-methylphenyl)sulfonyl]amino}-1,2-
diphenylethyl)benzenesulfonamide
Compounds 206 and 207 were made and tested as chiral ligands in the nitroaldol
reaction (Henry Reaction). The results are shown in section 2.6, Table 23, entry 2, 7
and 9). (R,R)-TsDPEN 36b and TEA in DCM, was added p-toluenesulfonyl chloride
205 to give 4-methyl-N-((R,R)-2{[(4-methylphenyl)sulfonyl]amino}-1,2-
diphenylethyl)benzenesulfonamide 206 (88% yield, Scheme 50).122-123
Scheme 50: Synthesis of compound 206.
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Synthesis of N-((1R,2S)-1-hydroxy-1-phenyl-2-propyl)-p-toluenesulfonamide:
(1R,2S)-Norephedrine 186 was dissolved in THF, and to this solution TEA and p-
toluenesulfonyl chloride 205 was added to afford N-((1R,2S)-1-hydroxy-1-phenyl-2-
propyl)-p-toluenesulfonamide 207 (51% yield, Scheme 51).124
Scheme 51: Synthesis of compound 207.
2.5. Asymmetric transfer hydrogenation (ATH) of ketone derivatives using a
FA:TEA mixture
Catalytic transfer hydrogenation of ketones to alcohols with 2-propanol sometimes
offers an attractive alternative to the reaction with molecular hydrogen because of
the favourable properties of the organic hydrogen source.125 However when the
method is applied to the asymmetric version,126-128 there are some downsides. The
occurrence of the reverse process originating from the structural similarity of the
hydrogen donor and product, both being secondary alcohols, frequently deteriorates
the enantiomeric purity of the chemical product.129 In addition, the unfavourable
ketone:alcohol equilibrium ratio often prevents a high conversion. Use of formic
acid130 in place of 2-propanol presents an obvious possibility for solving these
problems. Noyori131 et al., who found that Ru (II) complex modified with an arene
and a chiral N-tosylated 1,2-diamine serve as efficient catalysts for the asymmetric
reduction using a 5:2 FA:TEA azeotropic mixture under mild conditions. The
mechanism of hydrogen transfer from catalyst to ketones proceeds as classified by
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Morris,132 whereby two hydrogen atom are transferred to a substrate via a six-
membered transition state (TS) (Figure 20). A /CH interaction between a hydrogen
atom on the 6- arene and the aromatic ring of a substrate is pivotal to the control of
the absolute product stereochemistry.
Figure 20: Orientation of substrate acetophenone in ATH by catalyst.
2.5.1. Ruthenium (II)-catalyzed ATH of acetophenone using FA:TEA mixture.
Figure 21: Chiral nitrogen ligands used for ATH of ketones.
The reduction of acetophenone to 1-phenylethanol was carried out, the catalyst of
choice was the chiral Ru complex, consisting of [Ru(p-cymene)Cl2]2 or
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[Ru(C6H6)Cl2]2 with chiral amine ligand (Figure 21) and a 5:2 FA:TEA azotropic
mixture.
2.5.1.1. ATH of acetophenone using [Ru(p-cymene)Cl2]2 with chiral amine ligand
(Table 19).
Table 19: ATH of acetophenone in FA:TEA mixture catalysed by chiral Ru(II)
Complexes.a
Entry Ligand % yieldb % eec abs. configd
1 173 99 98 R
2 187 98 97 R
3 175 22 93 R
4 188 18 93 R
5 200 11 13 R
6 204 7 10 R
7 196 4 n/oe -
8 171 0 n/oe -
aThe reaction was carried out at 28 C using acetophenone (1 mmol), in a FA:TEA mixture (5:2, 2.5
cm3) with S/C=100. b,cEnantiomeric excess and conversion are determined by chiral GC. dDetermined
by the sign of optical rotation of isolated product. eNot obtained.
Different chiral amine ligands were evaluated including ligands based on a
combination of camphor compounds and diamines (171, 173, 175, 187 and 188),
ligands based on a combination of 2-formylbenzenesulfonic chloride and diamines
(196, 200 and 204). They were chosen with a range of different backbone structures
and functionalities in order to identify which ligands in combination with Ru (II)
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would form an active catalyst for the selective reduction of various ketones. The
results from a series of tests on these ligands are given in Table 19 and Table 20.
2.5.1.2. ATH of acetophenone using [Ru(C6H6)Cl2]2 with chiral amine ligand (Table
20).
For the reduction of acetophenone, the presence of NH2 in the ligands based on a
combination of camphor compounds and diamines (173 and 187), is crucially
important to get high yields and excellent selectivities. Ligands with benzyl group
substitution (175 and 188) gave only moderate yields and good selectivities.
Table 20: ATH of acetophenone in a FA:TEA mixture catalysed by
chiral Ru(II) complexes.a
Entry Ligand % yieldb % eec abs. configd
1 173 99 97 R
2 187 99 96 R
3 175 45 96 R
4 188 16 95 R
5 200 8 20 R
6 204 2 n/oe -
7 196 2 n/oe -
8 171 0 n/oe -
aThe reaction was carried out at 28 C using acetophenone (1 mmol), in a FA:TEA mixture (5:2, 2.5
cm3) with S/C=100. b,cEnantiomeric excess and conversion determined by chiral GC. dDetermined by
the sign of optical rotation of isolated product. eNot obtained.
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As a result of lacking a basic nitrogen atom, compound 171 gave no reduction due to
conjugations, Whereas other ligands based on a combination of 2-formyl
benzenesulfonyl chloride and diamine (196, 200 and 204) were not compatible with
this methodology; they gave poor conversion. Encouraged by these results, the study
on the ATH of various ketones using N-substituted DPEN derivatives (ligands 173,
187, 175 and 188) was investigated further.
2.5.2. ATH of ketones derivatives using [Ru(C6H6)Cl2]2 with chiral ligands 173,
187, 175 and 188 (Table 21).
Table 21: ATH of ketones in a FA:TEA mixture catalysed by
chiral Ru(II) complexes.a
Entry Ketone Ligand
173 187 175 188
%
Convb
%
eeb,c
%
Convb
%
eeb,c
%
Convb
%
eeb,c
%
Convb
%
eeb,c
1 57a 99 96(R) 99 96(R) 45 96(R) 16 95(R)
2 208 98 97(R) 20 78(R) 0 - 0.00 -
3 p-58c 95 94(R) 87 98(R) 52 95(R) 15 87(R)
4 209 99 92(R) 98 92(R) 99 90(R) 99 91(R)
5 210 99 8(S) 95 18(S) 98 10(S) 77 14(S)
aThe reaction was carried out at 28 C using ketone (1 mmol), in a FA/TEA mixture (5:2, 2.5 cm3)
with S/C=100. bEnantiomeric exess and conversion determined by chiral GC. cDetermined by the sign
of optical rotation of isolated product.
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2.5.3. ATH of ketones derivatives using [Ru(p-cymene)Cl2]2 with chiral ligands
173, 187, 175 and 188 (Table 22).
Table 22: ATH of ketones in FA:TEA mixture catalysed by chiral Ru(II) complexa.
Entry Ketone
Ligand
173 187 175 188
%
Conv.b.
%
eeb,c
%
Conv.b.
%
eeb,c
%
Conv.b.
%
eeb,c
%
Conv.b.
%
eeb,c
1 57a 99 97(R)c 98 98(R) 22 93(R) 18 93(R)
2 208 0.00 - 78 97(R) 0.00 - 0.00 -
3 p-58c 67 99(R)c 20 96(R) 0.00 - 0.00 -
4 209 97 95(R)c 99 96(R) 99 99(R) 79 92(R)
5 210 98 46(S)c 90 47(S) 0.00 - 0.00 -
aThe reaction was carried out at 28 C using ketone (1 mmol), in a FA/TEA mixture (5:2, 2.5 cm3)
with S/C=100. b,cEnantiomeric excess and conversion determined by chiral GC. dDetermined by the
sign of optical rotation of isolated product.
Four organometallic catalysts consisting of N-substituted DPEN derivatives (ligands
173, 187, 175 and 188) in combination with Ru(II) have been applied and have
demonstrated good activity in ATH of different ketones using FA:TEA as the
solvent and hydrogen source. The results clearly indicate that ligands in combination
with Ru(II) forms a competent catalyst for the selective reduction of various ketones.
substituted aryl ketones are highly compatible with this methodology. Near
quantitative conversion and high enantioselectivity were achieved for the majority of
substrates tested.
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Trifluoromethyl substitution reduced completely in most cases with excellent ee in
both Table 21 and Table 22. Acetophenone was reduced completely (ligands 173 and
187), lower conversion (16-45 %) (ligands 175 and 188) in both Table 21 and Table
22 with excellent ee. The p-methoxy substituted acetophenone was reduced
completely in most cases in Table 21 (only with ligand 188 15% conv.) and with
low to moderate conversion (ligand 173 and 187) in Table 22 with excellent ee. The
bicyclic compound (-tetralone) was reduced only by ligands 173 and 187 in Table
21, and ligand 187 in Table 22 with high ee. The non aromatic compound,
acetylcyclohexane, was reduced completely in most cases in Table 21 and with
ligands 173 and 187 in Table 22, However the enantiomeric excesses were low. The
reversed enantioselectivities for these reductions, relative to acetophenone
derivatives, suggest that (weaker) steric factors are directing the reaction, rather than
electronic ones.133
2.6. Copper(I)-Catalysed Henry reaction using chiral amine ligands
Scheme 52: Nitroaldol reaction.
The nitroaldol reaction is one of the most atom economic C-C bond forming
reactions.134 The resulting products, -nitroalcohols, are widely used organic
intermediates because of the many possible transformations of the nitro group into
other functional groups.135 A bis(sulphonamide)-diamine ligand 211, coordinated
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with Cu(I), catalyses various aldehyde substrate and gives the corresponding product
with high yield and selectivity.136
A series of chiral diamine ligands were applied to catalysis with various aldehyde
substrates to afford the corresponding nitroaldol products. As shown in Table 23,
good to moderate conversions were obtained, but the enantiomeric selectivities were
low in most cases. As mentioned by W. Jin137 et al., it may be the design of the
ligand that plays a pivotal role in the development of efficient metal-catalysed
asymmetric reactions such that the reactivity and enantiomer selectivity are closely
related to the chiral backbone and the substituents of the ligand moiety.
Table 23: Asymmetric Henry reaction of nitromethane and aldehyde catalysed by
CuBr-amine ligandsa.
Entry R Ligand Time (h) % Conv.b % eec
1 2-NO2-C6H4 171 48 96 5 (R)
2 2-NO2-C6H4 206 48 97 3 (R)
3 2-NO2-C6H4 204 48 49 25 (R)d
4 2-NO2-C6H4 194 48 88 2 (R)
5 2-NO2-C6H4 172 48 94 3 (R)
6 2-NO2-C6H4 175 48 47 5 (R)
7 4-NO2-C6H4 207 48 72 24 (R)
8 4-NO2-C6H4 193 48 68 6 (R)
9 2-MeO-C6H4 207 48 90 13 (R)
aReaction were carried out using aldehyde (0.25 mmol) , CuBr (10 mol%), ligand (10 mol%),
pyridine (1 equiv.) and nitromethane (10 equiv.) in methanol (1.0 cm3) at r.t. b and cDetermined by
chiral HPLC analysis. dDetermined by the sign of optical rotation of isolated product.
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2.7. Iron-catalyzed asymmetric hydrosilylation of acetophenone with chiral
amine ligands
Nishiyama et al,138 found that Fe(OAc)2-catalyzed hydrosilylation of ketones with
several hydrosilanes can be readily promoted in the presence of N,N,N-
bis(oxazolinylphenyl)amine 68 as a chiral ligand.
In this project, chiral bidentate and tetradentate amine ligands were evaluated in this
reaction but unfortunately using the procedure as reported by Nishiyama et al, it
seems to be that these types of ligands did not catalyse the reaction effectively and a
moderate to good conversion with low enantiomeric selectivity (5.0-0.8% ee) was
achieved, even without the ligand (53% conversion, Table 24, entry 6) or without the
iron metal (50% conversion, Table 24, entry 7 and 8).
Scheme 53: Hydrosilylation of acetophenone by chiral amine ligands.
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Table 24: Asymmetric hydrosilylation of acetophenone with iron salts and nitrogen
based ligands catalyst.a
Entry Cat. precursor Hydrosilane Ligand % Yieldb
1 FeCl2 Triethoxysilane 175 94
2 FeCl2 Triethoxysilane 196 82
3 FeCl2 Triethoxysilane 193 56
4 Fe(OAc)2 Triethoxysilane 175 66
5 FeCl2 Poly(methyl)hydrosiloxane 175 93
6 FeCl2 Triethoxysilane - 53
7 - Poly(methyl)hydrosiloxane 193 51
8 - Triethoxysilane 175 54
aReaction were carried out using acetophenone (1mmol), iron salt (2.0 mol %), ligand (3.0 mol %),
hydrosilane (2.0 mmol), THF (3.0 cm3), 65 C, 24 h. bDetermined by chiral GC.
2.8. Synthesis of pyridine compounds.
The pyridine substructure is one of the most prevalent heterocycles found in natural
products, pharmaceuticals, and functional materials.139 Many powerful
methodologies for the synthesis of these heterocycles rely on condensation of amines
and carbonyl compounds or cycloaddition reactions.140-141 Cross-coupling chemistry
also allows introduction of substituents to activated heterocycles.142 A series of
pyridine compounds were synthesised from pyridine derivatives using acid chloride,
coupling method, Mitsunobu reaction and pyridine-2-carboxylic anhydride. These
compunds used initially as a rate enhancing additive in the Pd(OAc)2 catalysed
acetoxylation of benzene.143
2.8.1. Attempts to synthesise pyridine compounds:
Thionyl chloride144 191 was added to pyridine-2-carboxylic acid 213 under reflux to
give a white crystalline residue of compound 214 (88% yield) which was dissolved
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in DCM, then reacted with 2-(1-hydroxyethyl)pyridine 127, and TEA to afford
pyridine-2-carboxylic acid 1-pyridin-2-yl-ethyl ester 215 (34% yield, Scheme 54).
Scheme 54: Synthesis of compound 215 via acid chloride.
Pyridine-2-carboxylic acid145 213 was dissolved in DCM, added to 2-(1-
hydroxyethyl) pyridine 127, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC),
and 4-(dimethylamino)pyridine (DMAP) to afford pyridine-2-carboxylic acid 1-
pyridin-2-yl-ethyl ester 215 (32% yield, Scheme 55).
Scheme 55: Synthesis of compound 215 by coupling with EDC.
Pyridine-2-carboxylic acid146 213 was mixed with pyridine, added to 2-(1-
hydroxyethyl) pyridine 127, N,N-dicyclohexylcarbodiimide (DCC) to afford
pyridine-2-carboxylic acid 1-pyridin-2-yl-ethyl ester 215 (28% yield, Scheme 56).
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Scheme 56 Synthesis of compound 215 by coupling with DCC.
Pyridine-2-carboxylic acid147 213 was dissolved in THF, added to 2-(1-
hydroxyethyl) pyridine 127 and triphenylphosphine (PPh3) at 0 C. Diethyl
azodicarboxylate (DEAD) was then added (below 10 C) to afford pyridine-2-
carboxylic acid 1-pyridin-2-yl-ethyl ester 215 (38% yield, Scheme 57).
Scheme 57: Synthesis of compound 215 by a Mitsunobu reaction.
A solution of pyridine-2-carboxylic acid148 213 and diisopropylethylamine in THF
was stirred for 10 min. at 0 C. To the reaction mixture a solution of triphosgene 216
in THF was added at 0 C and stirred for 1 h at r.t. to offered pyridine-2-carboxylic
anhydride 217 (48% yield, Scheme 58).
Scheme 58: Synthesis of compound 217.
To a stirred solution of pyridine-2-carboxylic anhydride 217 and DMAP in DCM at
r.t. for 10 min, a solution of 2-(1-hydroxyethyl) pyridine 127 in DCM was added,
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and stirring overnight afforded (R)-pyridine-2-carboxylic acid 1-pyridin-2-yl-ethyl
ester 215 (49% yield, Scheme 59).
Scheme 59: Synthesis of compound 215 using 217.
Using this protocol, relatively higher yields were obtained (49% yield) compared to
other methods, so other pyridine compounds were made in the same way using
pyridine-2-carboxylic anhydride 217 and the corresponding alcohol to afford (R)-
pyridine-2-carboxylic acid 1,2,3,4-tetrahydro-naphthalen-1-yl ester 219 (52% yield,
Scheme 60), and pyridine-2-carboxylic acid 1-(2-bromo-phenyl)-ethyl ester 221
(58% yield, Scheme 61).
Scheme 60: Synthesis of compound 219.
Scheme 61: Synthesis of compound 221.
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2.9. C-H Activation.*
The role of pyridine as a rate enhancing additive in the Pd(OAc)2 catalysed
acetoxylation of benzene was investigated, as reported by Sanford (Scheme 62).143
Three novel pyridine compounds 215, 219 and 221 were used as enhancing additive.
Scheme 62: Pd(OAc)2 catalysed acetoxylation of benzene with added pyridine.
As each compound (215, 219 and 221) contains a pyridine group, it was decided to
study whether these compounds would also be capable of coordination to Pd(OAc)2
to induce a rate enhancement. Initial investigation looked at reproductions of the
acetoxylation of benzene with added pyridine (25% scaling ratio) for 20 h.
The initial results showed only a minimum amount of the product (5% by
quantitative GC analysis) using 1 equivalent chlorobenzene (PhCl). The reaction was
also carried out using compounds 215 and 219 for 20 h to obtain about 11% yield.
The ratio of Pd(OAc)2:pyridine is extremely important as an excess of pyridine
quickly becomes inhibitory. The reaction was run on the same scale as has been
reported, without any ligand, with pyridine and with compounds 215, 219 and 221
for 3 h to yield 6.7%, 33.10%, 30.7%, 0.0 % and 0.0% respectively, and for 20 h to
yield 27.5%, 33.20%, 28.80%, 37.60% and 33.0% respectively. No appreciable
difference was seen for 215 as compared to pyridine, implying that only one of the
two pyridine groups coordinate to Pd(OAc)2 at any given time and that chelation
*This work was done in collaboration with M. Chem. final year student A. Wallace, under my
supervision.
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does not occur. Despite the slightly increased conversion achieved, they were still
considered too low to be any practical value with respect to their role in the reaction.
2.10. Iron-catalyzed asymmetric epoxidation of aromatic olefins.
Nishikawa et al.,149 studied iron-catalyzed asymmetric epoxidation of β,β-
disubstituted enones using a variety of complexes consisting of iron salts [FeCl2 and
Fe(OTf)2] and phenanthroline ligands attached to binaphthyl moieties 224.
Epoxidation of aromatic olefins (trans-stilbene or trans-chalcone, Scheme 63) were
investigated using iron compounds (FeCl2, Fe2(CO)9 and Fe(OTf)2) and chiral
ligand 215 in MeCN or DCM in presence of peracetic acid solution as an oxidant.
Although moderate to good conversion was obtained, the results shown that the
iron complex does not coordinate to the ligand (low selectivity in all cases).
Scheme 63: Epoxidation of aromatic olefins.
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Table 25: Asymmetric epoxidation of olefins.a
Entry Substrate Metal Solvent % Conv.b % eec
1 trans-stilbene Fe(OTf)2 DCM 30% 4% (R)
2 trans-stilbene Fe(OTf)2 MeCN 24% 25% (R)
3 trans-stilbene FeCl2 DCM 82% 2% (R)
4 trans-stilbene FeCl2 MeCN 55% 8% (R)
5 trans-stilbene Fe2(CO)9 DCM 60% 6% (R)
6 trans-stilbene Fe2(CO)9 MeCN 58% 8% (R)
7 trans-chalcone Fe(OTf)2 DCM 34% 6% (R)
8 trans-chalcone Fe(OTf)2 MeCN 2% -
9 trans-chalcone FeCl2 DCM 45% 2% (R)
10 trans-chalcone FeCl2 MeCN 90% 4% (R)
11 trans-chalcone Fe2(CO)9 DCM 43% 6% (R)
12 trans-chalcone Fe2(CO)9 MeCN 31% 2% (R)
aThe reaction was carried out at 0 C, ligand 215 (10 mol %), iron salt (5 mol %), peracetic acid
solution (1.5 equiv.) DCM or MeCN, 0.5 h. bConversion determined by 1NMR analysis.
cEnantiomeric excess determined by chiral HPLC analysis.
2.11. Asymmetric transfer hydrogenation (ATH) of ketone derivatives by mono-
ruthenium tridentate complexes.
At this point related work in the group had demonstrated that acetophenone could be
reduced with high enantioselectivity using compound 225 as a coordinating ligand. It
is proposed that this forms an active mono-ruthenium, tridentate complex in situ
from Ru3(CO)12.150
Ph
H
N
Ph NHTs
N
N
N
Ph
225
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Given the limited progress regarding use of the tridentate ligand complexes to study
of rate enhancement by pyridine in C-H activation and iron-catalyzed asymmetric
epoxidation of aromatic olefins, it was decided to further study the tridentate ligand
complexes with regard to their efficiency as ligands in the ATH of aryl ketones
derivatives.
2.11.1. Ligands design for ATH of ketones
Synthesis of (R,R)-pyridine-2-carboxylic acid [2-(toluene-4-sulfonylamino)-1, 2-
diphenyl-1, 2-ethylenediamine]-amide:151
Scheme 64: Synthesis of compound 226.
Pyridine-2-carboxylic acid 213 and TEA in anhydrous THF, was treated with ethyl
chloroformate at 0 C for 30 min. A solution of (1R,2R)-TsDPEN 36b in THF was
added dropwise and the reaction mixture was left at r.t. to yield (R,R)-pyridine-2-
carboxylic acid [2-(toluene-4-sulfonylamino)-1,2-diphenyl-1,2-ethylenediamine]-
amide 226 (86% yield, Scheme 64).
Synthesis of (R,R)-pyridine-2-carboxylic acid [2-(toluene-4-sulfonylamino)-
cyclohexyl]-amide:
Pyridine-2-carboxylic acid 213 and TEA in anhydrous THF was treated with ethyl
chloroformate at 0 C for 30 min. A solution of (R,R)-(−)-N-(4-toluenesulfonyl)-1,2-
diaminocyclohexane 227 in THF was added dropwise and the reaction mixture was
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left at r.t. to give (R,R)-pyridine-2-carboxylic acid [2-(toluene-4-sulfonylamino)-
cyclohexyl]-amide 228 (90% yield, Scheme 65).
Scheme 65: Synthesis of compound 228.
The reduction of secondary amides has been reported to be difficult, presumably due
to the unfavourable loss of stability due to conjugation of the amide bond.152-153
Therefore the reduced form of compounds 226 and 228 was thought to be best
achieved by reductive amination.
Synthesis of (R,R)-N-{1,2-diphenyl-2-[(pyridin-2-ylmethyl)-amino]-ethyl}-4-
methyl-benzenesulfonamide:154
To a stirred solution of (1R,2R)-TsDPEN 36b in DCM was added at r.t. 2-
pyridincaboxaldehyde 229 in DCM. The mixture was stirred o/n at r.t. to obtain
(R,R)-N-{1,2-diphenyl-2-[(pyridin-2-ylmethylene)-amino]-ethyl}-4-methyl-
benzenesulfonamide 230 (81% yield). This was dissolved in MeOH and NaBH4 was
added portionwise and the reaction allowed to stir until all the imine had been
consumed to afford (R,R)-N-{1,2-diphenyl-2-[(pyridin-2-ylmethyl)-amino]-ethyl}-4-
methyl-benzenesulfonamide 231 (62% yield, Scheme 66).
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Scheme 66: Synthesis of compound 231.
Thus, imine 230 was prepared in reasonably high yield from (R,R)-TsDPEN and 2-
pyridine carboxaldehyde. Compound 230 was found to be surprisingly stable over a
period of weeks and could even be purified by column chromatography.
Synthesis of (R,R)-4-Methyl-N-{2-[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-
benzenesulfonamide:155-156
Scheme 67: Synthesis of compound 233.
To a stirred solution of (1R,2R)-(−)-N-p-tosyl-1,2-cyclohexanediamine 227 in DCM
was added at r.t. 2-pyridincaboxaldehyde 229 in DCM. The mixture was stirred o/n
at r.t. to obtain (R,R)-4-methyl-N-{2-[(pyridin-2-ylmethylene)-amino]-cyclohexyl}-
benzenesulfonamide 232 (87% yield). This was dissolved in MeOH and NaBH4 was
added portion wise and the reaction allowed to stir until all the imine has been
consumed to afford (R,R)-4-methyl-N-{2-[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-
benzenesulfonamide 233 (61% yield, Scheme 67).
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Synthesis of (R,R)-{2-[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-carbamic acid
tert-butyl ester:
(R,R)-1,2-Diaminocyclohexane 234 was first add to di-tert-butyl dicarbonate 235 to
give t-Boc derivative 236 (72% yield, Scheme 68).157
Scheme 68: Synthesis of compound 236.
The mono-Boc product 236 treated with 2-pyridinecaboxaldehyde 229 in DCM to
give the imine 237 (80% yield), that was reduced by NaBH4 to afford (R,R)-{2-
[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-carbamic acid tert-butyl ester 238 (77%
yield, Scheme 69).
Scheme 69: Synthesis of compound 238.
2.11.2. Optimisation of reaction conditions for ATH of ketones.
ATH is the reduction of a multiple bond with the aid of a hydrogen donor in the
presence of a catalyst.158 To carry out the ATH of ketone substrates, reaction were
first optimised with respect to reaction time, concentration and catalyst loading using
compound 231 and acetophenone as an representive ketone (Table 26). An optimum
ratio of 1:3 Ru3(CO)12 : ligand was determined. This is rationalised by the
decomposition of the ruthenium trimer to generate 3 equivalents of ruthenium in situ
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that is a 1:1 ratio of Ru: ligand. Thus, a catalyst loading of 2 mol% refers to 0.66
mol%: 2 mol% Ru3(CO)12: ligand. Experiments were carried out using different
concentrations and catalyst loading for 72 h (Table 26). In all cases, conversion
increase with respect to time while enantiomeric excesses decreased with respect to
time possibly due to slow racemisation of the products.
Table 26: A summary of initial ATH of acetophenone with ligand 231 in order to
optimise reaction conditions.a
Entry Conc. x mol%:
y mol%
Time/h
24 48 72
%
Conv.b
% eec %
Conv.b
% eec %
Conv.b
% eec
1 0.1 m 1 : 0.33 86 95 (R)d 90 93 (R) 90 92 (R)
2 0.2 m 1 : 0.33 95 92 (R) 97 86 (R) 97 85 (R)
3 0.5 m 1 : 0.33 95 89 (R) 97 84 (R) 97 83 (R)
4 0.1 m 2 : 0.66 96 95 (R) 97 92 (R) 98 91 (R)
aThe reaction was carried out at 80 C using acetophenone (1 mmol), ligand (2 mol %) and Ru3(CO)12
(0.66 mol %) in 10 cm3 IPA, 72 h. b,cEnantiomeric excess and conversion determined by chiral GC.
dDetermined by the sign of optical rotation of isolated product.
Among different concentration and catalyst loading used in the reactions, it was
found that a reaction concentration of 0.1 mol dm-3 combined with a catalyst loading
of 2 mol% returned optimal results.
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Figure 22: Comparison of ATH of acetophenone conversion at different
concentrations using compound 231.
Figure 23: Comparison of ee of ATH of acetophenone at different
concentrations using compound 231.
The reaction reached completion after only 48 h, so the reaction was repeated using
compound 233 (Table 27), which gave almost the same trends of results. Figure 22
shows a comparison of ATH of acetophenone at different concentrations using
compound 231, and Figure 23 shows a comparison of ee for ATH of acetophenone at
different concentrations using compound 231. Surprisingly the reduction of
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acetophenone using compound 238 for 48 h (0.1 mol dm-3 concentration, 2 mol%
catalyst loading) gave almost the same conversion and ees compared to compounds
231 and 233 (96%, 88% respectively).
Table 27: A summary of initial ATH of acetophenone with ligand 233 in order to
optimise reaction conditions.a
Entry Conc. x mol%:
y mol%
Time/h
24 48
% Conv.b % eec % Conv.b % eec
1 0.1 m 1 : 0.33 47 92 (R)d 62 91 (R)
2 0.2 m 1 : 0.33 89 91 (R) 96 88 (R)
3 0.5 m 1 : 0.33 93 88 (R) 94 87 (R)
4 0.1 m 2 : 0.66 96 94 (R) 97 90 (R)
aThe reaction was carried out at 80 C using acetophenone (1 mmol), ligand (2 mol %) and Ru3(CO)12
(0.66 mol %) in 10 cm3 IPA, 48 h. b,cEnantiomeric excess and conversion determined by chiral GC.
dDetermined by the sign of optical rotation of isolated product.
2.11.3. Mechanistic considerations.
A suggested mechanism of action for the ATH of an aryl ketone using compound
231 as a ligand is illustrated in Figure 24: Initial decomposition of Ru3(CO)12 with
CO release, then ligation by 231 and proton transfer forms the coordinatively
saturated active species 239. Aryl ketones can be reduced by 239 via an outer sphere,
concerted mechanism as shown in transition state 240.
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Figure 24: Possible mechanism of action for class of tridentate catalysts, using 231
as an example.
In contrast to the bifunctional TsDPEN-Ru catalysts developed by Noyori, the
orientation of approach may be dominated by a favourable π/π interaction between 
the pyridine group in the ligand and the aromatic substituent on the respective
ketone. Hydrogen donation by IPA solvent regenerates 239 to complete the catalytic
cycle.
Compound 226 was employed as a ligand in the ATH of acetophenone. As expected,
given the proposed need for a basic amine in the catalyst, no reduction product was
observed after two days. The amide bond functionality appears to prevent the
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coordination of the corresponding nitrogen to ruthenium to form the active catalyst,
and the lone pair is not available due to conjugation (Figure 25).
Figure 25: Illustration of how the amide bond functionality in compound 226
prevents coordination to form the active catalyst.
A substrate concentration of 0.1 mol dm-3 combined with a catalyst loading of 2
mol% returned optimal results for ATH of acetophenone, a series of ketone
derivatives were then reduced by ATH using compound 231 and 233, the results of
the reaction were summarised in Table 28 and Table 29 respectively.
Clearly, substituted aryl ketones are highly compatible with this methodology. Near
quantitative conversion and high enantioselectivity were achieved for the majority of
substrates tested.
Most of the substituted aryl ketones gave high conversion and good
enantioselectivities (Table 29). Among the substituted aryl ketones tested, it was
found that the presence of meta-methoxy substituent on the aromatic ring yields
optimal results under the ATH conditions employed for 48 h (98% conv., 94% ee).
Acetophenone was reduced completely with only 88% ee compared to other
substituted aryl ketones, which may indicate the effect of substitution on enhancing
ee. Trifluoromethyl and chloro substituted acetophenone were reduced completely
with 91% ees.
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Table 28: A summary of ATH of ketone derivatives with compound 233 in
conjunction with Ru3(CO)12.a
Entry Ketones
Time
24 h 48 h
% Conv.b % eec % Conv.b % eec
1 57a 96 94 (R)d 97 90 (R)
2 208 18 89 (R) 26 86 (R)
3 p-58c 53 93 (R) 68 88 (R)
4 209 92 87 (R) 100 86 (R)
5 210 80 17 (S) 86 17 (S)
aThe reaction was carried out at 80 C using acetophenone (1 mmol), ligand (2 mol %) and Ru3 (CO)12
(0.66 mol %) in 10 cm3 IPA, 48 h. b,cEnantiomeric excess and conversion determined by chiral GC.
dDetermined by the sign of optical rotation of isolated product.
The bicyclic compounds 208 and 245 were reduced in 84 and 95% with 91 and 93%
ees respectively, also the long chain high molecular weight compound 244 reduced
in 85% with 91% ee (Table 29, entries 2 and 10).
Acetylcyclohexane (Table 29, entry 10) was reduced in lower rates compared to aryl
ketones, however the enantiomeric excesses was low (Table 29 entry 10), the
reversed enantioselectivities for these reductions, relative to acetophenone
derivatives, suggest that weaker steric factors are directing the reaction, rather than
electronic ones.
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Table 29: A summary of ATH of ketone derivatives with compound 231 in
conjunction with Ru3(CO)12.a
aThe reaction was carried out at 80 C using acetophenone (1 mmol), ligand (2 mol %) and Ru3 (CO)12
(0.66 mol %) in 10 cm3 IPA, 48 h. b,cEnantiomeric excess and conversion determined by chiral GC.
dDetermined by the sign of optical rotation of isolated product.
Entry Ketones
Time
24 h 30 h 48 h
%Conv.b % eec %Conv.b % eec %Conv.b % eec
1 57a 96 94(R)d 97 90(R) 97 88(R)
2 208 72 95(R) 81 93(R) 84 93(R)
3 o-58c 98 90(R) 99 90(R) 99 89(R)
4 m-58c 97 96(R) 98 94(R) 98 94(R)
5 p-58c 89 96(R) 90 93(R) 90 92(R)
6 p-58d 98 92(R ) 99 91(R) 99 91(R)
7 209 98 93(R) 99 91(R) 99 91(R)
8 244 81 91(R) 84 90(R) 85 90(R)
9 245 90 99(R) 94 94(R) 95 91(R)
10 210 79 20(S) 85 19(S) 88 19(S)
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Figure 26 shows the observed conversion as a function of time for different ketones
reduction and Figure 27 shows the observed ees as a function of time for different
ketones reduction.
Figure 26: Conversion to products in ATH of ketones derivatives using 231.
Figure 27: Comparison of ee in ATH reduction of ketones using compound 231.
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2.11.4. Investigation into ATH of ortho-substituted aryl ketones.
As the ATH of the different aryl ketone derivatives were successful, almost
quantitative conversion and high ees was obtained for most of the reduced substrates.
An investigation was carried out into ortho-substituted aryl ketones and the results
summarised in Table 30. Principally, different groups ortho-substituted were
investigated as this would allow for a systematic investigation into the importance of
the nature of the substituent at the ortho position, from which it was thought that a
distinct trend would emerge.
Most of the substrates were reduced in near quantitative conversion and high
enantioselectivity and are highly compatible with this methodology. Conversion
improved with smaller sized electron withdrawing groups (fluorine and chlorine)
compared to unsubstituted acetophenone. Among the reduced substituents, lower
conversion was obtained for large substituents iodide and trifluoromethyl groups.
Justification for the low conversion of the large iodide would be that this substituent
becomes too great and causes an unfavourable orthogonal orientation of the arene
group to undergo this π/π interaction.  Alternatively, these substituents may simply 
cause the ketone to become too bulky to effectively interact with the active catalyst.
Whereas in the aryl ketone being less bulky and so increases conversion, whilst
retaining selectivity induced by the favourable π/π interaction. 
Data for the ATH of 2-iodo- and 2-trifluoromethyl- acetophenone have been
excluded due to low conversions. Among the substrates reduced, 2-methyl
acetophenone yielded optimal results after 48 h, achieving almost quantitative
conversion and ee of 93.8%. The electron donating effect of the methyl substituent
may encourage more favourable π/π interaction to achieve this selectivity, whilst 
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sterically it appears to be of optimum size to encourage high conversion without
being too large to prevent approach to the catalyst. Figure 28 shows the observed
conversion as a function of time for reduction of different ortho-substituted aryl
ketones, and Figure 29 shows the observed ees as a function of time for reduction of
different ortho-substituted aryl ketones reduction.
Figure 28: Comparison of conversion of substrates containing different substituents
at the ortho position of the arene group.
Figure 29: Comparison of ee of products containing different substituents at the
ortho position of the arene group.
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Table 30: A summary of ATH of a number of aryl ketones containing a substituent
at the ortho position.a
aThe reaction was carried out at 80 C using substrate (1 mmol), ligand (2 mol %) and Ru3 (CO)12
(0.66 mol %) in 10 cm3 IPA, 48 h. b,cEnantiomeric excess and conversion determined by chiral GC.
dThis work was done in collaboration with M. Chem. final year student A. Wallace, under my
supervision.
2.12. Non linear experiment of chiral tridentate pyridine ligand 231
To study the effect of the combination of RR and SS configurated chiral tridentate
pyridine ligands 231 on the ee values of the ATH of acetophenone mentioned above
series of experiments were carried out. Solutions of both ligand enantiomers in 2-
propanol were prepared, then mixed together to make the required percentage for
both ligand enantiomers configurations (Table 31).
Entry R
Time/h
4.0 20 24 48
%
Convb
%eec
%
Convb
%eec
%
Convb
%eec
%
Convb
%eec
1 H 41.1 97 92.8 94.1 93.9 92.7 95.2 91.1
2 F 77.3 87.3 >99 85.4 >99 84.1 >99 83.7
3 Cl 70.1 88.9 >99 88.6 >99 87.9 >99 87.6
4 Br 0.0 - 64.4 92.4 91.6 90.1 99.0 86.2
5 I 0.0 - 0.0 - 0.0 - 3.1 9.1
6 CF3 0.00 - 0.00 - 28.0 19.8 33.3 17.6
7 Me 42.7 97.1 95.6 95.6 98.3 95.1 >99 93.8
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O
Ru3(CO)12 (0.68 mol %)
IPA, 80 °C,48 h
OH231 (R,R)ligand (x mol %)
231 (S,S)ligand (x mol %) Ph
H
N
Ph NHTs
N
Ph
H
N
Ph NHTs
N
231 (R,R) 231 (S,S)
Scheme 70: ATH of acetophenone by ligand 231 enantiomers.
Table 31: Ligand required ees.
Entry RR enantiomer SS enantiomer Ligand ees
1 2 mol% 0.00 mol% 100% (R)
2 1.8 mol% 0.20 mol% 80% (R)
3 1.6 mol% 0.40 mol% 60% (R)
4 1.4 mol% 0.60 mol% 40% (R)
5 1.2 mol% 0.80 mol% 20% (R)
6 1.0 mol% 1.0 mol% 0.00
Then the ATH of acetophenone with chiral mono-ruthenium tridentate ligand 231
(both ligand enantiomers RR and SS ) were carried out to get the product ees. Table
32 shows the ligand and product ees and Figure 30, shows the relation between
ligand and product ees.
Table 32: Ligand and product ees.
Entry ligand ees product ees
1 100 90
2 80 70.5
3 60 46.2
4 40 28.1
5 20 12.4
6 0 2
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Figure 30: Ligands and product ees
Plotting the ligand ees% against the product ees% shows no interaction between the
ligand of both configuration (RR and SS) or no non-linear effect between both
ligands configuration (RR and SS).
2.13. Conclusions
Although the synthesis of tetradentate amine ligands based on a combination of
diamine and camphor compounds was not possible, bidentate ligands have been
synthesised and evaluated as chiral ligands. The epoxidation of trans-stilbene, ligand
175 gave the epoxide in 91% conv., 36% ee (S,S) and compound 179 gave only 12%
conversion. In hydrosilylation reactions, ligand 175 gave 94% yield with low
enantiomeric induction this may indicate that such ligands do not catalyse the
reaction. Ligands 173, 187, 175 and 188 in combination with Ru(II) using a 5:2
FA/TEA azeotropic mixture have been applied to and demonstrated good activity in
ATH of different ketones. No reduction was seen using ligand 171, indicating the
need for a basic amine in the catalyst as the lone pair is not available in 171 due to
conjugation. In nitroaldol reactions, ligands 171, 172 and 206 gave products with
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high yield but low ee in all cases. This is because the selectivity is related to the
chiral ligand backbone.
Formation of bidentate and tetradentate ligands using 2-formylbenzenesulfonyl
chloride and diamine compounds was successful, and the new novel compounds
were evaluated as chiral ligands in the epoxidation of trans-stilbene using
compounds 193, 194, 195 and 196 to give moderate to good conversion (30-90%)
but low ees. For hydrosilylation reactions compound 196 gave high conversion but
low ee. Compounds 196, 200 and 204 gave poor conversion for ATH of
acetophenone.
The rate enhancement induced by 1 equivalent of pyridine in the Pd(OAc)2 catalysed
acetoxylation of benzene was carried out as reported by Sanford. Three novel
compounds were prepared 215, 219 and 221, each containing at least one pyridine
group and so enabling coordination to Pd(OAc)2. Additional functionalities were
incorporated in compounds 215, 219 and 221 (an extra pyridine group, a large
bicyclic group and a halide, respectively) that were envisaged to provide further
assessment as to the role of pyridine in causing such a rate enhancement. The
reaction was carried out (25% scaling ratio) for 20 h using pyridine, compounds 215
and 219, low conversion was obtained in all cases (5%). The reaction was then run
on the same scale as had been reported, using pyridine, compounds 215, 219 and
221. Despite the slightly increased conversion achieved, they were still considered
too low to be any practical value with respect to their role in the reaction.
Epoxidation of aromatic olefins (trans-stilbene or trans-chalcone) have been studied
using iron complex (FeCl2, Fe2(CO)9 and Fe(OTf)2) and chiral ligand 215 in MeCN
or DCM using peracetic acid as an oxidant, although moderate conversions were
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obtained, the results show that the iron complex does not coordinated to the ligand
(low selectivity in all cases).
Inspired by the development of a class of mono-ruthenium tridentate ligands, several
novel compounds were prepared (226, 231, 233 and 238). Compound 226 was not
effective as a coordinating ligand using ATH conditions. This helps to support the
proposal that 3 available sites are needed to ligate to ruthenium to form the active
catalyst.
ATH conditions were optimised using compound 231 or 233 and Ru3(CO)12 as
reagents. It is noteworthy to mention that the use of a base to form the active catalyst
is not needed. A variety of ketones were observed to undergo reduction with high,
and in some cases, almost quantitative conversion. High enantioselectivity was also
achieved, which may be induced via a favourable π/π interaction between the 
substrate and active catalyst. It was found that the presence of meta-methoxy
substituent on the aromatic ring yields optimal results under the ATH conditions
employed (98% conv., 94% e.e.). Also for the reduction of ortho-substituted aryl
ketones, 2-methyl acetophenone yielded optimal results after 48 h, achieving almost
quantitative conversion and e.e. of 93.8%.
In the ATH of acetophenone, combination of both enantiomers of ligand 231 in the
reaction shows no non-linear effect between both ligands configuration (RR and SS).
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3 Experimental
3.1. General experimental:
All the air sensitive reactions were carried out under an argon atmosphere. NMR
spectra were recorded on a Bruker DPX-300 (300 MHz) or a Bruker DPX-400 (400
MHz). All chemical shifts are reported in ppm downfield from TMS (Me4Si).
Coupling constants (J) are reported in Hz. Multiplicity in 1H-NMR is reported as
singlet (s), doublet (d), broad singlet (br s), broad doublet (br d), triplet (t), quartet
(q) and multiplet (m). Mass spectra were recorded on an Esquire 2000. High
resolution mass spectra were recorded on Bruker Micro ToF. Infrared spectra were
recorded on PerkinElmer spectrum100. The optical rotations were measured on
Optical Activity Ltd. AA-1000 Polarimeter. The Chiral HPLC measurements were
carried out on HPLC consisting of a Gilson 811B Dynamic Mixer, a Gilson 805
Monometer Module, a Gilson 305 Piston Pump, Merck-Hitachi L-4000 UV detector
linked to HEWLETT PACKARD 3396 Series II integrator with CHIRAL PAK
IA/IB column (0.46 cm x 25 cm). The chiral GC measurements were done on
HEWLETT PACKARD 5890 linked to HEWLETT PACKARD HP3396A
integrator or PERKIN-ELMER 8500 chromatography linked to PC running
DataApex Clarity software with Chrompak CP-Chirasil Dex Cβ column. Melting 
points were determined on a Stuart scientific melting point apparatus and are
uncorrected. Purification of compounds was done by flash column chromatography
using silica gel LC60A40-63 micron.
The known compounds 160,159 161159, 181113, 114 and 192117, 118 were not included.
Experimental
109
3.2. Procedures for section 2.1
Synthesis of (R,R)-N-(2-benzylamino-1,2-diphenyl-ethyl)-4-
methylbenzenesulfonamide (37b):
This compound is known and fully characterised.102,160 To a stirred solution of (R,R)-
TsDPEN (300 mg, 0.82 mmol) and molecular sieves (1.0 g) in dry MeOH (8.0 cm3),
was added benzaldehyde (0.10 cm3, 0.94 mmol) followed by 3 drops of glacial
AcOH. The reaction was followed by TLC until the imine was formed (3 h) and then
NaBH3CN (0.15 g, 2.39 mmol) was added and the reaction was stirred o/n at r.t. The
molecular sieves were filtered through filter paper and the solution was concentrated
under reduced pressure to remove the MeOH. The residue was dissolved in CHCl3
(50 cm3), washed with saturated NaHCO3 solution (30 cm3) and then dried over
anhydrous MgSO4. The solvent was removed to give a crude product which was
purified by silica gel column chromatography (EtOAc:Hexane, 30:70), to give (R,R)-
N-(2-benzylamino-1,2-diphenyl-ethyl)-4-methylbenzenesulfonamide 37b as a white
solid (0.22 g, 0.48 mmol, 60%). Mp 138-141 C; []D20 = +58.0 (c 0.72, CHCl3);
max(neat) 3338, 3308, 3086, 3064, 3028, 2788, 2713, 1599, 1494, 1453, 1348, 1324
and 1152 cm1; H (300 MHz, CDCl3) 7.37-7.32 (2H, m, ArH), 7.30-7.23 (3H, m,
ArH), 7.18-7.10 (5H, m, ArH), 7.07-7.01 (5H, m, ArH), 6.90-6.07 (4H, m, ArH),
6.15 (1H, br s, NH), 4.30 (1H, d, J 7.8, CHPh), 3.68 (1H, d, J 7.8, CHPh), 3.62 (1H,
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d, J 13.2, CHaHb), 3.41 (1H, d, J 13.2, CHaHb), 2.32 (3H, s, CH3), 1.67 (1H, br s,
NH), C (75 MHz, CDCl3) 142.66 (C), 139.26 (C), 138.96(C), 138.21 (C), 136.93
(C), 129.04 (2 x CH), 128.40 (2 x CH), 128.35 (2 x CH), 128.20 (CH), 127.97 (2 x
CH), 127.88 (2 x CH), 127.52 (3 x CH), 127.45 (2 x CH), 127.23 (CH), 127.09
(CH), 127.04 (2 x CH), 66.74 (CHPh), 63.06 (CHPh), 50.85 (CH2), 21.37 (CH3). m/z
(ESI) 457.1 [M+H]+. HRMS found (ESI) 455.1784 (C28H27N2O2S [MH] requires
455.1788 , error = 0.9 ppm).
Synthesis of (R,R)-N-4-methylbenzyl-1,2-diphenyl-N-tosylethane-1,2-diamine
(157):
This compound has been reported but not fully characterised.159 To a stirred solution
of (R,R)-TsDPEN (300 mg, 0.82 mmol) and molecular sieves (1.0 g) in dry MeOH
(8.0 cm3), was added p-tolualdehyde (0.14 cm3, 1.2 mmol) followed by 3 drops of
glacial AcOH. The reaction was followed by TLC until the imine was formed (3 h)
and then NaBH3CN (0.16 g, 2.39 mmol) was added and the reaction was stirred o/n
at r.t. The molecular sieves were filtered through filter paper and the solution was
concentrated under reduced pressure to remove the MeOH. The residue was
dissolved in CHCl3 (50 cm3), washed with saturated NaHCO3 solution (30 cm3) and
then dried over anhydrous MgSO4. The solvent was removed to give a crude solid
which was purified by silica gel column chromatography (EtOAc:Hexane 35:65) to
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give (R,R)-N-4-methylbenzyl-1,2-diphenyl-N-tosylethane-1,2-diamine 157 as a
white solid (0.27 g, 0.57 mmol, 69%). Mp 150-153 C; []D20 = -38.9 (c 0.50,
CHCl3); max(neat) 3668, 3269, 2974, 2901, 1902, 1600, 1514, 1436, 1325, 1159,
1087, 799, 753, 697 and 669 cm1; H (300 MHz, CDCl3) 7.36 (2H, d, J 8.0, ArH),
7.20-7.08 (6H, m, ArH), 7.10-6.90 (10H, m, ArH), 6.15 (1H, br s , NH), 4.29 (1H, d,
J 7.8, CHPh), 3.60 (1H, d, J 7.8, CHPh), 3.57 (1H, d, J 13.2, CHaHb), 3.37 (1H, d, J
13.2, CHaHb), 2.34 (3H, s, CH3), 2.31 (3H, s, CH3), 1.68 (1H, br s, NH); C (75.47
MHz,CDCl3) 142.70 (C), 138.98 (C), 138.27 (C), 136.99 (C), 136.82 (C), 136.25
(C), 129.15 (2 x CH), 129.11 (2 x CH), 128.41 (2 x CH), 127.99 (2 x CH), 127.94 (2
x CH), 127.58 (3 x CH), 127.54 (2 x CH), 127.29 (CH), 127.12 (2 x CH), 66.95
(CHPh), 63.11 (CHPh), 50.58 (CH2), 21.17 (CH3), 21.13 (CH3. m/z (ESI) 471.2
[M+H]+. HRMS found (ESI) 471.2085 (C29H31N2SO2 [M+H]+ requires 471.2069,
error = 3.4 ppm).
Synthesis of N-[2-(2-bromo-benzylamino)-1,2-diphenyl-ethyl]-4-methyl-
benzenesulfonamide (163):
This compound is novel. The procedure is as same as for preparation of compound
(R,R)-N-(2-benzylamino-1,2-diphenyl-ethyl)-4-methylbenzenesulfonamide 36b,
using (R,R)-TsDPEN (300 mg, 0.82 mmol), molecular sieves (1.0 g), dry MeOH (10
cm3), o-bromobenzaldehyde (0.11 cm3, 0.94 mmol) glacial AcOH (3 drops) and
NaBH3CN (0.15 g, 2.39 mmol to give N-[2-(2-bromo-benzylamino)-1,2-diphenyl-
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ethyl]-4-methyl-benzenesulfonamide 163 as a white solid compound (0.62 g, 1.16
mmol, 85%), Mp 46-49 C; []D25 = -36 (c 0.1, CHCl3); max(neat) cm1 3248, 3028,
1602, 1589, 1389, 1452, 1323, 1153, 1090, 1024, 811, 750 and 665 cm1; H (400
MHz, CDCl3) 7.48 (1H, d, J 7.6, ArH), 7.35 (2H, d, J 8.0, ArH), 7.22 (1H, t, J 7.4,
ArH), 7.16-7.15 (3H, m, ArH), 7.11-7.06 (5H, m, ArH), 7.05-6.95 (6H, m, ArH),
6.05 (1H, br s, NH), 4.32-4.29 (1H, q, J 4.0, CHPh), 3.69 (1H, d, J 7.2, CHPh), 3.64
(1H, d, J 13.2, CHaHb), 3.48 (1H, d, J 13.2, CHaHb), 2.32 (3H, s, CH3); C
(100MHz,CDCl3) 142.64 (C), 138.67 (C), 138.36 (C), 136.89 (C), 132.83 (CH),
130.41 (CH), 129.06 (2 x CH), 128.80 (CH), 128.35 (2 x CH), 127.99 (2 x CH),
127.57 (CH), 127.51 (2 x CH), 127.34 (CH), 127.30 (3 x CH), 127.07 (2 x CH),
124.09 (C), 67.01 (CHPh), 63.13 (CHPh), 51.26 (CH2), 21.39 (CH3). m/z (ESI)
557.0 [M+Na]+. HRMS found (ESI) 535.1048 (C28H28 79Br N2O2S [M+H]+ requires
535.1049, error = 0.3 ppm), found 537.1030 (C28H28 81Br N2O2S [M+H]+ requires
537.1030, error = 0.0 ppm).
Synthesis of (R,R)-N-isobutyl-1,2-diphenyl-N-tosylethane-1,2-diamine (162) :
This compound is known and fully characterised.161 To a stirred solution of (R,R)-
TsDPEN (0.30 g, 0.82 mmol) and molecular sieves (1.0 g) in dry MeOH (8 cm3),
was added isobutyraldehyde (0.08 cm3, 0.96 mmol) followed by 3 drops of glacial
AcOH. The reaction was followed by TLC until the imine was formed (3 h) and then
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NaBH3CN (0.15 g, 2.5 mmol) was added and the reaction was stirred o/n at r.t. The
molecular sieves were filtered through filter paper and the solution was concentrated
under reduced pressure to remove the MeOH. The residue was dissolved in CHCl3
(50 cm3), washed with saturated NaHCO3 solution (30 cm3) and then dried over
anhydrous MgSO4. The solvent was removed to give a crude solid which was
purified by silica gel column chromatography (EtOAc:Hexane 30:70) to afford
(R,R)-N-isobutyl-1,2-diphenyl-N-tosylethane-1,2-diamine 162 as a white solid (0.22
g, 0.52 mmol, 63%). Mp 112–114 C; []D20 = 27 (c 0.5, CHCl3); max(neat) 3358,
3272, 3031, 2958, 2822, 1599, 1495, 1432, 1326, 1275, 1156, 1147, 1089, 915, 844,
807, 765, 753, 697 and 672 cm1; H (300 MHz, CDCl3) 7.36 (2H, d, J 10.8, ArH),
7.13-7.11 (3H, m, ArH), 7.05-7.01 (5H, m, ArH), 6.95-6.87 (4H, m, ArH), 4.23 (1H,
d, J 7.9, CHPh), 3.57 (1H, d, J 7.9, CHPh), 2.33 (3H, s, CH3(C6H4) SO2), 2.22-2.06
(2H, m, CH2), 1.65-1.56 (1H, m, CH), 1.37 (1H, br s, NH), 0.82 (3H, d, J 9.2, CH3),
0.80 (3H, d, J 9.2, CH3); C (75 MHz, CDCl3) 142.69 (C), 139.42 (C), 138.45 (C),
137.05 (C), 129.10 (2 x CH), 128.30 (2 x CH), 127.91 (2 x CH), 127.57 (2 x CH),
127.42 (CH), 127.36 (2 x CH), 127.27 (CH), 127.15 (2 x CH), 68.01 (CH), 63.20
(CH) , 55.25 (CH2), 28.52 (CH) , 21.45 (CH3) , 20.66 (CH3) , 20.41 (CH3). m/z (ESI)
423.2 [M+H]+. HRMS found (ESI) 423.2114 (C25H31N2O2S [M+H]+ requires
423.2096, error = 4.2 ppm).
Synthesis of (R,R)-N-(2-((R,R)-1,2-diphenyl-2-(tosylamino)ethylamino)ethyl)-
1,2-diphenyl-N-tosylethane-1,2-diamine (165):
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This compound is known and fully characterised.161 (R,R)-TsDPEN (1.5 g, 4.0
mmol) and 1,2-dibromoethane (0.17 cm3, 2 mmol) were placed in a glass sealed
vessel and heated at 130 C o/n. The crude product was dissolved in CHCl3 (30 cm3)
and washed with a 20 % NaOH solution (15 cm3). When the NaOH solution was
added, a white solid precipitated. The compound was extracted with CHCl3 (3 x 40
cm3), dried over MgSO4 and the solvent was evaporated providing the crude product
which consisted of the tetradentate ligand and unreacted TsDPEN. The crude product
was purified by silica gel column chromatography (EtOAc:Hexane 40:60) to afford
(R,R)-N-(2-((R,R)-1,2-diphenyl-2-(tosylamino)ethylamino)ethyl)-1,2-diphenyl-N-
tosylethane-1,2-diamine 165 as a white solid (0.73 g, 0.96 mmol, 46%). Mp 169–172
C; []D20 = +22 (c 0.5, CHCl3); max(neat) 3269, 3030, 1599, 1495, 1453, 1329,
1149, 1090, 1056, 937, 809, 763, 696 and 672 cm1; H (300 MHz, CDCl3) 7.45-7.43
(4H, m, ArH), 7.14-7.11 (6H, m, ArH), 7.01-6.92 (12H, m, ArH), 6.87-6.83 (6H, m,
ArH), 4.40 (2H, d, J 8.7, 2PhCHNHTs), 3.72 (2H, d, J 8.7, 2PhCHNHR), 2.40–2.25
(4H, m, 2 x CH2 ), 2.29 (6H, s, 2 x CH3); C (75 MHz, CDCl3) 142.69 (2C), 139.47
(2C), 138.17 (2C), 137.53 (2C), 129.04 (4 x CH), 128.27 (4 x CH), 127.93 (4 x CH),
127.84 (4 x CH), 127.49 (4 x CH), 127.45 (2 x CH), 127.16 (2 x CH), 126.99 (4 x
CH), 68.02 (2 x CH), 63.75 (2 x CH), 46.59 (2 x CH2), 21.42 (2 x CH3). m/z (ESI)
759.3 [M+H]+. HRMS found (ESI) 759.3080 (C44H47N4S2O4 [M+H]+ requires
759.3022, error = 7.6 ppm).
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Synthesis of (S,S)-N-benzyl-1,2-diphenyl-N-tosylethan-1,2-diamine (164):
This compound is novel. To a stirred solution of N-(2-amino-1,2-diphenyl)-4-
methoxy-benzenesulfonamide (0.10 g, 0.26 mmol) and molecular sieves (0.50 g) in
dry MeOH (5.0 cm3), was added benzaldehyde (0.020 cm3, 0.28 mmol) followed by
2 drops of glacial AcOH. The reaction was followed by TLC until the imine was
formed (3 h) and then NaBH3CN (0.065 g, 1.04 mmol) was added and the reaction
was stirred o/n at r.t. The molecular sieves were filtered through filter paper and the
solution was concentrated under reduced pressure to remove the MeOH. The residue
was dissolved in CHCl3 (20 cm3), washed with saturated NaHCO3 solution (10 cm3)
and then dried over anhydrous MgSO4. The solvent was removed to give the crude
compound which was purified by silica gel column chromatography (EtOAc:Hexane
30:70), to afford (S,S)-N-benzyl-1,2-diphenyl-N-tosylethan-1,2-diamine 164 as a
white solid (0.088 g, 0.18 mmol, 69%). Mp 78–81 C; []D31 = + 27.6 (c 0.5,
CHCl3); max(neat) 3325, 3028, 2785, 2362, 1595, 1578, 1496, 1453, 1437, 1323,
1263, 1150, 1048, 1024, 922, 842, 819, 754, 729, 697 and 669 cm1; H(300 MHz;
CDCl3) 7.42–7.40 (2H, d, J 8.8, ArH), 7.31-7.24 (3H, m, ArH), 7.17-7.14 (5H, m,
ArH), 7.05-6.99 (3H, m, ArH), 6.97-6.89 (4H, m, ArH), 6.65 (2H, d, J 8.8, ArH),
6.16 (1H, br s, NHTs), 4.30 (1H, d, J 8.0, PhCHNHTs), 3.76 (3H, s, OCH3), 3.68
(1H, d, J 8.0, PhCHNBn), 3.62 (1H, d, J 13.2, CHaHb), 3.41 (1H, d, J 13.2, CHaHb),
1.71 (1H, br s, NHbenzyl); C (75 MHz; CDCl3): 162.37 (C), 139.19 (C), 138.74 (C),
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137.99 (C), 131.51(C) , 139.14 (2 x CH), 128.42 (2 x CH), 128.38 (2 x CH), 128.01
(2 x CH), 127.91 (2 x CH), 127.69 (CH), 127.54 (2 x CH), 127.48 (2 x CH), 127.28
(CH), 127.21 (CH), 113.60 (2 x CH), 66.76 (CH), 63.09 (CH), 55.46 (CH3), 50.94
(CH2). m/z (ESI) 473.2 [M+H]+. HRMS found (ESI) 473.1895 (C28H29N2SO3
[M+H]+ requires 473.1898, error = 0.6 ppm).
Synthesis of (1R,2R)-N1-(3,5-Dimethylbenzyl)-1,2-diphenyl-N2-tosylethane-1,2-
diamine (158):
This compound is known and fully characterised.159 The procedure is as same as for
preparation of compound (R,R)-N-isobutyl-1,2-diphenyl-N-tosylethane-1,2-diamine
162 to afford (1R,2R)-N1-(3,5-Dimethylbenzyl)-1,2-diphenyl-N2-tosylethane-1,2-
diamine 158 as a white solid (0.35 g, 0.72 mmol, 88%). Mp 127–129 C; []D22 =
36.4 (c 0.48, CHCl3); max(neat) 3340, 3291, 3034, 2915, 2767, 1600, 1493, 1454,
1426, 1323, 1152, 1114, 1088, 1029, 915, 854, 802, 714, 697 and 671 cm1; H (300
MHz; CDCl3) 7.64 – 6.96 (17H, m, ArH), 6.42 (1H, br s, NHTs), 4.56 (1H, d, J 7.2,
PhCHNHTs), 3.95 (1H, d, J 7.3, PhCHNbenzyl), 3.80 (1H, d, J 13.1, CHaHb), 3.59
(1H, d, J 13.1, CHaHb), 2.58 (3H, s, CH3), 2.54 (6H, s, 2CH3), 1.87 (1H, br s,
NHbenzyl); C (75 MHz; CDCl3) 142.62 (C), 139.28 (C), 139.09 (C), 138.43 (C),
137.96 (C), 136.94 (C), 136 23 (C), 129.16 (2 x CH), 129.11 (2 x CH), 128.72 (2 x
CH), 128.41 (3 x CH), 127.98 (2 x CH), 127.5 (2 x CH), 127.93, 127.35 (2 x CH),
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125.62 (CH), 66.8 (CH), 63.0 (CH), 50.8 (CH2), 21.42 (CH3), 21.20 (CH3), 21.11
(CH3). m/z (ESI) 485.2 [M+H]+. HRMS found 485.2259 (C30H33N2SO2 [M+H]+
requirs 485.2252, error = 1.4 ppm).
Synthesis of N,N-bis((R,R)-1,2-diphenyl-2-(tosylamino)ethyl)pyridine-2,6-
dicarboxamide (166):
This compound is novel. (R,R)-TsDPEN (0.3 g, 0.8 mmol) was dissolved161 in DCM
(15 cm3) and then 2,6-pyridinedicarbonyl dichloride (0.08 g, 0.4 mmol) and TEA
(0.1 cm3, 0.8 mmol) were added and the reaction was stirred o/n at r.t. The mixture
was washed with saturated NaHCO3 solution (20 cm3), extracted with CHCl3 (3 x 25
cm3) and then dried over anhydrous MgSO4. The solvent was removed to afford
N,N-bis((R,R)-1,2-diphenyl-2-(tosylamino)ethyl)pyridine-2,6-dicarboxamide 166 as
a light yellow solid (0.34 g, 0.4 mmol, 98 %). Mp 168–170 C; []D20 = +192 (c 0.5,
CHCl3); max(neat) 3338, 3175, 1664, 1524, 1445, 1319, 1152, 1090, 931, 812, 697
and 667 cm1; H (300 MHz, CDCl3) 9.62 (2H, d, J 8.4, ArH), 8.18 (2H, d, J 8.0,
ArH), 7.62 (4H, d, J 8.0, ArH), 7.34-7.32 (4H, m, ArH), 7.17-7.08 (6H, m, ArH),
7.02-6.94 (13H, m, ArH), 6.65 (1H, br s, NH), 5.51 (2H, dd, J 8.4, 8.6,
2PhCHNHTs), 5.10 (2H, d, J 10.4, 2PhCHNHR), 2.27 (6H, s, 2CH3); C (75 MHz;
CDCl3) 163.76 (2 x C=O), 147.76 (2C), 142.50 (2C), 139.20 (2C), 138.75 (CH),
138.23 (2C), 138.02 (2C), 129.07 (6 x CH), 128.20 (3 x CH), 128.08 (3 x CH),
127.95 (3 x CH), 127.69 (4 x CH), 127.33 (CH), 127.24 (2 x CH), 127.06 (6 x CH),
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125.06 (2 x CH), 62.21 (2 x CH), 59.62 (2 x CH), 21.34 (2 x CH3). m/z (ESI) 886.2
[M+Na]+. HRMS found (ESI) 886.2717 (C49H45N5NaS2O6 [M+Na]+ requires
886.2703, error = 2.9 ppm).
Synthesis of (R,R)-N-3-(((R,R)-1,2-diphenyl-2-
(tosylamino)ethylamino)methyl)benzyl)-1,2-diphenyl-N-tosylethane-1,2-
diamine (159):
This compound is novel. The procedure is as same as for preparation of compound
N,N-bis((R,R)-1,2-diphenyl-2-(tosylamino)ethyl)pyridine-2,6-dicarboxamide 166,
using (R,R)-TsDPEN (200 mg, 0.55 mmol), molecular sieves (1.0 g), dry MeOH (10
cm3), phthaldialdehyde (0.04 cm3, 0.27 mmol) glacial AcOH (3 drops) and
NaBH3CN (0.16 g, 2.50 mmol) to give (R,R)-N-3-(((R,R)-1,2-diphenyl-2-
(tosylamino)ethylamino)methyl)benzyl)-1,2-diphenyl-N-tosylethane-1,2-diamine
159 as a white solid (0.18 g, 0.21 mmol, 77%). Mp 70–73 C; []D20 = 57 (c 0.5,
CHCl3); max(neat) 3247, 3028, 2324, 1599, 1493, 1453, 1321, 1153, 1091, 919, 811,
774, 697 and 667 cm1; H (300 MHz; CDCl3) 7.38-7.36 (4H, m, ArH), 7.24-7.12
(8H, m, ArH), 7.04-6.94 (15H, m, ArH), 6.85-6.83 (5H, m, ArH), 6.34 (2H, br s,
2NH), 4.32 (2H, d, J 8.3, 2PhCHNHTs), 3.77 (2H, d, J 8.0, 2 PhCHNHR), 3.65 (2H,
d, J 13.2, 2 x CHaHb), 3.41 (2H, d, J 13.2, 2 x CHaHb), 2.29 (6H, s, 2 x CH3); C (75
MHz; CDCl3) 142.67 (2C), 139.97 (2C), 139.04 (2C), 138.05 (2C), 136.95 (2C),
129.03 (5 x CH), 128.45 (CH), 128.27 (4 x CH), 127.83 (4 x CH), 127.75 (4 x CH),
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127.52 (2 x CH), 127.46 (5 x CH), 127.41 (CH), 127.08 (4 x CH), 126.95 (2 x CH),
67.17 (2 x CH), 63.38 (2 x CH), 50.40 (2 x CH2), 21.36 (2 x CH3). m/z (ESI) 835.3
[M+H]+. HRMS found (ESI) 835.3360 (C50H51N4S2O4 [M+H]+ requires 835.3334,
error = 3.1 ppm).
Synthesis of (R,R)-N-4-methylbenzyl-N-tosylcyclohexane-1,2-diamine (167):
This compound is novel. To a stirred solution of (R,R)-(−)-N-p-tosyl-1,2-
cyclohexanediamine (0.30 g, 1.1 mmol) and molecular sieves (1.0 g) in dry MeOH
(8.0 cm3), was added p-tolualdehyde (0.14 cm3, 0.1.2 mmol) followed by 3 drops of
glacial AcOH, the reaction was followed by TLC until the imine was formed (3h)
and then NaBH3CN (0.15 g, 2.39 mmol) was added and the reaction was stirred o/n
at r.t. The molecular sieves were filtered through filter paper and the solution was
concentrated under reduced pressure to remove the MeOH. The residue was
dissolved in CHCl3 (50 cm3), washed with saturated NaHCO3 solution (30 cm3) and
then dried over anhydrous MgSO4. The solvent was removed to give a crude product
which was purified by silica gel column chromatography (EtOAc:Hexane 30:70), to
give (R,R)-N-4-methylbenzyl-N-tosylcyclohexane-1,2-diamine 167 as a white solid
(0.35 g, 0.94 mmol, 85%). Mp 120-123C; []D20= -4.60 (c 5.65, CHCl3); max(neat)
3319, 3200, 2942, 2868, 1597, 1448, 1389, 1336, 1272, 1154, 1091, 800, 773, 692
and 660 cm1; H (400 MHz, CDCl3) 7.72 (2H, d, J 8.2 ArH), 7.21 (2H, , d, J 8.0
ArH), 7.13 (4H, s, ArH), 3.73 (1H, d, J 13.1 CHaHb), 3.53 (1H, d, J 13.1 CHaHb),
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2.71-2.65 (1H, m, CHNHTs), 2.38 (3H, s, CH3), 2.35 (3H, s, CH3), 2.28-2.23 (1H,
m, CHNHbenzyl), 2.15-2.07 (2H, m, CH2), 1.70-1.62 (2H, m, CH2), 1.22-0.95 (4H,
m, 2 x CH2); C (100 MHz; CDCl3) 142.91 (C), 137.15 (C), 136.62 (C), 136.28 (C),
129.35 (2 x CH), 128.85 (2 x CH), 127.78 (2 x CH), 126.92 (2 x CH), 59.42 (CH),
57.12 (CH), 49.44 (CH2), 32.66 (CH2), 30.81 (CH2), 24.33 (CH2), 24.30 (CH2),
21.27 (CH3), 20.64 (CH3). m/z (ESI) 373.2 [M+H]+. HRMS found (ESI) 373.1939
(C21H29N2SO2 [M+H]+ requires 373.1944, error = 1.4 ppm).
Synthesis of (R,R)-N,N-dibenzyl-1,2-diphenylethane-1,2-diamine (168) :
This compound has been reported and fully characterised.162-166 (R,R)-DPEN (0.50 g,
2.36 mmol), benzyl bromide (0.56 cm3, 4.72 mmol), K2CO3 (0.72 g, 5.19 mmol),
and THF (20 cm3) were stirred at r.t for 48 h. The reaction mixture was concentrated
under reduced pressure, diluted with EtOAc (40 cm3), washed with water (3x 20
cm3), dried over anhydrous MgSO4 and concentrated under reduced pressure, the
product was isolated by gradient flash column chromatography (EtOAc:Hexane
10:90), to give (R,R)-N,N-dibenzyl-1,2-diphenylethane-1,2-diamine 168 as a clear
colourless oil (0.49 g, 1.25 mmol, 53%). [α]D
27 = +32.4 (c 1.0 in CHCl3); vmax (neat)
3058.9, 2115.6, 2004.8, 1735.3 and 1589.6 cm-1; H (300 MHz; CDCl3) 7.30-7.19
(10H, m, ArH), 7.19-7.12 (6H, m, ArH), 7.05-7.03 (4H, m, ArH), 3.71 (2H, s, 2 x
CHPh), 3.66 (2H, d, J 13.3, 2 x CHaHb), 3.49 (2H, d, J 13.3, 2 x CHaHb), 2.33 (2H,
br s, NH2); C (75 MHz ) 141.18 (2C), 140 61 (2C), 128.28 (3 x CH), 128.07 (3 x
CH), 127.95 (5 x CH), 127.44 (5 x CH), 126.88 (2 x CH), 126.74 (2 x CH), 68.36 (2
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x CHPh), 51.35 (2 x CH2). m/z (ESI) 393.2 [M+H]+. HRMS found (ESI) 393.2328
(C28H29N2 [M+H]+ requires 393.2325, error = 7.6 ppm).
Synthesis of 4-methyl-N-((R,R)-2{[(4-methylphenyl)sulfonyl]amino}-1,2-
diphenylethyl)benzenesulfonamide (206):
This compound has been reported but not fully characterised.161, 102, 103
To a solution of (R,R)-TsDPEN (0.5 g, 1.37 mmol) and TEA (0.21 cm3, 1.5 mmol)
in DCM (10 cm3) cooled in an ice-bath was added p-toluenesulfonyl chloride (0. 26
g, 1.37 mmol) in DCM (2 cm3) in a dropwise manner. The mixture was stirred for 30
min and then warmed to r.t. The reaction progress was monitored by TLC and the
reaction was found to be complete after 16 h. The resulting mixture was washed with
water (20 cm3), saturated NaHCO3 (20 cm3), brine (20 cm3) and then was dried over
anhydrous MgSO4. The product was isolated by gradient flash column
chromatography (EtOAc:Hexane 30:70), to give 4-methyl-N-((R,R)-2{[(4-
methylphenyl)sulfonyl]amino}-1,2-diphenylethyl)benzenesulfonamide 206 as a fine
white solid (0.25 g, 0.48 mmol, 88%). Mp 209–210 C; []D22 = +40.5 (c 1.76,
CHCl3); max(neat) 3311, 1456, 1326, 1152, 1082, 1062, 913, 807, 754, and 666
cm1; H (400 MHz; CDCl3) 7.47 (4H, d, J 8.0, ArH), 7.71-6.93 (10H, m, ArH), 6.71
(4H, d, J 8.0, ArH), 5.45-5.42 (2H, m, 2x NH), 4.46-4.43 (2H, m, 2 x CHNH), 2.33
(6H, s, 2 x C6H4CH3); C (100 MHz; CDCl3) 143.11 (2C), 136.82 (2C), 136.21
(2C), 129.24 (4 x CH), 128.01 (4 x CH), 127.62 (2 x CH), 127.55 (4 x CH),
127.10 (4 x CH), 62.33 (2 x CHPh), 21.41 (2 x CH3). m/z (ESI) 543.1 [M+Na]+.
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HRMS found (ESI) 543.1379 (C28H28N2NaO4S2 [M+Na]+ requires 543.1383, error =
0.7 ppm); found: C, 64.8; H, 5.3; N, 5.6; S, 13.4 %. Calculated for C28H28N2O4S2: C,
64.6; H, 5.4; N, 5.5; S, 12.3 %.
3.3. Procedures for section 2.3
Synthesis of N-(2-amino-1,2-diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-
bicyclo[2.2.1]hept-1-yl)-methanesulfonamide (173):
This compound is known and fully characterized.107-111 (R,R)-DPEN (0.2 g, 0.94
mmol) was dissolved in DCM (15 cm3) and the reaction was cooled to 0 C, then
TEA (0.14 cm3, 1mmol) was added followed by (1S)-(+)-camphorsulfonyl chloride
(0.25 g, 1mmol). The system was allowed to stay at r.t. and stirred o/n. The mixture
was washed with water (10 cm3) and the organic phase was separated, dried over
anhydrous MgSO4 and solvent removed, which was purified by silica gel column
chromatography using (EtOAc:Hexane:MeOH 1:1:1), to give N-(2-amino-1,2-
diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-
methanesulfonamide 173 as a white solid compound (0.25 g, 0.60 mmol, 60%). Mp
58-61 C; []D25 = +40.3 (c 0.12, CHCl3); max(neat) 3276, 2954, 1735, 1601, 1453,
1321, 1143, 1049, 919, 765, 699 cm1; H (300 MHz, CDCl3) 7.25-7.22 (3H, m,
ArH), 7.21-7.18 (4H, m, ArH), 7.17-7.12 (3H, m, ArH), 6.60 (1H, br s, NH), 4.60 (
1H, m, CHPh), 4.25 (1H, d, J 6.9, CHPh), 2.63 (1H, d, J 15.0, CHaHb), 2.47 (1H, d,
J 15.0, CHaHb), 2.44 (1H, m, -CH-camphor), 1.99 (4H, m, 2 x CH2(camphor)), 1.87
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(1H, m, -CH2(camphor)), 1.67 (1H, br s, NH), 1.37 (1H, m, -CH2(camphor)), 0.78
(3H, s, CH3), 0.39 (3H, s, CH3); C (75 MHz,CDCl3) 216.65 (C=O), 141.43 (C),
139.23 (C), 128.48 (2 x CH), 128.28 (2 x CH), 127.68 (CH), 127.60 (2 x CH),
127.51 (CH), 127.17 (2 x CH), 64.93 (CHPh), 60.66 (CHPh), 59.39, 51.68 (CH2),
48.17, 43.03 (CH2), 42.43 (CH2), 27.24 (CH2), 26.73 (CH2), 19.50 (CH3), 19.24
(CH3). m/z (ESI) 425.0 [MH] . HRMS found (ESI) 427.2049 (C24H31N2O3S
[M+H]+ requires 427.2050, error = 0.2 ppm).
Synthesis of N-[2-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-1,2-diphenyl-ethyl]-4-methyl-
benzenesulfonamide(171):
This compound is novel. The procedure is as same as for preparation of compound
N-(2-amino-1,2-diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-
methanesulfonamide 173 using (R,R)-TsDPEN (513 mg, 1.40 mmol), TEA (0.21
cm3, 1.50 mmol), DCM (15 cm3) was added to (1S)-(+)-camphorsulfonyl chloride
(0.38 g, 1.50 mmol) to give N-[2-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-1,2-diphenyl-ethyl]-4-methyl-benzenesulfonamide 171 as
a white solid compound (0.49 g, 0.83 mmol, 61%). Mp 93-96 C; []D24 = +56.1 (c
0.10, CHCl3); max(neat) 3670, 2979, 1733, 1382, 1242, 1056, 892, and 698 cm1; H
(300 MHz, CDCl3) 7.48 (2H, d, J 6.3, Ar-H), 7.13-7.08 (4H, m, Ar-H), 7.04-6.93
(5H, m, Ar-H), 6.83-6.81 (2H, m, Ar-H), 6.58 (1H, d, J 7.2, Ar-H), 5.6 (1H, d J 3.3,
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NH), 4.59 (1H, t, J 7.2, CHPh), 4.52 (1H, q, J 3.3, CHPh), 2.67 (1H, d, J 11.4,
CHaHb), 2.59 (1H, d, J 11.4, CHaHb), 2.34 (3H, s, -CH3-tosyl), 2.23 (1H, m, -CH-
camphor), 1.92-1.86 (4H, m, 2 x CH2-camphor), 1.38 (1H, t, J 7.2, CH2-camphor),
1.26 (1H, t, J 5.4, CH2-camphor), 0.76 ( 3H, s, CH3), 0.30 (3H, s, CH3); C (75
MHz,CDCl3) 216.69 (C=O), 142.96 (C), 137.05 (C), 136.64 (2 x C), 136.61 (2 x C),
129.18 (2 x CH), 128.57 (2 x CH), 128.24 (CH), 128.09 (2 x CH), 127.96 (2 x CH),
127.89 (2 x CH), 127.57 (CH), 127.24 (2 x CH), 63.29 (CHPh), 62.19 (CHPh), 59.47
(C), 52.19 (CH2), 48.74 (C), 43.01 (CH2), 42.95 (CH), 27.62 (CH2), 26.98 (CH2),
21.46 (CH3), 19.40 (CH3), 19.08 (CH3). m/z (ESI) 579.0 [MH]. HRMS found(ESI)
579.1975 (C31H37N2O5S2 [MH] requires 579.1983, error = 2.1 ppm).
Synthesis of N-[2-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-cyclohexyl]-4-methyl-benzenesulfonamide (172):
This compound is known and fully characterized106, The procedure is as same as for
preparation of compound N-(2-amino-1,2-diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-
bicyclo[2.2.1]hept-1-yl)-methanesulfonamide 173, using (R,R)-(−)-N-p-tosyl-1,2-
cyclohexanediamine (380 mg, 1.40 mmol), TEA (0.21 cm3, 1.50 mmol), DCM (15
cm3) (1S)-(+)-camphorsulfonyl chloride (0.38 g, 1.5 mmol) to give N-[2-(7,7-
dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-cyclohexyl]-4-
methyl-benzenesulfonamide 172 as a white solid (0.49 g, 1.02 mmol, 73%). Mp 67-
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69 C; []D24 = +27.4 (c 1.0, CHCl3), lit17 []D22= 23.3 (c 1.2, CHCl3); max(neat)
3275, 2938, 1737, 1599, 1444, 1322, 1152, 1090, and 901 cm1; H (300 MHz,
CDCl3) 7.78 (2H, d, J 8.4, ArH), 7.30 (2H, d, J 8.4, ArH), 5.41 (1H, br s, NH), 5.13
(1H, d, J 6.8, NH), 3.39 (1H, d, J 15.2, CHaHb), 3.12 (1H, m, CHNHTs), 3.02 (1H, d,
J 15.2, CHaHb), 2.84-2.76 (1H, m, CHNHSO2), 2.42 ( 3H, s, CH3-Ar), 2.30-1.15
(15H, m, (CH2)4, (CH2)2 CHCH2), 1.03 (3H, s, C(CH3)), 0.903 (3H, s, C(CH3); C
(75 MHz,CDCl3) 216.77 (C=O), 143.21 (C), 137.33 (C), 129.61 (2 x CH), 127.13 (2
x CH), 59.29 (C), 57.31 (CH), 56.88 (CH), 51.23 (CH2), 48.72 (C), 42.90 (CH2),
42.66 (CH), 33.59 (CH2), 33.33 (CH2), 27.08 (CH2), 26.52 (CH2), 24.49 (CH2),
24.12 (CH2), 21.51 (CH3), 19.80 (CH3), 19.61 (CH3). m/z (ESI) 481.0 [MH].
HRMS found (ESI) 483.1830 (C23H35N2O5S2 [M+H]+ requires 483.1836, error = 1.4
ppm).
Synthesis of C-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-N-[2-(7,7-dimethyl-
2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-cyclohexyl]-
methanesulfonamide (174):
This compound is novel. The procedure is as same as for preparation of compound
N-(2-amino-1,2-diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-
methanesulfonamide 173, using (R,R)-1,2-diaminocyclohexane (432 mg, 3.78
mmol), TEA (0.56 cm3, 4.03 mmol), DCM (15 cm3) was added to (1S)-(+)-
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camphorsulfonyl chloride (1.01 g, 4.03 mmol) to give C-(7,7-dimethyl-2-oxo-
bicyclo[2.2.1]hept-1-yl)-N-[2-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-cyclohexyl]-methanesulfonamide 174 as a white solid
(0.86 g, 1.6 mmol, 69% ). Mp 188-190 C; []D25 = +52.3 (c 0.11, CHCl3);
max(neat) 3221, 2932, 1735, 1466, 1313, 1200, 1181, 1067, 1046, 898, 757, 709
cm1; H (300 MHz, CDCl3) 5.44 (2H, d, J 4.8, 2 x NH), 3.55 (2H, d, J 11.4, CH2),
3.28 (2H, m, 2 x CH), 2.99 (2H, d, J 11.1, CH2), 2.41-1.25 (22H, m, (CH2)4, 2 x
(CH2)2 CHCH2), 1.07 ( 6H, s, 2 x CH3), 0.89 (6H, s, 2 x CH3); C (75 MHz,CDCl3)
216.99 (2 x CO), 58.99 ( 2 C), 56.56 (2 x CH), 51.10 (2 x CH2), 48.36 (2 x C), 43.09
(2 x CH2), 42.73 (2 x CH), 34.09 (2 x CH2), 27.01 (2 x CH2), 25.31 (2 x CH2),
24.06 (2 x CH2), 19.79 (2 x CH3), 19.66 (2 x CH3). m/z (ESI) 541.0 [MH].
HRMS found (ESI) 541.2413 (C26H41N2O6S2 [MH] requires 541.2412, error = 0.3
ppm).
Synthesis of N-(2-benzylamino-1,2-diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-
bicyclo[2.2.1]hept-1-yl)-methanesulfonamide (175):
This compound is novel. To a stirred solution of N-(2-amino-1,2-diphenyl-ethyl)-C-
(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-methanesulfonamide 173 (0.48 g, 1.13
mmol) and molecular sieves (1.0 g) in dry MeOH (8.0 cm3), was added
benzaldehyde (0.18 cm3, 1.25 mmol) followed by 3 drops of glacial AcOH, the
reaction was followed by TLC until the imine was formed (3h) and then NaBH3CN
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(0.21 g, 3.30 mmol) was added and the reaction left to stirrer o/n at r.t. The
molecular sieves were filtered through filter paper and the solution was concentrated
under reduced pressure to remove the MeOH. The residue was dissolved in CHCl3
(50 cm3), washed with saturated NaHCO3 solution (30 cm3) and then dried over
anhydrous MgSO4. The solvent was removed to give a crude solid compound, which
was purified by silica gel column chromatography (EtOAc:Hexane 30:70), to give N-
(2-benzylamino-1,2-diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-
methanesulfonamide 175 as a white solid (0.48 g, 0.93 mmol, 83%). Mp 52-55 C;
[]D24 = +22.5 (c 0.12, CHCl3); max(neat) 3662, 2964, 1736, 1454, 1328, 1145,
1048, 918 cm1; H (300 MHz, CDCl3) 7.37-7.28 (2H, m, ArH), 7.26-7.23 (4H, m,
ArH), 7.18-7.12 (7H, m, ArH), 7.09-7.06 (2H, m, ArH), 6.54 (1H, d, J 7.2, NH),
4.62 (1H, t, J 7.8, CHPh), 3.87 (1H, d, J 8.4, CHPh), 3.73 (1H, d, J 13.5, CHaHb),
3.49 (1H, d, J 13.5, CHaHb), 2.68 (1H, d, J 15.0, CHcHd), 2.40 (1H, d, J 15.0,
CHcHd), 2.29-1.35 (7H, m, (CH2)2CHCH2-camphor), 0.75 (3H, s, CH3), 0.35 (3H, s,
CH3); C (75 MHz,CDCl3) 139.93 (C), 139.35 (C), 138.49 (C), 128.32 (4 x CH),
128.15 (4 x CH), 128.05 (2 x CH), 127.99 (2 x CH), 127.68 (CH), 127.47 (CH),
126.88 (CH), 66.45 (CHPh), 64.09 (CHPh), 59.11 (C), 51.16 (CH2), 50.84 (CH2),
48.34 (C), 42.76 (CH2), 42.48 (CH), 26.91 (CH2), 26.86 (CH2), 19.40 (CH3), 19.21
(CH3). m/z (ESI) 517.2 [M+H]+. HRMS found (ESI) 517.2517 (C31H37N2O3S
[M+H]+ requires 517.2519, error = 1.2 ppm).
Synthesis of N-[2-(2-hydroxyimino-7,7-dimethyl-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-1,2-diphenyl-ethyl]-4-methyl-benzenesulfonamide
(179):
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This compound is novel. Hydroxylamine hydrochloride167 (0.171 g, 2.46 mmol), N-
[2-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-1,2-diphenyl-
ethyl]-4-methyl-benzenesulfonamide 171 (0.66 g, 1.13 mmol) and pyridine (0.16
cm3, 2.07 mmol), were heated under reflux in EtOH (10 cm3) for 5 h. After cooling
most of the EtOH in the reaction mixture was removed. Water was then added
causing the crude oxime to precipate from the solution as a white crystals which was
isolated by filtration and washed by distilled water. The crystals materials was
collected, dried under vacuum to afford N-[2-(2-hydroxyimino-7,7-dimethyl-
bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-1,2-diphenyl-ethyl]-4-methyl-
benzenesulfonamide 179 as a white fine solid ( 0.64 g, 1.07 mmol, 91%). Mp 120-
124 C; []D24 = -24.5 (c 0.10, CHCl3); max(neat) 3261, 2294, 1457, 1319, 1147,
1057, 926, 811, 768, 768 and 698 cm1; H (100 MHz, CDCl3) 8.16 ( 1H, s, NOH),
7.45 (2H, d, J 8.4, ArH), 7.18-7.09 (4H, m, ArH), 7.03-6.94 (6H, m, ArH), 6.85-6.82
(2H, m, ArH), 6.01 ( 1H, br, s, NH), 4.68 (2H, d, J 6.9, 2 x CHPh), 2.76 (1H, d, J
15.0, CHaHb), 2.55 (1H, d, J 15.0, CHaHb), 2.30 (3H, s, CH3), 2.10-1.81 (6H, m, 3 x
CH2-camphor), 1.32-1.25 (1H, m, CH-camphor), 0.73 (3H, s, CH3), 0.46 (3H, s,
CH3), 0.31 (1H, br s, NH); C (75 MHz,CDCl3) 167.31 (C), 143.07 (C), 137.24 (C),
137.01 (C), 136.89 (C), 129.07 (2 x CH), 128.40 (2 x CH), 128.36 (2 x CH), 127.98
(CH), 127.77 (2 x CH), 127.67 (2 x CH), 127.38 (CH), 127.05 (2 x CH), 62.92
(CHPh), 61.93 (CHPh), 54.58 (CH2), 53.09 (C), 50.71 (C), 42.83 (CH), 33.01 (CH2),
Experimental
129
30.62 (CH2), 27.39 (CH2), 21.26 (CH3), 19.35 (CH3), 18.46 (CH3). m/z (ESI) 594.0
[MH]. HRMS found (ESI) 594.2109 (C31H36N3O5S2 [MH] requires 594.2102,
error = 1.1 ppm).
Synthesis of N-[2-(2-hydroxyimino-7,7-dimethyl-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-cyclohexyl]-4-methyl-benzenesulfonamide (180):
This compound is novel. The procedure is as same as for preparation of compound
N-[2-(2-hydroxyimino-7,7-dimethyl-bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-
1,2-diphenyl-ethyl]-4-methyl-benzenesulfonamide 179, using hydroxylamine
hydrochloride (97.8 mg, 1.35 mmol), N-[2-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-
1-ylmethanesulfonylamino)-cyclohexyl]-4-methyl-benzenesulfonamide (300 mg,
0.622 mmol), dry EtOH (10 cm3), pyridine (0.08 cm3, 0.94 mmol), to give N-[2-(2-
hydroxyimino-7,7-dimethyl-bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-
cyclohexyl]-4-methyl-benzenesulfonamide 180 as a white solid (0.19 g, 0.38 mmol,
62%). Mp 118-122 C; []D24 = -13.5 (c 0.10, CHCl3); max(neat) 3244, 2938, 1595,
1440, 1317, 1184, 1091, 928, 905, 843 and 665cm1; H (300 MHz, CDCl3) 8.32
(1H, s, NOH), 7.76 (2H, d, J 8.1, ArH), 7.29 (2H, d, J 8.1 ArH), 6.09 (1H, d, J 6.3,
NH), 5.59 (1H, d, J 6.3, NH), 3.48 (1H, d, J 15.0, CH), 3.15 (1H, d, J 15.0, CH),
2.99-2.89 (1H, m, CHaHb), 2.66-2.62 (1H, m, CHaHb), 2.43 (3H, s, CH3), 2.28-1.14
(15H, m, (CH2)2CHCH2-camphor, (CH2)4-hexyl), 0.97 ( 3H, s, CH3), 0.87 ( 3H, s,
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CH3); C (100 MHz,CDCl3) 167.83 (C), 143.11 (C), 137.55 (C), 129.69 (2 x CH),
127.07 (2 x CH), 57.07 (CH), 56.71 (CH), 54.90 (2 x CH2), 53.02 (C), 50.81 (C),
43.03 (CH), 33.95 (CH2), 33.30 (CH2), 33.18 (CH2), 29.52 (CH2), 27.33 (CH2),
24.33 (CH2), 21.53 (CH3), 19.49 (CH3), 18.87 (CH3). m/z (ESI) 496.0 [MH].
HRMS found (ESI) 496.1942 (C23H34N3O5S2 [MH] requires 496.1945, error = 0.7
ppm).
Synthesis of N-(2-amino-1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-
bicyclo[2.2.1]hept-1-yl)-methanesulfonamide (187):
This compound is novel. In a three-necked flask168 equipped with a reflux condenser,
N-(2-amino-1,2-diphenyl-ethyl)-C-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-
methanesulfonamide 173 (2.05 g, 4.80 mmol) was dissolved in a mixed solvent (10
cm3, MeOH/THF 1:1). To this, NaBH4 (0.70 g, 18.2 mmol) was added slowly. The
mixture was stirred for another 4 h. The reaction mixture was quenched with
saturated aqueous ammonium chloride, and the solid was filtered. The filtrate was
extracted with DCM (3 x 10 cm3). The organic phase was washed with water (3 x 10
cm3) and was dried over anhydrous MgSO4. The solvent was removed under reduced
pressure. The crude product was recrystallized from acetone and n-hexane to give N-
(2-amino-1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-yl)-
methanesulfonamide 187 as a white crystals ( 1.96 g, 4.6 mmol, 91%). Mp 66-69
C; []D25 = -47.8 (c 0.10, CHCl3); max(neat) 3510, 2951, 1602, 1453, 1389, 1371,
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1138, 1074, 1057, 762 and 698 cm1; H (400 MHz, CDCl3) 7.44-7.42 (4H, m, ArH),
7.40-7.35 (4H, m, ArH), 7.33-7.29 (2H, m, ArH), 6.10 (1H, br s, NH), 4.56 (1H, d, J
4.3, CHPh), 4.40 (1H, d, J 4.3, CHPh), 3.92-3.88 (1H, m, CH), 2.59 (1H, d, J 13.6,
CHaHb), 1.89 (1H, d, J 13.6, CHaHb), 1.71-1.33 (7H, m, (CH2)2CHCH2-camphor),
1.03-0.96 (1H, m, NH), 0.81 (3H, s, CH3), 0.49 (3H, s, CH3); C (100 MHz,CDCl3)
141.84 (C), 139.98 (C), 128.77 (2 x CH), 128.72 (2 x CH), 128.15 (CH), 127.86
(CH), 126.77 (2 x CH), 126.67 (2 x CH), 76.47 (CHPh), 63.33 (CHPh), 59.88 (CH),
52.18 (CH2), 50.01 (C), 48.31 (C), 44.28 (CH), 38.77 (CH2), 30.47 (CH2), 27.11
(CH2), 20.09 (CH3), 19.53 (CH3). m/z (ESI) 427.0 [MH]. HRMS found (ESI)
429.2206 (C24H33N2O3S [M+H]+ requires 429.2206, error = 0 ppm).
Synthesis of N-(2-benzylamino-1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-
bicyclo[2.2.1]hept-1-yl)-methanesulfonamide (188):
This compound is novel. The procedure is as same as for preparation of compound
N-(2-amino-1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-
yl)-methanesulfonamide 187, using N-(2-benzylamino-1,2-diphenyl-ethyl)-C-(7,7-
dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-methanesulfonamide 175 (280 mg, 0.54
mmol), MeOH/THF 1:1, 10 cm3), was added NaBH4 (0.78 mg, 2.06 mmol) to give
N-(2-benzylamino-1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-
bicyclo[2.2.1]hept-1-yl)-methanesulfonamide 188 as a white solid compound (0.24
g, 0.46 mmol, 85%). Mp 65-68 C; []D25 = -40.6 (c 0.10, CHCl3); max(neat) cm1
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3255, 2949, 1453, 1389, 1204, 1059, 1027, 845, and 697 cm1; H (400 MHz,
CDCl3) 7.32-7.21 (13H, m, ArH), 7.13 (2H, , d, J 7.2, ArH), 6.1 (1H, br s, NH), 4.53
(1H, d, J 6.8, CHPh), 3.94 (1H, d, J 6.2, OH), 3.52 (1H, d, J 6.8, CHPh), 3.63 (1H,
d, J 13.2, CHaHb), 3.45 (1H, d, J 13.2, CHaHb), 2.73 (1H, d, J 13.6, CHcHd), 1.90
(1H, d, J 13.6, CHcHd), 1.72-1.64 (2H, m, CH2-camphor), 1.59-1.56 (2H, m, CH2-
camphor), 1.39-1.35 (2H, t, J 6.8, CH2-camphor, 1.02-0.96 (1H, m, CH-camphor),
0.82 (3H, s, CH3), 0.43 (3H, s, CH3); C (100 MHz,CDCl3) 139.15 (2C), 138.79 (C),
128.65 (2 x CH), 128.52 (2 x CH), 128.44 (2 x CH), 128.01 (CH), 127.94 (3 x CH),
127.70 (2 x CH), 127.44 (2 x CH), 127.15 (CH), 76.24 (CHPh), 65.76 (CHPh), 63.17
(CH), 52.70 (C), 50.72 (C), 50.0 (CH2), 48.33 (CH2), 44.20 (CH), 38.76 (CH2),
30.32 (CH2), 26.99 (CH2), 20.01 (CH3), 19.55 (CH3). m/z (ESI) 517.0 [MH].
HRMS found (ESI) 519.2669 (C31H39N2O3S [M+H]+ requires 519.2676, error = 1.4
ppm).
Synthesis of N-[2-(2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-1,2-diphenyl-ethyl]-4-methyl-benzenesulfonamide
(189):
This compound is novel. The procedure is as same as for preparation of compound
N-(2-amino-1,2-diphenyl-ethyl)-C-(2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-
yl)-methanesulfonamide 187, using N-[2-(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-
ylmethanesulfonylamino)-cyclohexyl]-4-methyl-benzenesulfonamide 171 (504 mg,
0.87 mmol), MeOH/THF 1:1, 10 cm3), was added NaBH4 (125 mg, 3.3 mmol) to
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give N-[2-(2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-ylmethanesulfonylamino)-
1,2-diphenyl-ethyl]-4-methyl-benzenesulfonamide 189 as a white solid compound
(0.31 g, 0.53 mmol, 62%). Mp 107-110 C; []D26 = +5.85 (c 0.10, CHCl3);
max(neat) cm1 3265, 2952, 1455, 1315, 1206, 1155, 1090, 1059, 930, 764, 750 and
669 cm1; H (300 MHz, CDCl3) 7.45 (2H, d, J 8.1, ArH), 7.20-7.08 (5H, m, ArH),
7.04-6.95 (5H, m, ArH), 6.80 (2H, d, J 6.9, ArH), 5.96 (1H, d, J 7.5, NH), 4.70 (1H,
d, J 7.2, CHPh), 4.59 (1H, d, J 7.3, CHPh), 4.04-3.99 (1H, m, CH), 3.25 (1H, d, J
3.6, OH), 3.02 (1H, d, J 13.8, CHaHb), 2.30 (3H, s, CH3), 2.17 (1H, d, J 13.8,
CHaHb), 1.72-1.22 (6H, m, 3 x CH2-camphor), 1.07-0.99 (IH, m, NH), 0.86 (3H, s,
CH3), 0.46 (3H, s, CH3); C (75 MHz,CDCl3) 144.33 (C), 141.05 (C), 140.41 (C),
139.85 (C), 130.90 (2 x CH), 130.06 (2 x CH), 129.85 (2 x CH), 129.69 (4 x CH),
129.49 (CH), 129.09 (CH), 128.57 (2 x CH), 77.88 (CHPh), 64.53 (CHPh), 64.17
(CH), 55.20 (CH2), 52.01 (C), 50.07 (C), 46.13 (CH), 40.79 (CH2), 32.08 (CH2),
28.84 (CH2), 22.38 (CH3), 21.52 (CH3), 21.11 (CH3). m/z (ESI) 605.0 [M+Na]+.
HRMS found (ESI) 605.2135 (C31H38N2NaO5S2 [M+Na]+ requires 605.2114, error =
3.3 ppm).
Synthesis of (1R,4S)-(-)-camphor oxime (178):
This compound is known and fully characterized.167 Hydroxylamine hydrochloride
(0.20 g, 2.83 mmol), (1R)-(+)-camphor (0.21 g, 1.37 mmol) and pyridine (0.16 cm3,
1.95 mmol) were heated under reflux in EtOH (10 cm3) for 5 h. After cooling, most
of the EtOH in the reaction mixture was removed in vacuo. Water was then added,
causing the crude oxime to precipitate from the solution as colourless crystals, which
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were isolated by filtration and washed with distilled water. The crystalline material
was collected, dried under vacuum and recrystallized from absolute EtOH to afford
(1R,4S)-(-)-camphor oxime 178 (0.1 g, 0.60 mmol, 44%); Mp 119-121 C; []D20 = -
30 (c 1.0, CHCl3); max(neat) cm1 3293,1684 cm-1; H (300 MHz, CDCl3) 8.30 (1H,
s, NOH), 2.56 (1H, dt, J 17.9, 3.9, CH2-camphor), 2.06 (1H, d, J 17.9, CH2-
camphor), 1.94-1.66 (3H, m, CH2 and CH-camphor), 1.51-1.41 ( 1H, m, CH2-
camphor), 1.29-1.20 (1H, m, CH2-camphor), 1.03 (3H, s, CH3), 0.92 (3H, s, CH3),
0.81 (3H, s, CH3); C (75 MHz,CDCl3) 170.13 (C), 51.79 (C), 48.25 (C), 43.71
(CH), 33.04 (CH2), 32.62 (CH2), 27.06 (CH2), 19.43 (CH3), 18.51 (CH3), 11.09
(CH3). m/z (ESI) 168.0 [M+H]+. HRMS found (ESI) 168.1309 (C10H17NO [M+H]+
requires 168.1310, error = 1.4 ppm).
Synthesis of (1R,4S)-(-)-camphor nitrimine (183):
This compound is known and fully characterized.167 (1R, 4S)-(-)-Camphor oxime
(0.15 g, 0.91 mmol) in glacial AcOH (5.0 cm3) was treated with 5% aqueous sodium
nitrite (2.5 cm3). A bright yellow colour developed and dispersed over 30 min. After
a further 1.5 h, the crude product was precipitated as a colourless solid by the
addition of water and isolated by filtration. After drying under vacuum, the crude
product was recrystallized from EtOH to afford (1R, 4S)-(-)-camphor nitrimine 183
as a colourless crystalline solid (0.013g, 0.067 mmol, 44%). Mp 42-45 C; []D20 = -
10 (c 1.0, CHCl3); max(neat) 1645 and 1569 cm1; H (300 MHz, CDCl3) 2.69 (1H,
td, J 18.6, 4.8, CH), 2.13 (1H, d, J 18.6, CH), 2.05-1.79 (3H, m, CH2 and CH), 1.65-
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1.51 (1H, m, CH), 1.37-1.28 (1H, m, CH), 1.04 (3H, s, CH3), 0.98 (3H, s, CH3), 0.88
(3H, s, CH3); C (75 MHz,CDCl3) 189.80 (C), 51.79 (C), 48.25 (C), 43.71 (CH),
33.04 (CH2), 32.62 (CH2), 27.06 (CH2), 19.43 (CH3), 18.51 (CH3), 11.09 (CH3).
found: C, 60.47; H, 8.14; N, 14.07. Calculated for C10H16N2O2: C, 60.58; H, 8.17; N,
14.01.
Synthesis of (1R, 1'R, 2S, 4'R)-1-phenyl-2-(1,7,7-trimethylbicyclo[2.2.1]hept-2-
ylideneamino)propan-1-ol (185):
This compound is known and fully characterized.115 In a round-bottomed flask,
containing a minimal amount of pre-dried 4 A molecular sieves, (1R, 4S)-(-)-
camphor nitrimine (0.12 g, 0.59 mmol) was dissolved in 1,2-dichloroethane (20
cm3). To the resulting solution was added norphedrine (0.08 g, 0.54 mmol) and the
reaction was heated under reflux for 24 h under a nitrogen atmosphere. The reaction
was then gravity filtered and the filtrate was washed with CHCl3 (20 cm3). The
resulting solution was extracted with a saturated aqueous solution of NaHCO3 (3x 15
cm3 ). The organic layer was washed with a saturated aqueous solution of brine (20
cm3) and dried over anhydrous MgSO4. The solvents was removed by rotary
evaporation and crude product was purified by column chromatography
(EtOAc:Hexane, 30:70), to give ((1R,1'R,2S,4'R)-1-phenyl-2-(1,7,7-
trimethylbicyclo[2.2.1]hept-2-ylideneamino)propan-1-ol 185 as a colourless crystals
(0.12 g, 0.42 mmol, 71%). Mp 84-85 C; []D20 = -2.9 (c 1.0, MeOH); max(neat)
3200, 288, 1668, 1043 cm-1; H (300 MHz, CDCl3) 7.38-7.24 (5H, m, ArH), 4.64
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(1H, d, J 5.2, OH(CH)Ph), 3.55-3.49 (1H, m, CH3(CH)NR), 3.36 (1H, br s, OH),
2.27-2.04 (2H, m, CH2-camphor), 1.89-1.68 (3H, m, CH2-camphor and CH), 11.09-
1.04 (2H, m, CH2-camphor), 0.96 (3H, d, J 6.4, CH3 (CH)NR), 0.91 (3H, s, CH3),
0.87 (3H, s, CH3), 0.70 (3H, s, CH3); C (75 MHz,CDCl3) 141.93 (C), 127.87 (2 x
CH), 127.02 (CH), 126.42 (2 x CH), 76.53 (CH), 62.01 (CH), 46.80 (C), 43.42 (CH),
35.44 (C), 31.88 (C), 31.27 (CH2), 27.33 (CH2), 26.64 (CH2), 19.37 (2 x CH3), 18.92
(CH3), 11.47 (CH3). m/z (ESI) 486.1 [M+H]+. HRMS found (ESI) 286.2163
(C19H27NO [M+H]+ requires 286.2152, error = 3.8 ppm). Analysis calculated for
C19H27NO: C, 79.95; H, 9.54; N, 4.91. Found: C, 79.88; H, 9.69; N, 5.12.
3.4. Procedures for section 2.4
Synthesis of N-Tosyl-N-((2-methyl(o-(p-tosyl-1,2-diphenylethyl)-
aminophenyl)sulfonyl)-1,2-diphenyl-1,2-diaminoethane (193):
This compound is novel. 2-Formylbenzenesulfonyl chloride119 192 (0.215 g, 1.05
mmol) was dissolved in DCM (5 cm3) and stirred at r.t. for 10 min, then (R,R)-
TsDPEN (0.771 g, 2.10 mmol) was added followed by TEA ( 0.3 cm3, 2.10 mmol)
and the reaction kept stirring for o/n. The reaction diluted with CHCl3, washing with
water (1 cm3), brine (1 cm3), drying over anhydrous MgSO4 and then solvent
removed to give the imine (0.96 g, 1.09 mmol, 52 %), as a complex mixture and this
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was used directly in the next step. To a stirred solution of the imine (0.803 g, 0.91
mmol) in dry THF (20 cm3) was slowly added 0.5 cm3 LiAlH4 (1M in THF), The
resulting mixture was stirred at r.t. for o/n, the reaction was carefully quenched with
water (0.5 cm3), 15 % NaOH solution (0.5 cm3) and water (1.5 cm3), filtered through
silica, washed with DCM, the organic layer was separated, dried over anhydrous
MgSO4 and then solvent removed. The crude compound was purified by column
chromatography (EtOAc:Hexane 1:1) to give N-Tosyl-N-((2-methyl(o-(p-tosyl-1,2-
diphenylethyl)-aminophenyl)sulfonyl)-1,2-diphenyl-1,2-diaminoethane 193 as a
white solid compound (0.51 g, 0.58 mmol, 64%). Mp 124-128 C; []D25 = + 38.75
(c 0.12, CHCl3); max(neat) 3254, 3030, 1599, 1455, 1319, 1154, 1091, 1063, 925,
810, 757, 697 cm1; H (300 MHz, CDCl3) 7.51-7.36 (8H, m, ArH), 7.23-7.14 ( 5H,
m, ArH), 6.94-6.87 (12H, m, ArH ), 6.85 ( 3H, q, J 5.7, ArH), 6.75 ( 4H, t, J 6.6,
ArH), 6.11 (1H, d, J 4.5, NH), 6.05 (1H, d, J 5.1, NH), 4.81 (1H, q, J 4.8, CHPh),
4.71 (1H, t, J 5.7, CHPh), 4.42 (1H, d, J 7.2, CHPh), 4.09 (1H, d, J 9.6, CHaHb),
3.92 (1H, d, J 7.2, CHPh), 3.83 (1H, d, J 9.6, CHaHb), 2.68 (1H, br s, NH), 2.27
(3H, s, CH3); 2.24 (3H, s, CH3), 1.7 (1H, br s, NH); C (75 MHz,CDCl3) 142.84
(2C), 138.32 (C), 137.93 (C), 137.66 (C), 137.18 (C), 137.04 (C), 136.85(C) , 136.39
(C), 136.19 (C), 132.27 (CH), 131.75 (CH), 129.15 (CH), 129.07 (3 x CH), 129.02
(3 x CH), 128.59 (2 x CH), 128.26 (2 x CH), 128.04 (2 x CH), 127.81 (4 x CH),
127.69 (3 x CH), 127.48 (CH), 127.27 (3 x CH), 127.20 (3 x CH), 127.10 (2 x CH),
126.90 (CH), 69.30 (CH), 63.81 (CH), 63.46 (CH), 62.18 (CH), 50.67 (CH2), 21.36
(CH3), 21.32 (CH3). m/z (ESI) 885.4 [M+H]+. HRMS found (ESI) 885.2801
(C49H49N4O6S3 [M+H]+ requires 885.2809, error 1.1 ppm).
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Synthesis of N-tosyl-N-(2-methyl(o-(p-tosyl-1,2 -diaminocyclohexyl)sulfonyl)-
1,2-diaminocyclohexane) (178):
This compound is novel, The procedure is as same as for preparation of compound
N-tosyl-N-((2-methyl(o-(p-tosyl-1,2-diphenylethyl)-aminophenyl)sulfonyl)-1,2-
diphenyl-1,2-diaminoethane 193, using 2-formylbenzenesulfonyl chloride (0.24 g,
1.16 mmol), DCM (5 cm3), (R,R)-toluene sulfonyl-1,2-diaminocyclohexane (0.85 g,
2.23 mmol), TEA (0.32 cm3, 2.32 mmol), 1.3 cm3 LiAlH4 (1M in THF) to give N-
tosyl-N-(2-methyl(o-(p-tosyl-1,2-diaminocyclohexyl)sulfonyl)-1,2-
diaminocyclohexane 194 as a white solid compound (0.65 g, 0.94 mmol, 67%). Mp
118-121 C; []D25 = +11 (c 0.10, CHCl3); max(neat) 3267, 2933, 1599, 1448, 1319,
1154, 1092, 899, 813, 762, 662 cm1; H (300 MHz, CDCl3) 7.96 (1H, dd, J 1.6, 7.5,
ArH), 7.84 (2H, d, J 6.6, ArH), 7.74 ( 2H, d, J 8.1, ArH) 7.75-7.40 ( 3H, m, ArH),
7.31-7.28 ( 4H, m, ArH), 5.43 (1H, br s, NH), 4.75 (1H d, J 8.7, NH), 4.56 ( 1H, d, J
12.0, CHaHb), 3.68 ( 1H, d, J 12.0, CHaHb), 3.10 (1H, t, J 10.2, CH), 2.98 ( 1H, d, J
8.7, CH), 2.86 ( 1H, t, J 10.8, CH), 2.43 (3H, s, CH3), 2.41 (3H, s, CH3), 2.33-2.28
(1H, m, CH), 1.99-96 (16H, m, CH2-hexyl); C (75 MHz,CDCl3) 143.61 (C), 142.96
(C), 139.97 (C), 138.18 (C), 137.82 (C), 137.13 (C), 132.92 (CH), 132.59 (CH),
129.86 (2 x CH), 129.45 (2 x CH), 128.55 (CH), 127.91 (CH), 127.26 (2 x CH),
126.88 (2 x CH), 62.25 (CH), 57.59 (CH), 57.36 (CH), 56.97 (CH), 50.48 (CH2),
33.20 (CH2), 32.99 (CH2), 31.49 (CH2), 31.12 (CH2), 28.88 (CH2), 24.41 (CH2),
24.25 (CH2), 23.76 (CH2), 21.54 (CH3), 21.52 (CH3). m/z (ESI) 689.4 [M+H]+.
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HRMS found (ESI) 689.2500 (C33H45N4O6S3 [M+H]+ requires 689.2496, error = 0.6
ppm).
Synthesis of N-benzyl-2-(benzylamino-methyl)-benzenesulfonamide (179):
This compound is novel, The procedure is as same as for preparation of compound
N-tosyl-N-((2-methyl(o-(p-tosyl-1,2-diphenylethyl)-aminophenyl)sulfonyl)-1,2-
diphenyl-1,2-diaminoethane 193, using 2-formylbenzenesulfonyl chloride (0.52 g,
2.54 mmol), DCM (5 cm3), benzyl amine (0.55 g, 5.08 mmol), TEA (0.70 cm3, 5.08
mmol), 0.40 cm3 LiAlH4 (1M in THF) to give N-benzyl-2-(benzylamino-methyl)-
benzenesulfonamide 195 as a white solid compound (0.33 g, 0.88 mmol, 74%). Mp
99-103 C; max(neat) 3676, 2988, 1453, 1394, 1230, 1056, 868 and 731 cm1; H
(300 MHz, CDCl3) 8.05 (1H, d, J 5.7, ArH), 7.52-7.43 (2H, m, ArH), 7.30 (1H, m,
ArH), 7.21-7.12 (6H, m, ArH), 7.07-7.02 (4H, m, ArH), 6.7 (1H, br s, NH), 4.24
(2H, s, CH2), 3.94 (2H, s, CH2), 3.69 (2H, s, CH2), 1.59 (1H, br s, NH); C (75
MHz,CDCl3) 139.21 (C), 138.43 (C), 136.77 (C), 136.57 (C), 132.67 (CH), 132.41
(CH), 129.74 (CH), 128.62 (2 x CH), 128.37 (2 x CH), 128.09 (3 x CH), 127.92 (2 x
CH), 127.39 (CH), 127.36 (CH), 53.65 (CH2), 52.51 (CH2), 47.48 (CH2). m/z (ESI)
367.2 [M+H]+. HRMS found 367.1470 (C21H23N2O2S [M+H]+ requires 367.1475,
error = 1.2 ppm).
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Synthesis of 2-(1-benzylamino-ethyl)-N-(1-phenyl-ethyl)-benzenesulfonamide
(180):
This compound is novel, The procedure is as same as for preparation of compound
N-tosyl-N-((2-methyl(o-(p-tosyl-1,2-diphenylethyl)-aminophenyl)sulfonyl)-1,2-
diphenyl-1,2-diaminoethane 193, using 2-formylbenzenesulfonyl chloride (0.63 g,
3.06 mmol), DCM (8 cm3), R-(+)-α-methyl benzyl amine (0.80 cm3, 6.12 mmol),
TEA (0.85 cm3, 6.12 mmol), 1.4 cm3 LiAlH4 (1M in THF) to give 2-(1-
benzylamino-ethyl)-N-(1-phenyl-ethyl)-benzenesulfonamide 196 as a white solid
compound (0.61 g, 1.55 mmol, 56%). Mp 94-97 C; []D24 = +67.7 (c 0.11,
CHCl3); max(neat) 3676, 2973, 1453, 1394, 1309, 1155, 1065, 756 and 696 cm1; H
(300 MHz, CDCl3) 7.88 (1H, m, ArH), 7.43-7.23 ( 7H, m, ArH), 7.16-7.13 ( 4H, m,
ArH), 7.01-6.98 ( 2H, m, ArH), 4.37 (1H, q, J 6.7, CH), 4.03 (1H, d, J 12.0, CHaHb),
3.93 (1H, d, J 12, CHaHb), 3.75 ( 1H, q, J 6.6, CH), 1.28 (3H, d, J 6.9, CH3), 1.25
(3H, d, J 6.8, CH3); C (75 MHz,CDCl3) 143.66 (C), 142.36 (C), 140.08 (C), 136.48
(C), 132.27 (CH), 132.03 (CH), 128.88 (CH), 128.57 (2 x CH), 128.19 (2 x CH),
127.68 (CH), 127.29 (CH), 127.12 (CH), 126.50 (2 x CH), , 126.20 (2 x CH), 58.31
(CH), 54.02 (CH), 50.49 (CH2), 22.79 (CH3), 22.50 (CH3). m/z (ESI) 395.2 [M+H]+.
HRMS found (ESI) 395.1785 (C23H27N2O2S [M+H]+ requires 395.1788, error = 0.2
ppm).
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Synthesis of 2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-2-phenyl-ethylamine
(203):
This compound is known and was fully characterised.121 To a magnetically stirred
solution of L-(-)-norphedrine (0.30 g, 1.98 mmol) and imidazole (0.27 g, 3.98 mmol)
in DCM (5.0 cm3) under nitrogen was added TBSCl (0.32 g, 2.08 mmol). The
reaction was stirred at r.t. for 3 h, quenched with water (3.0 cm3) and extracted with
DCM (5.0 x 3 cm3), the combined organic layer were dried over anhydrous MgSO4,
filtered and concentrated under reduced pressure to yield 2-(tert-butyl-dimethyl-
silanyloxy)-1-methyl-2-phenyl-ethylamine 203 as a viscous yellow compund (0.37
g, 1.39 mmol, 70%); []D28 = -35.8, (c 0.12, CHCl3); max(neat) 2955, 1752, 1471,
1251, 1085, 1061, 915, 773, 743, and 700 cm1; H (400 MHz, CDCl3) 7.30-7.7.23
(5H, m, ArH), 4.41 (1H, d, J 7.2, CH3(CH)NH2), 3.05-2.97 (1H, m, Ph(CH)O), 1.19
(1H, br s, NH), 1.02 (3H, d, J 8.4, CH3(CH)NH2), 0.90 (9H, s, 3 x CH3(CH)Si), 0.03
(3H, s, CH3-Si), -0.18 (3H, s, CH3-Si); C (100 MHz,CDCl3) 141.83 (C), 127.82 (2 x
CH), 127.25 (CH), 127.01 (2 x CH), 80.01(CH-OSi), 53.47 (CHNH2), 25.92 (3 x
CH3-C), 18.87 (CH3CHNH2), 18.143 (CH3), -4.65(CH3-Si), -5.08 (CH3-Si). m/z
(ESI) 266.1 [M+H]+. HRMS found(ESI) 266.1930 (C15H28NOSi [M+H]+ requires
266.1935, error = 1.7 ppm).
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Synthesis of N-(2-hydroxy-1-methyl-2-phenyl-ethyl)-2-[(2-hydroxy-1-methyl-2-
phenyl-ethylamino)-methyl]-benzenesulfonamide (204):
This compound is novel. 2-Formylbenzenesulfonyl chloride119 (0.44 g, 2.13 mmol)
was dissolved in DCM ( 20 cm3), then 2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-
2-phenyl-ethylamine 203 (1.13 g, 4.26 mmol) was added followed by TEA (0.60
cm3, 4.26 mmol) and the reaction kept stirred at r.t. for o/n, diluted with CHCl3 (10
cm3), washed with water (10 cm3) and then with brine (10 cm3), drying over
anhydrous MgSO4. The solvent was removed to give an imine intermediate (1.14 g,
1.67 mmol, 40 % ), which used directly in the next step. To the imine (1.10 g, 1.60
mmol) in dry THF ( 20 cm3) was slowly added 1.5 cm3 LiAlH4 (1M in THF), the
resulting mixture was stirred at r.t. for o/n, the reaction was carefully quenched with
water (0.5 cm3), 15% NaOH aqeous solution (0.5 cm3), and water (1.50 cm3), filtered
through silica, washed with DCM (10 cm3), the organic layer was separated, dried
over anhydrous MgSO4 and solvent removed . Purified by column chromatography
(EtOAc:hexane 60:40) to give N-(2-hydroxy-1-methyl-2-phenyl-ethyl)-2-[(2-
hydroxy-1-methyl-2-phenyl-ethylamino)-methyl]-benzenesulfonamide 204 as a
white solid compound (0.52 g, 1.2 mmol, 71%). Mp 64-68 C; []D26 = + 16.3 (c
0.1, CHCl3); max(neat) 3483, 2978, 1449, 1317, 1160, 1065, 968, 830, 747, and 698
cm1; H (300 MHz, CDCl3) 8.11 (1H, dd, J 2.4, 7.5, ArH), 7.54-7.45 (2H, m, ArH),
7.38-7.35 (2H, m, ArH), 7.33-7.29 (4H, m, ArH), 7.25-7.22 (2H, m, ArH), 7.18-7.15
(3H, m, ArH), 6.80 (1H, br s, NH), 5.07 (1H, d, J 3.3, CH), 4.48 (1H, d, J 2.7, CH),
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4.45 (1H, d, J 12.0, CHaHb), 4.16 (1H, d, J 12.0, CHaHb), 3.69-3.66 (1H, m, CH),
3.08-3.05 (1H, m, CH), 0.97 (3H, d, J 6.6, CH3), 0.82 (3H, d, J 6.9, CH3); C
(75MHz,CDCl3) 141.36 (C), 140.80 (C), 140.43 (C), 137.13 (C), 132.75 (CH),
132.39 (CH), 129.10 (CH), 128.33 (2 x CH), 128.25 (CH), 128.15 (2 x CH), 127.39
(CH), 127.29 (CH), 125.82 (4 x CH), 74.51 (CH), 73.49 (CH), 59.31 (CH), 55.89
(CH), 50.07 (CH2), 13.81 (CH3), 13.29 (CH3). m/z (ESI) 453.0 [MH]. HRMS
found (ESI) 455.2001 (C25H31N2O4S [M+H]+ requires 455.1999, error = 0.4 ppm).
Synthesis of acetic acid acetoxy-(2-chlorosulfonyl-phenyl)-methyl ester (198):
This compound is known but not fully characterized.117 Conc. H2SO4 (2 drops) was
added to a solution of 2-formylbenzenesulfonyl chloride (1.05 g, 5.12 mmol) in
acetic anhydride (1.26 cm3, 12.3 mmol), then the mixture was stirred for 45 min.
Then solvent removed, purified by flash column chromatography using
(EtOAc:hexane 30:70), to give acetic acid acetoxy-(2-chlorosulfonyl-phenyl)-methyl
ester 198 as a white solid (1.13 g, 3.96 mmol, 72%). Mp 72-75 C. max(neat) 3107,
1752, 1437, 1365, 1195, 1178, 1163, 1072, 999, 907, 780 and 733 cm1; H (400
MHz, CDCl3) 8.40 (1H, s,ArCH(OAc)2), 8.17 (1H, dd, J 1.6, 8.0, ArH), 7.91 (1H,
dd, J 1.6, 7.6, ArH), 7.82 (1H, td, J 1.2, 8.8, ArH), 7.67 (1H, td, J 1.6, 9.2, ArH),
2.16 (6H, s, 2 x CH3(COO)); C (100 MHz,CDCl3) 168.11 (2 x CO), 142.25 (C),
135.61 (CH) , 134.41 (C), 130.56 (CH), 129.44 (CH), 128.39 (CH), 85.46 (CH),
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20.60 (2 x CH3). m/z (ESI) 328.9 [M+Na]+. HRMS found (ESI) 328.9852
(C11H11NaClO6S [M+Na]+ requires 328.9857, error= 1.4 ppm).
Synthesis of (R,R)-acetic acid acetoxy-[2-(2-amino-1,2-diphenyl-ethylsulfamoyl)-
phenyl]-methyl ester (199):
This compound is novel. A solution of acetic acid acetoxy-(2-chlorosulfonyl-
phenyl)-methyl ester 198 (0.2 g, 0.67 mmol) in DCM (5.0 cm3) was added to (R,R)-
DPEN (0.14 g, 0.67 mmol), TEA (0.1 cm3 , 0.8 mmol) and DCM (5.0 cm3). The
mixture was stirred for 3 h at r.t., then washed with water (10 cm3), brine (10 cm3)
and dried over anhydrous MgSO4, solvent removed, The product was purified by
flash column using (EtOAc:Hexane 40:60), to give (R,R)-acetic acid acetoxy-[2-(2-
amino-1,2-diphenyl-ethylsulfamoyl)-phenyl]-methyl ester 199 as a white solid
compound (0.28 g, 0.58 mmol, 87%). Mp = 122-125 C; []D22 = +18.2 (c 0.5,
CHCl3); max(neat) 3032, 1751, 1455, 1369, 1325, 1158, 1130, 1044, 723 and 698
cm1; H (400 MHz, CDCl3) 8.45 (1H, s, ArCH(OAc)2), 7.63 (1H, dd, J 1.6, 10.4,
ArH), 7.40 (1H, td, J 1.6, 10.0, ArH), 7.33 (1H, dd, J 1.6, 10.4, ArH), 7.14-7.04
(6H, m, ArH), 6.96-6.88 (5H, m, ArH), 4.53 (1H, d, J 7.2, CHPh), 4.09 (1H, d, J 7.2,
CHPh), 2.18 (3H, s, CH3), 2.14 (3H, s, CH3); C(100 MHz,CDCl3) 171.02 (C=O),
169.94 (C=O), 160.79, 138.61, 137.28, 132.96, 129.68 (CH), 129.34 (CH), 128.47
(CH), 128.18 (2 x CH), 127.91 (2 x CH), 127.84 (CH), 127.06 (2 x CH), 127.36
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(CH), 127.29 (CH), 127.22 (CH), 127.10 (CH), 86.11 (CH), 59.84 (CH), 57.34 (CH),
20.65 (CH3), 20.57 (CH3). m/z (ESI) 483.0 [M+H]+. HRMS found (ESI) 483.1574
(C25H27N2O6S [M+H]+ requires 483.1584, error = 0.1 ppm).
Synthesis of (R,R)-acetic acid acetoxy-[2-(2-benzylamino-1,2-diphenyl-
ethylsulfamoyl)-phenyl]-methyl ester (200):
This compound is novel. A solution120 of (R,R)-acetic acid acetoxy-[2-(2-amino-1,2-
diphenyl-ethylsulfamoyl)-phenyl]-methyl ester 199 (0.15 g, 0.31 mmol) and
benzaldehyde (0.1 cm3, 0.89 mmol) in benzene was refluxed to achieve azeotropic
removal of water for 6 h. After removal of the solvent, a solution of the imine ( 0.56
g, 0.98 mmol) in acetonitrile (10 cm3) was stirred in an ice bath for 15 min., then
NaBH3CN was added (0.12 g, 1.96 mmol), followed by a few drops of AcOH.
Stirring was continued for additional 3 h at r.t. After solvent removed , the product
was dissolved in DCM, washed with saturated NaHCO3 , the organic layer was
separated, dried over anhydrous MgSO4 and solvent removed. The product was
purified by flash column using (EtOAc:Hexane 30:70), to give (R,R)-acetic acid
acetoxy-[2-(2-benzylamino-1,2-diphenyl-ethylsulfamoyl)-phenyl]-methyl ester 200
as a white solid (0.43 g, 0.75 mmol, 76%). Mp 134-137 C; []D25 = +11 (c 0.1,
CHCl3); max(neat) 2987, 2901, 1750, 1494, 1554, 1240, 1199, 1055, 904 and 697
cm1; H (400 MHz, CDCl3) 8.43 (1H, s, ArCH(OAc)2), 7.63 (1H, dd, J 1.6, 10.4,
ArH), 7.44-7.28 (6H, m, ArH), 7.12-6.77 (12H, m, ArH), 4.86 (1H, d, J 11.6,
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CHPh), 3.77 (1H, d, J 11.6, CHPh), 3.66 (1H, d, J 12.0, CHaHb), 3.52 (1H, d, J 12.0,
CHaHb), 2.17 (3H, s, CH3(CO), 2.09 (3H, s, CH3(CO)); C (100 MHz,CDCl3) 168.89
(C=O), 168.85 (C=O), 139.44 (C), 138.96 (C), 138.55 (C), 137.29 (C), 133.35 (C),
132.23 (CH), 129.34 (CH), 129.27 (CH), 128.33 (3 x CH), 128.15 (3 x CH), 127.83
(4 x CH), 127.55 (3 x CH), 127.42 (CH), 127.13 (CH), 126.90 (CH), 86.44 (Ar(CH)-
Ac), 66.80 (CH), 63.93 (CH), 50.74 (CH2), 20.78 (CH3), 20.69 (CH3). m/z (ESI)
571.2 [MH]. HRMS found (ESI) 573.2049 (C32H33N2O6S [M+H]+ requires
573.2054, error = 0.8 ppm).
Synthesis of N-((R,S)-1-hydroxy-1-phenyl-2-propyl)-p-toluenesulfonamide
(207):
This compound is known but not fully characterised.124 (1R,2S)-Norephedrine (0.27
g, 1.85 mmol) was dissolved in THF (20 cm3). To this solution TEA (0.28 cm3, 2.05
mmol) was added and the solution was placed in an ice bath. To this solution, p-
toluenesulfonyl chloride (0.35 g, 1.85 mmol) was added and the water bath was
removed after several minutes. After 1 h, the reaction was quenched with saturated
NaHCO3 (15 cm3) and the THF removed under vacuum after which the
sulphonamide was extracted with EtOAc and the solvents were removed. The
resulting white solid was triturated with diethyl ether to afford N-((1R,2S)-1-
hydroxy-1-phenyl-2-propyl)-p-toluenesulfonamide 207 as viscous white compound
(0.24 g, 0.89 mmol, 51%); []D24 = -2.3 (c 1.0, CH2Cl2); max(neat) 3509, 3208,
1598, 1324, 1160, 1092 and 702; H (400 MHz, CDCl3) 7.77 (2H, d, J 8.4, Ar-H),
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7.34-7.24 (7H, m, Ar-H), 4.85 (1H, d, J 8.4, OH), 4.78 (1H, t, J 4.0, CH), 3.62-3.54
(1H, m, CH), 2.59 (1H, d, J 4.8, NH), 2.42 (3H, s, CH3(Tosyl), 0.84 (3H, d, J 6.8,
CH3(CH)NH; C (100 MHz,CDCl3) 143.48 (C), 140.26 (C), 137.84 (C), 129.75 (2 x
CH), 128.30 (2 x CH), 127.66 (CH), 126.99 (2 x CH), 126.04 (2 x CH), 75.67 (CH),
54.90 (CH), 21.45 (CH3), 14.43 (CH3). m/z (ESI+) 328.1 [M+Na].+ HRMS found
306.1168 (C16H19NO3 S [M+H]+ requires 306.1164, error = 1.3 ppm).
3.5. Procedures for section 2.8
Synthesis of pyridine-2-carboxylic acid 1-pyridin-2-yl-ethyl ester (217):
This compound is known but not fully characterized.148 A solution of pyridine-2-
carboxylic acid (1.0 g, 8.12 mmol) and diisopropylethylamine (1.50 cm3, 8.12 mmol)
in THF (15 cm3) was stirred for 10 min. at 0 C. To the reaction mixture a solution
of triphosgene (0.40 g, 1.35 mmol) in THF (3.00 cm3) was added at 0 C, then stirred
for 1 h. The reaction mixture was additionally stirred for 1 h at r.t. After filtration of
the reaction mixture to remove diisopropylethylammonium chloride, the filtrate was
concentrated under reduced pressure, EtOAc was added to the residue (20 cm3), the
mixture was washed with water (10 cm3). The organic layer was separated and
washed with water (10 cm3), brine (10 cm3), dried over anhydrous MgSO4. The
solvent was evaporated to offered pyridine-2-carboxylic anhydride 217 as brown
viscous compound (0.84 g, 3.68 mmol, 46%); max(neat) 3057, 1781, 1735, 1582,
1467, 1436, 1271, 1243, 1219, 1009, 801, 741 and 691 cm1; H (400 MHz, acetone-
d6) 8.68-8.66 (2H, m, PyH), 8.30-8.28 (2H, m, PyH), 8.08 (2H, td, J 1.6, 7.6, PyH),
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7.69-7.65 (2H, m, PyH); C (100 MHz, acetone-d6) 207.34 (2 x C=O), 164.39 (C),
151.52 (2 x CH), 148.17 (C), 139.61 (2 x CH ), 129.94 (2 x CH), 127.91 (2 x CH).
m/z (ESI) 251.0 [M+Na]+. HRMS found (ESI) 229.0609 (C12H9N2O3 [M+H]+
requires 229.0608, error = 0.4 ppm).
Synthesis of (R)-pyridine-2-carboxylic acid 1-pyridin-2-yl-ethyl ester (215):
This compound is novel. To a stirred solution of pyridine-2-carboxylic anhydride
217 (0.80 g, 3.51 mmol) and DMAP (0.043 g, 0.351 mmol) in DCM (10 cm3) at r.t.
for 10 min, a solution of (R)-1-(pyridin-2-yl) ethanol (0.43 g, 3.51 mmol) in DCM
(3.00 cm3) was added. After the reaction mixture had been stirred for 1 h, it was
quenched with saturated aqueous NaHCO3 (10 cm3). The organic layer was
separated, dried over anhydrous MgSO4, and solvent removed, purified on silica gel
column chromatography (EtOAc:hexane 90:10) to give (R)-pyridine-2-carboxylic
acid 1-pyridin-2-yl-ethyl ester 215 as a viscous yellow compound (0.39 g, 1.70
mmol, 49%); []D28 = +11.2, (c 0.13, CHCl3); max(neat) 2984, 1717, 1588, 1512,
1435, 1242, 1087, 1067, 993 and 744 cm1; H (400 MHz, CDCl3) 8.80 (1H, d, J 5.6,
PyH), 8.60 (1H, d, J 4.8, PyH), 8.17 (1H, d, J 8.0, PyH), 7.84 (1H, td, J 2.0, 8.0,
PyH), 7.69 (1H, td, J 1.6, 7.6, PyH), 7.51-7.47 (2H, m, PyH), 7.22-7.19 (1H, m,
PyH), 6.26 (1H, q, J 6.8, CH), 1.8 (3H, d, J 6.8, CH3); C (100MHz,CDCl3) 164.29
(C=O), 159.92 (C), 149.75 (CH), 148.99 (CH), 147.87 (C), 136.72 (CH), 136.58
(CH), 126.68 (CH), 125.04 (CH), 122.48 (CH), 120.07 (CH), 74.21 (CH), 20.45
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(CH3). m/z (ESI) 251.1 [M+Na]+. HRMS found (ESI) 229.0965 (C13H13N2O2
[M+H]+ requires 229.0972, error= 2.7 ppm).
Synthesis of (R)-pyridine-2-carboxylic acid 1,2,3,4-tetrahydro-naphthalen-1-yl
ester (219):
This compound is novel. The procedure is as same as for the preparation of
compound (R)-pyridine-2-carboxylic acid 1-pyridin-2-yl-ethyl ester 215, using
pyridine-2-carboxylic anhydride 217 (1.4 g, 6.0 mmol), in DCM (10 cm3), DMAP
(0.15 g, 0.6 mmol), (R)-1,2,3,4-tetrahydronaphthalen-1-ol (0.90 cm3, 6.0 mmol) in
DCM (3.00 cm3) to give (R)-pyridine-2-carboxylic acid 1,2,3,4-tetrahydro-
naphthalen-1-yl ester 219 as dark brown solid compound (0.28 g, 1.10 mmol, 48%).
Mp 80-83 C; []D28 = +42.8, (c 0.1, CHCl3); max(neat) 2940, 1703, 1585, 1435,
1288, 1245, 1132, 1058, 995, 741, and 693 cm1; H (400 MHz, CDCl3) 8.79-8.76
(1H, m, PyH), 8.10 (1H, d, J 10.4, PyH), 7.80 (1H, td, J 2.0, 10.0, PyH), 7.47-7.43
(1H, m, PyH), 7.37 (1H, d, J 10.0, ArH), 7.24-7.14 (3H, m, ArH), 6.35 (1H, t, J 6.8,
CH), 2.97-2.75 (2H, m, CH2-hexyl), 2.20-2.06 (3H, m, CH2-hexyl), 1.94-1.85 (1H,
m, CH2-hexyl); C (100 MHz,CDCl3) 164.21 (C=O), 149.65 (CH), 147.95 (C),
137.68 (C), 136.54 (CH), 133.82 (C), 129.17 (CH), 128.72 (CH), 127.83 (CH),
126.40 (CH), 125.78 (CH), 124.78 (CH), 71.29 (CH), 28.80 (CH2), 28.66 (CH2),
18.60 (CH2). m/z (ESI) 276.0 [M+Na]+. HRMS found (ESI) 276.0992
(C16H15NNaO2 [M+Na]+ requires 276.0995, error = 0.2 ppm).
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Synthesis of pyridine-2-carboxylic acid 1-(2-bromo-phenyl)-ethyl ester (221):
This compound is novel. The procedure is as same as for the preparation of
compound (R)-pyridine-2-carboxylic acid 1-pyridin-2-yl-ethyl ester 215, using
pyridine-2-carboxylic anhydride 217 (1.76 g, 7.7 mmol), in DCM (10 cm3), DMAP
(0.19 g, 0.77 mmol), 1-(2-bromophenyl) ethanol (1.55 cm3, 7.7 mmol) in DCM
(3.00 cm3) to give pyridine-2-carboxylic acid 1-(2-bromo-phenyl)-ethyl ester 221 as
a viscous dark brown compounds (1.5 g, 4.92 mmol, 63%); max(neat) 2983, 1717,
1570, 1436, 1301, 1242, 1121, 1086, 1040, 993, 744, and 706 cm1; H (400 MHz,
CDCl3) 8.80-8.78 (1H, m, PyH), 8.13 (1H, d, J 8.0, ArH), 7.83 (1H, td, J 2.0, 8.0,
ArH), 7.61 (1H, dd, J 1.6, 7.6, ArH), 7.55 (1H, dd, J 1.2, 8.0, PyH), 7.49-7.44 (1H,
m, PyH), 7.32 (1H, td, J 1.2, 7.6, PyH), 7.14 (1H, td, J 1.6, 7.6, ArH), 6.49-6.47 (1H,
q, J 6.8, CH), 1.72 (1H, d, J 6.4, CH3); C (100 MHz,CDCl3) 164.26 (C=O), 149.83
(CH), 147.99 (C), 140.63(C), 136.84 (CH), 132.75 (CH), 129.10 (CH), 127.75 (CH),
126.78 (CH), 126.74 (CH), 125.13 (CH), 121.68 (C), 72.94 (CH), 21.03 (CH3). m/z
(ESI) 327.9 [M+Na]+. HRMS found (ESI) 327.9944 (C14H1279BrNaNO2 requires
327.9944 [M+Na]+ error = 0.00 ppm), found 329.9924 (C14H1281BrNaNO2 requires
329.9924 [M+Na]+ error = 0.00 ppm).
3.6. Procedures for section 2.10
Synthesis of (R,R)-pyridine-2-carboxylic acid [2-(toluene-4-sulfonylamino)-
cyclohexyl]-amide (228):
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This compound is known and fully characterized.151 A solution of pyridine-2-
carboxylic acid (0.23 g, 1.86 mmol) and TEA (0.80 cm3, 5.58 mmol) in inhydrous
THF (10 cm3) was treated with ethyl chloroformate (0.16 cm3, 2.05 mmol) at 0 C
for 30 min. A solution of (R,R)-(−)-N-(4-toluenesulfonyl)-1,2-diaminocyclohexane
(0.50 g, 1.86 mmol) in THF (5 cm3) was added dropwise and the reaction mixture
was left at r.t. for o/n. After completion of the reaction (checked by TLC), most of
the THF was removed in vacuo and the crude reaction mixture was partitioned
between EtOAc and water. The organic layer was washed with water (5.0 cm3), brine
(5.0 cm3), and dried over anhydrous MgSO4. It was concentrated in vacuo to give a
crude product, which was purified by silica gel column chromatography using
(EtOAc:Hexane 60:40) to give (R,R)-pyridine-2-carboxylic acid [2-(toluene-4-
sulfonylamino)-cyclohexyl]-amide 228 as a white solid compound (0.63 g, 1.69
mmol, 90%). Analysis was carried out without further purification. Mp 179-182C;
[]D25 = -1.2, (c 0.1, CHCl3); max(neat) 3319, 3062, 2937, 2859, 1657 (C=O stretch),
1594, 1516, 1443, 1318, 1154, 1084 and 1000 cm1; H (400 MHz, CDCl3) 8.42-8.40
(1H, m, PyH), 8.11 (1H, d, J 10.4, PyH), 7.88 (1H, td, J 2.4, 10.4, PyH), 7.65 (1H,
d, J 11.2, PyH), 7.53 (2H, d, J 11.2, ArH), 7.48-7.42 (1H, m, ArH), 6.75 (2H, d, J
10.8, ArH and NH), 5.98 (1H, d, J 7.2, NH), 3.84-3.76 (1H, m, TosylNH(CH), 3.04-
2.96 (1H, m, CONH(CH)), 2.26-2.22 (1H, m, CH2-hexyl), 2.12 (3H, s, CH3), 1.98-
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1.95 (1H, m, CH2-hexyl), 1.78-1.73 (2H, m, CH2-hexyl), 1.51-1.25 (4H, m, 2 x CH2-
hexyl); C (100 MHz,CDCl3) 165.35 (C=O), 148.79 (C), 147.72 (CH), 142.11(C),
137.86 (C), 137.25 (CH), 129.06 (2 x CH), 126.48 (2 x CH), 126.21 (CH), 122.28
(CH), 60.14 (CH), 51.89 (CH), 34.91 (CH2), 32.22 (CH2), 24.53 (CH2), 24.35 (CH2),
21.29 (CH3). m/z (ESI) 374.1 [M+H]+. HRMS found (ESI) 374.1534 (C19H24N3O3S
[M+H]+ requires 374.1533, error = 0.3 ppm).
Synthesis of (R,R)-pyridine-2-carboxylic acid [2-(toluene-4-sulfonylamino)-1, 2-
diphenyl-1, 2-ethylenediamine]-amide (226):
This compound is novel. The procedure is as same as for preparation of compound
(R,R)-pyridine-2-carboxylic acid [2-(toluene-4-sulfonylamino)-cyclohexyl]-amide
228 using pyridine-2-carboxylic acid (0.11 g, 0.82 mmol) and TEA (0.34 cm3, 2.46
mmol) in inhydrous THF (10 cm3),(1R,2R-TsDPEN) (0.3 g, 0.82 mmol), ethyl
chloroformate (0.09 cm3, 0.90 mmol) to yield (R,R)-pyridine-2-carboxylic acid [2-
(toluene-4-sulfonylamino)-1, 2-diphenyl-1, 2-ethylenediamine]-amide 226 as a white
crystalline powder (0.33 mg, 0.708 mmol, 86.5%). Analysis was carried out without
further purification. Mp 229-230 °C; [α]D
27 -52.75 ( c 0.40 in CHCl3); νmax 3351 (N-
H stretch), 3064, 3034, 2934, 1651 (C=O stretch), 1507 , 1331, 1159 (S=O stretch)
and 697 cm-1; δH (400 MHz, CDCl3) 8.78 (1 H, d, J 7.6, NH), 8.48 (1 H, d, J 4.7,
Experimental
153
PyH), 8.21 (1 H, d, J 7.8, PyH), 7.83-7.79 (1 H, m, PyH), 7.42-7.36 (3 H, m, 2 x
ArH + PyH), 7.20-6.9 (10 H, m, ArH), 6.84 (2 H, d, J 4.7, ArH), 5.37 (1 H, dd, J 8.4,
10.0, CHPh), 4.76 (1 H, dd, J 7.6, 10.2, CHPh), 2.19 (3 H, s, CH3); δC (100 MHz,
CDCl3); 165.33 (C=O), 148.68 (C), 148.04 (CH), 142.26 (C), 138.04 (C), 137.95 (2
x C), 137.33 (CH), 128.93 (2 x CH), 128.54 (2 x CH), 127.94 (CH), 127.91(2 x
CH), 127.63 (2 x CH), 127.57 (2 x CH), 127.25 (CH), 126.69 (2 x CH), 126.36
(CH), 122.51 (CH), 64.01 (CH), 59.15 (CH), 21.29 (CH3). m/z (ESI) 472.2 [M+H]+.
HRMS found (ESI) 472.1693 (C27H26N3O3S [M+H]+ requires 472.1689, error = 0.8
ppm).
Synthesis of (R,R)-4-methyl-N-{2-[(pyridin-2-ylmethylene)-amino]-cyclohexyl}-
benzenesulfonamide (232):
This compound is known but not fully characterized.169-170 To a stirred solution of
(1R,2R)-(−)-N-p-tosyl-1,2-cyclohexanediamine (0.5 g, 1.86 mmol) in DCM (20
cm3) were added at r.t. to 2-pyridincaboxaldehyde (0.28 g, 1.86 mmol) in DCM (10
cm3). The mixture was stirred o/n at r.t. Anhydrous MgSO4 was added, the solution
filtered and solvent removed at reduced pressure to obtain (R,R)-4-methyl-N-{2-
[(pyridin-2-ylmethylene)-amino]-cyclohexyl}-benzenesulfonamide 232 as a white
solid compound ( 0.57 g, 1.59 mmol, 87%). Mp 134-137 C; []D27 = +22.5, (c 0.5,
CHCl3); max(neat) 2933, 1654, 1473, 1312, 1091, 1061, 944 932, 733 and 657 cm1;
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H (400 MHz, CDCl3) 8.62-8.60 (1H, m, PyH), 8.25 (1H, s, PyH), 7.67-7.62 (4H, m,
PyH + ArH), 7.33-7.28 (1H, m, ArH), 7.03 (2H, d, J 8.4, ArH + NH), 4.89 (1H, s,
N=CH), 3.36-3.29 (1H, m, CH), 3.08-3.02 (1H, m, CH), 2.29 (3H, s, CH3), 2.26-
2.25 (1H, m, CH2-hexyl), 1.74-1.70 (4H, m, 2 x CH2-hexyl), 1.61-1.55 (1H, m, CH2-
hexyl), 1.38-1.31 (2H, m, CH2-hexyl); C (100 MHz,CDCl3) 161.92 (CH), 154.10
(C), 149.16 (CH), 142.49 (C), 138.06 (C), 136.14 (CH), 129.24 (2 x CH), 126.92 (2
x CH), 124.66 (CH), 121.44 (CH), 72.63 (CH), 57.54 (CH), 33.15 (CH2), 33.02
(CH2), 24.60 (CH2), 23.79 (CH2), 21.45 (CH3). m/z (ESI) 358.1 [M+H]+. HRMS
found (ESI) 358.1595 (C19H24N3O2S [M+H]+ requires 358.1584, error = 1.4 ppm).
Synthesis of (R,R)-4-Methyl-N-{2-[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-
benzenesulfonamide (233):
This compound is known and fully characterized.155-156 (R,R)-4-methyl-N-{2-
[(pyridin-2-ylmethylene)-amino]-cyclohexyl}-benzenesulfonamide 232 (0.50 g, 1.4
mmol) was dissolved in MeOH (20 cm3) and NaBH4 (0.16 g, 4.2 mmol) was added
portionwise and the reaction allowed to stir until all the imine consumed. The
solvent was evaporated and the residue taken up in diethyl ether (15 cm3) and sat.
NaHCO3 (15 cm3). The organic layer was separated and the aqueous layer extracted
with diethyl ether (2 x 15 cm3). The combined organic extracts were dried over
MgSO4, filtered and concentrated in vacuo to afford the crude product, which was
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purified by silica gel column chromatography using (EtOAc:Hexane 30:70) to give
(R,R)-4-methyl-N-{2-[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-
benzenesulfonamide 233 as a white solid (0.31 g, 0.86 mmol, 61%). Mp 102-105
C; []D27 = -21.3, (c 0.38, CH2Cl2), lit35 []D25 = -25, (c 0. 53, CH2Cl2); max(neat)
3255, 3056, 2935, 2857, 1595, 1578, 1499, 1320, 1157, 1088, 809, 705 cm1; H
(400 MHz, CDCl3) 8.64-8.62 (1H, m, PyH), 7.79 (1H, t, J 2.4, PyH), 7.76 (1H, t, J
2.4, PyH), 7.67 (1H, td, J 2.4, 10.0 PyH), 7.24-7.17 (4H, m, ArH), 3.90 (1H, d, J
20.8, CHaHb), 3.78 (1H, d, J 20.8, CHaHb), 2.74-2.66 (1H, m, CH), 2.39 (3H, s,
CH3), 2.27-2.24 (1H, m, CH), 2.23-2.18 (1H, m, CH2-hexyl), 2.07-2.02 (1H, m,
CH2-hexyl), 1.67-1.60 (2H, m, CH2-hexyl), 1.26-0.98 (4H, m, 2 x CH2-hexyl); C
(100 MHz,CDCl3) 159.76 (C), 148.71 (CH), 142.94 (C), 137.41 (C), 136.71 (CH),
129.43 (2 x CH), 127.14 (2 x CH), 122.09 (CH), 122.03 (CH), 60.01 (CH), 57.54
(CH), 50.93 (CH2), 33.48 (CH2), 32.34 (CH2), 24.64 (CH2), 24.33 (CH2) 21.46
(CH3). m/z (ESI) 360.1 [M+H]+. HRMS found (ESI) 360.1740 (C19H25N3O3S
[M+H]+ requires 360.1740, error = 0.0 ppm).
Synthesis of (R,R)-N-{1,2-diphenyl-2-[(pyridin-2-ylmethylene)-amino]-ethyl}-4-
methyl-benzenesulfonamide (230):
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This compound is known but not fully characterized.149 To a stirred solution of
(1R,2R-TsDPEN) (0.5 g, 1.36 mmol) in DCM (20 cm3) were added at r.t. 2-
pyridincaboxaldehyde (0.21 g, 1.36 mmol) in DCM (10 cm3). The mixture was
stirred o/n at r.t. Anhydrous MgSO4 was added, the solution filtered and solvent
removed at reduced pressure to obtain (R,R)-N-{1,2-diphenyl-2-[(pyridin-2-
ylmethylene)-amino]-ethyl}-4-methyl-benzenesulfonamide 230 as a white solid
compound (0.51 g, 1.10 mmol, 81%). Mp 130-133 C; []D27 = + 56.13, (c 0.0.5,
CHCl3); max(neat) 3027, 1734, 1590, 1348, 1162, 1090, 996, 750, and 663 cm1; H
(400 MHz, CDCl3) 8.60 (1H, d, J 6.0, PyH), 8.01 (1H, d, J 10.4, PyH), 7.83 (1H, td,
J 2.4, 7.6, PyH), 7.62 (2H, d, J 11.2, ArH), 7.32-7.28 (1H, m, PyH), 7.24-7.16 (10H,
m, ArH), 6.98 (2H, dd, J 2.2, 7.2, ArH), 5.94 (1H, s, N=CH), 4.65 (1H, d, J 8.8,
CH), 4.32 (1H, d, J 8.8, CH), 2.42 (3H, s, CH3); C (100MHz,CDCl3) 158.58 (C),
148.99 (CH), 143.72 (C), 139.59 (C), 138.99 (C), 136.85 (CH), 134.09 (C), 129.49
(2 x CH), 128.37 (2 x CH), 128.21 (2 x CH), 127.93 (2 x CH), 127.55 (CH), 127.46
(CH), 127.21 (2 x CH), 126.88 (2 x CH), 123.69 (CH), 123.29 (CH), 78.72 (CH),
71.72 (CH), 69.69 (CH), 21.68 (CH3). m/z (ESI) 456.1 [M+H]+. HRMS found (ESI)
456.1741 (C27H26N3O2S [M+H]+ requires 456.1740, error = 0.9 ppm).
Synthesis of (S,S)-N-{1,2-Diphenyl-2-[(pyridin-2-ylmethyl)-amino]-ethyl}-4-
methyl-benzenesulfonamide (231):
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This compound is novel. (R,R)-N-{1,2-diphenyl-2-[(pyridin-2-ylmethylene)-amino]-
ethyl}-4-methyl-benzenesulfonamide 230 (0.50 g, 1.1 mmol) was dissolved in
MeOH (20 cm3) and NaBH4 (0.13 g, 3.3 mmol) was added portionwise and the
reaction allowed to stir until all the imine has been consumed. The solvent was
evaporated and the residue taken up in diethyl ether (15 cm3) and sat. NaHCO3 (15
cm3). The organic layer was separated and the aqueous layer extracted with diethyl
ether (2 x 15 cm3). The combined organic extracts were dried over MgSO4, filtered
and concentrated in vacuo to afford the crude product, which was purified by silica
gel column chromatography using (EtOAc:hexane 20:80) to give (R,R)-N-{1,2-
diphenyl-2-[(pyridin-2-ylmethyl)-amino]-ethyl}-4-methyl-benzenesulfonamide 231
as a white solid compound (0.32 g, 0.68 mmol, 62%). Mp 108-110 C; []D25 = -
38.75, (c 0.4, CHCl3); max(neat) 3029, 1593, 1453, 1325, 1155, 1091, 915, 844, 752
and 698 cm1; H (400 MHz, CDCl3) 8.54 (1H, d, J 4.8, PyH), 7.59 (1H, td, J 1.2,
7.6, PyH), 7.42 (2H, d, J 8.0, PyH), 7.17-7.09 (5H, m, ArH), 7.03-6.95 (7H, m,
ArH), 6.92-6.89 (2H, m, ArH), 4.35 (1H, d, J 8.0, CHPh), 3.76 (1H, d, J 14.8,
CHaHb), 3.72 (1H, d, J 8.0, CHPh), 3.61 (1H, d, J 14.8, CHaHb), 2.31 (3H, s, CH3);
C (100MHz,CDCl3) 159.04 (C), 148.87 (CH), 142.75 (C), 138.88 (C), 138.46 (C),
137.18 (C), 136.61 (CH), 129.02 (2 x CH), 128.15 (2 x CH), 127.73 (2 x CH),
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127.66 (2 x CH), 127.49 (2 x CH), 127.37 (CH), 127.06 (CH), 127.01 (2 x CH),
122.11 (CH), 121.96 (CH), 67.40 (CH), 63.25 (CH), 51.70 (CH2), 21.35 (CH3). m/z
(ESI) 458.1 [M+H]+. HRMS found (ESI) 458.1896 (C27H28N3O2S [M+H]+ requires
458.1897, error = 0.3 ppm).
Synthesis of (R,R)-(2-Amino-cyclohexyl)-carbamic acid tert-butyl ester (236):
This compound is known but not fully characterised.157 A solution of 3.0 cm3 of HCl
in MeOH (3M) was stirred at 0 C for 15 min. Then, to this solution, was carefully
added (R,R)-1,2-diaminocyclohexane (0.5 g, 4.36 mmol) at 0 C. The mixture was
stirred for 15 min at r.t. before adding water (1.0 cm3) and stirring for another 0.5 h.
To the solution, (Boc)2O (0.95 g, 8.76 mmol) in 4.0 cm3 of MeOH was added at r.t.
for 10 min, and the resultant solution was stirred for 1 h. The mixture was
concentrated in vacuo. Unreacted diamine was removed by diethyl ether (30 cm3 x
2). The residue was dissolved in DCM (20 cm3), treated with 2 N NaOH solution (15
cm3). The product in the organic layer was washed with of brine (20 cm3) dried over
anhydrous MgSO4, and concentrated in vacuo to yield a mono-Boc product 236 as a
white solid, (0.68 g, 3.18 mmol, 72%). Mp 109-112 C; []D25 = -1.2, (c 0.1, CHCl3);
max(neat) 2929, 1691, 1545, 1317, 1240, 1040, 1016, 965, 850 and 759 cm1; H
(400 MHz, CDCl3) 4.46 (1H, br s, NH), 3.14-3.12 (1H, m, CH), 2.32 (1H, td, J 5.6,
10.1, CH), 2.04-1.98 (2H, m, CH2), 1.72-1.69 (2H, m, CH2), 1.45 (9H, s, t-butyl),
1.37 (2H, br s, NH2), 1.29-1.07 (4H, m, 2 x CH2); C (100 MHz,CDCl3) 156.49
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(C=O), 57.69 (C), 55.63 (CH), 55.01, (CH), 35.20 (CH2), 32.86 (CH2), 28.36 (3 x
CH3), 25.15 (CH2), 25.04 (CH2). m/z (ESI) 215.2 [M+H]+. HRMS found (ESI)
215.1751 (C11H23N2O2 [M+H]+ requires 215.1754, error= 1.6 ppm).
Synthesis of (R,R)-{2-[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-carbamic acid
tert-butyl ester (238):
This compound is novel. To a solution of (R,R)-(2-amino-cyclohexyl)-carbamic acid
tert-butyl ester 236 (0.6 g, 2.81 mmol) in DCM (20 cm3) was added at r.t. (0.42 cm3 ,
2.81 mmol) of 2-pyridine carboxaldehyde in DCM (10 cm3). The mixture was stirred
at r.t. o/n, anhydrous MgSO4 was added, the solution filtered and the solvent
removed to leave the imine intermediate (0.71 g, 2.30 mmol, 80%), which is used
directly in the next step, (0.70 g, 2.3 mmol) of the imine was placed in round bottom
flask and dissolved in MeOH (30 cm3), then NaBH4 (0.26 g, 6.9 mmol) was added
slowly and the mixture stirred o/n. The solvent was removed, then the residue
dissolved in DCM (20 cm3), washed with water (15 x 3 cm3) and solvent removed to
give a crude product, which was purified by silica gel column chromatography using
(EtOAc:EtOH 90:10) to give (R,R)-{2-[(pyridin-2-ylmethyl)-amino]-cyclohexyl}-
carbamic acid tert-butyl ester 238 as a yellow oil compound (0.63 g, 2.01mmol,
77%); []D26 = -16.12, (c 0.22, CHCl3); max(neat) 2927, 1686, 1522, 1389, 1253,
1167, 1012, 848 and 753 cm1; H (400 MHz, CDCl3) 8.55 (1H, d, J 4.4, PyH), 7.63
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(1H, td, J 1.6, 7.6, PyH), 7.31 (1H, d, J 8.0, PyH), 7.17-7.14 (1H, m, PyH), 5.34
(1H, br s, NH), 4.04 (1H, d, J 15.2, CHaHb), 3.88 (1H, d, J 15.1, CHaHb), 3.33-3.31
(1H, m, CH(NH)Boc), 2.30-2.25 (2H, m, CH2), 2.18-2.15 (1H, m, CH(NH)CH2-
Pyr), 2.11-2.08 (1H, m, NH), 1.72-1.64 (2H, m, CH2), 1.46 (9H, s, t-butyl), 1.30-
1.07 (4H, m, CH2); C (100 MHz,CDCl3) 160.41 (C=O), 156.05 (C), 148.97 (CH),
136.42 (CH), 122.26 (CH), 121.82 (CH), 66.52 (C), 60.63 (CH), 54.57 (CH), 51.94
(CH2), 33.07 (CH2), 31.87 (CH2), 28.41 (3 x CH3), 24.70 (CH2), 24.61 (CH2). m/z
(ESI) 306.2 [M+H]+. HRMS found (ESI) 306.2172 (C17H28N3O2 [M+H]+ requires
306.2176, error = 1.2 ppm).
3.7. General procedure for asymmetric transfer hydrogenation of ketones:
A mixture of catalyst (2 mol%) and Ru3 (CO)12 (0.67 mol%) in IPA (10 cm3) was
stirred at 80 C under an inert atmosphere in schlenk tube for 30 min. To this
solution, ketone (1 mmol) was added and the resulting mixture was stirred at 80 C
for 48 h. The reaction mixture was filtered through a short column of silica using
(EtOAc:hexane 1:1), a small amount of the filtrate was dilluted in EtOAc and then
injected on the GC to determine the conversion and enantiomeric excess.
Racemic:
The ketone (1mmol) was dissolved in MeOH (5cm3) in schlenk tube, then NaBH4 (3
mmol) was added slowly and the mixture was stirred at r.t. for o/n. The solvent was
removed and the mixture was dissolved in DCM (10 cm3), washed with water (10
cm3), filtered and solvent removed. a small amount of the residue was dilluted in
EtOAc and then injected on the GC to determine the conversion.
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3.8. Reduction of ketones using tethered ruthenium diamine chiral complexes171
A solution of tethered ruthenium diamine chiral ligands (0.0150 mmol) in FA:TEA
(5:2) azeotropic (1.5 cm3) was stirred in a flame dried schlenk tube at 28 C for 30
min. Substrate (3 mmol) in DCM (1.5 cm3) was added. The reaction mixture was
stirred at 28 C and monitored by TLC. After the starting materials was consumed,
the reaction mixture was diluted by DCM (20 cm3) and washed by sat. NaHCO3
solution (3 x 15 cm3). The organic phase was dried over anhydrous MgSO4 and
concentrated under reduced pressure. The residue was purified by flash
chromatography.
3.9. General procedure for the addition of nitro methane to aldehydes.172
Under an argon atmosphere, the ligand (0.025 mmol, 10 mmol%) and CuBr (0.025
mmol, 10 mmol%) were suspended in anhydrous methanol (1.0 cm3). After stirring
for 1 h at r.t., nitro methane (10 mmol) and the aldehyde (1.0 mmol) were added and
the reaction was stirred for a specific amount of time at r.t. The volatile components
were then removed under reduced pressure, and the crude product was purified by
flash column chromatography on silica gel (EtOAc:Hexane 20-30 %) to give the
pure product. Conversions were determined by NMR and enantiomeric access were
determined by HPLC analysis on a chiral OD-H column. The absolute
configurations of the products were assigned by comparison to literature values.
(S)-1-(4-Nitrophenyl)-2-nitroethanol
This compound has been reported and fully characterised.173 Colourless oil. lit.173
[α]D
25 = +30.5 (c 1.3, CH2Cl2) 88% ee; H (400 MHz, CDCl3)  8.28−8.25 (2H, m, 
ArH), 7.66−7.61 (2H, m, ArH), 5.63−5.59 (1H, m, CH), 4.64−4.57 (2H, m, CH2),
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3.24 (1H, brs, OH); δC (100 MHz, CDCl3) 148.17, 145.06, 126.92 (2C), 124.16 (2C),
80.60 (CH2), 69.94 (CH). Enantiomeric excess was determined by HPLC with a
Chiralcel OD-H column (n-hexane:IPA 80:20, 1.0 cm3/min, 254 nm); R isomer 11.1
minutes, S isomer 13.4 minutes.
(S)-1-(2-Nitrophenyl)-2-nitroethanol
This compound has been reported and fully characterised.173 Brown solid, Mp 80−81 
oC. lit.173 [α]D25= −169.4 (c 0.22, CH2Cl2) 87% ee; H (400 MHz, CDCl3) 8.08 (1H,
dd, J 8.4, 1.4, ArH), 7.96 (1H, dd, J 7.8, 2.4, ArH), 7.80−7.72 (1H, m, ArH), 
7.60−7.52 (1H, m, ArH), 6.09−6.03 (1H, m, CH), 4.88 (1H, dd, J 13.8, 2.4, CHaHb),
4.56 (1H, dd, J 13.8, 9.2, CHaHb), 3.14 (1H, d, J 4.0, OH); δC (100 MHz, CDCl3)
147.10, 145.06, 126.92 (2C), 124.16 (2C), 80.60 (CH2), 69.94 (CH). Enantiomeric
excess was determined by HPLC with a Chiralcel OD-H column (n-hexane:IPA
85:15, 1.0 cm3/min, 254 nm); R isomer 9.4 minutes, S isomer 10.2 minutes.
(S)-1-(2-Methoxyphenyl)-2-nitroethanol
This compound has been reported and fully characterised.173 Yellow oil, lit.173
[α]D
25 = +35.6 (c 1.06, CH2Cl2) 72% ee; H (400 MHz, CDCl3) 7.42 (1H, d, J 7.7,
ArH), 7.34−7.29 (1H, m, ArH), 6.98 (1H, t, J 7.2, ArH), 6.88 (1H, d, J 8.0, ArH),
5.62−5.58 (1H, m, CH), 4.85 (1H, d, J  8.1, OH), 4.64−4.51 (2H, m, CH2), 3.86 (3H,
s, OCH3); δC (100 MHz, CDCl3) 156.04, 129.81, 127.19, 126.10, 121.14, 110.59,
79.91 (CH2), 67.78 (CH), 55.44 (CH3). Enantiomeric excess was determined by
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HPLC with a Chiralcel IB column (n-hexane:IPA 90:10, 0.50 cm3/min, 210 nm); R
isomer 17.4 minutes, S isomer 18.7 minutes.
3.10. Iron-catalysed hydrosilylation reaction of acetophenone.174
Acetophenone (1.0 mmol), ligand (0.03 mmol), Fe(OAc)2 (0.02 mmol) were placed
in a flask under nitrogen atmosphere, THF (3.0 cm3) was added, and the mixture was
stirred for 1 h at 65 C, then (EtO)3SiH (2.0 mmol) was added and the mixture was
stirred for 24 h at 65 C. TBAF (THF solution, 1M, 1.0 cm3). KF (112 mg), MeOH
(1.0 cm3) and H2O (1.0 cm3) were adde at 0 C. The mixture were extracted with
EtOAc (5 x 2.0 cm3) and washed with H2O (5.0 cm3) and brine (5.0 cm3). The
combined organic layer was dried over anhydrous MgSO4 and concentrated under
reduced pressure. The residue was purified by flash column chromatography on
silica gel (EtOAc:hexane 30:70) to give 1-phenylethanol. Conversion and
enantiomeric excess were determined by GC.
3.11. Iron-catalyzed asymmetric epoxidation reaction of aromatic alkene175
A solution of Fe(OTf)2 (0.025 M solution in CH3CN (0.31 cm3, 7.8 mol) was added
to ligand (10 mg, 15.6 mol) under nitrogen atmosphere at r.t. After rinsed with
additional CH3CN (0.31 cm3), the reaction mixture was stirred at r.t. for 3h. To the
reaction of iron complex was added a solution of corresponding enone in CH3CN
(0.156 mmol) and the mixture was cooled in ice bath. To the reaction was rapidly
added CH3CO3H (32 wt% solution in CH3CO2H, 0.05 cm3, 0.234 mmol). After
being stirred in ice bath for 30 min., the reaction was quenched by adding a mixture
of 10% aq. NaS2O3 (2.0 cm3) and aq. NaHCO3 (2.0 cm3), and diluted with EtOAc
(5.0 cm3). The organic layer was separated and washed with brine (5.0 cm3), dried
over MgSO4 and concentrated at reduced pressure. The residue was purified by silica
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gel column chromatography (EtOAc:Hexane 15-20 %) to affered the corresponding
epoxide. Conversions were determined by NMR and enantiomeric access were
determined by HPLC analysis on a chiral OD-H column.
(2R,3S)-trans-Epoxy-3-phenyl-1-phenylpropan-1-one.
This compound has been reported and fully characterised.176 Colorless crystals; lit.176
[α]D
23 = 183.6 (c 1.00, CHCl3) 69% ee (2R,3S); H (400 MHz, CDCl3) 8.02-7.99
(2H, m, ArH), 7.62-7.36 (8H, m, ArH ), 4.29 (1H, d, J 2.0, CH), 4.08 (1H, d, J 2.0,
CH) ); δC (100 MHz, CDCl3) 171.91, 135.51, 134.07, 133.80, 130.33, 130.23,
129.12, 128.93 (2C), 128.83, 128.52, 128.41, 125.85, 61.07 (CH), 59.46 (CH).
Enantiomeric excess was determined by HPLC with a Chiralcel OD-H column
(n-hexane:IPA 90:10, 1.0 cm3/min, 254 nm); R isomer 15.86 minutes, S isomer 17.
minutes.
3.12. Analysis of reduction products.
1-Phenylethanol.
This compound has been reported and fully characterised.177 Colourless oil. [α]D22
+47.6 (c 0.2, CHCl3) 94% ee (R), lit.177 [α]D23 +36.4 (c 2.4, CHCl3) 76% ee (R); H
(300 MHz, CDCl3) 7.42-7.28 (5H, m, ArH), 4.83 (1H, q, J 6.4, CHOH), 3.57 (1H, br
s, OH), 1.49 (3H, d, J 6.4, CH3); C (75 MHz,CDCl3) 146.1 (C), 128.4 (2 x CH),
127.3 (CH), 125.6 (2 x CH), 70.1 (CH), 25.2 (CH3). Enantiomeric excess and
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conversion determined by chiral GC; (Chrompak cyclodextrin 50m x 0.25 mm x
0.25 μm column, T = 115 C, P = 15 psi, retention times 9.4 (acetophenone), R
isomer 14.56 minutes, S isomer 15.76 minutes.
1-(4-(trifluoromethyl)phenyl)ethanol.
This compound has been reported and fully characterised.178 Colourless oil.  [α]D26
+17.9 (c 0.5, CHCl3) 94% ee (R) , lit.178 [α]D23 -31.5 (c 5.49, CHCl3) 90% ee (R); H
(400 MHz, CDCl3) 7.59 (2H, d, J 8.2, 2 x ArH), 7.45 (2H, d, J 8.2, 2 x ArH), 4.92
(1H, q, J 6.5, CHOH), ), 2.40 (1H, br s, OH), 1.48 (3H, d, J 6.5, CHCH3); C (100.6
MHz,CDCl3) 149.7 (C), 129.8 (C), 125.7 (2 x CH), 125.4 (CF3), 69.8 (CH), 69.8
(CH), 25.3 (CH3). Enantiomeric excess and conversion determined by chiral GC;
(Chrompak cyclodextrin 50m x 0.25 mm x 0.25 μm column, T = 130C, P = 15 psi,
retention times 6.87 (trifluoromethylacetophenone), R isomer 13.46 minutes, S
isomer 14.78 minutes.
1-Cyclohexylethanol.
This compound has been reported and fully characterised.179 Colourless oil. 19% ee
(S), lit.179 [α]D21 +3.51 (c 3.1, CHCl3) 95% ee (S); H (400 MHz, CDCl3) 3.54-3.51
(1H, m, CHOH), 2.09 (1H, br s, OH), 1.88-1.63 (5H, m, cyclohexyl), 1.14 (3H, d, J
6.3, CH3), 1.31-0.91 (5H, m, cyclohexyl); C (100.6 MHz,CDCl3) 72.1(CH), 45.1
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(CH), 28.7 (CH2), 28.5 (CH2), 26.6 (CH2), 26.3 (CH2), 26.2 (CH2), 20.3 (CH3).
Conversion determined by GC analysis: Chrompak cyclodextrin--236M-19 50 m x
0.5 mm x  0.25 μm, T = 82 C, P= 15 psi H2, det = FID 220 C, retention times
ketone 26.70 min., alcohol 50.25, 51.95 minutes. Enantiomeric excess and
conversion determined by GC for the acetate derivative: analysis: Chrompak
cyclodextrin--236M-19 50 m x 0.5 mm x  0.25 μm, T = 115 C, P= 15 psi H2, det =
FID 220 C, retention times R isomer 12.51 minutes, S isomer 13.58 minutes.
Preparation of the acetate derivative: The reduction product (10 mg ) was dissolved
in of DCM (1 cm3). To this was then added acetic anhydride (0.02 cm3) and DMAP
(3 crystals). The reaction was stirred overnight and then volatiles were removed by
rotary evaporation. A small amount of the residue was dilluted in EtOAc and then
injected on the GC.
1-(2-Methoxyphenyl)ethanol.
HO
O
This compound has been reported and fully characterised.180 Colourless oil.  [α]D24
+24.8 (c 2.0, CHCl3) 90% ee (R), lit180 [α]D22 +32.3 (c 2.0, CHCl3) 94% ee (R); H
(400 MHz, CDCl3) 7.33 (1H, dd, J 7.5, 1.7, ArH), 7.21 (1H, dt, J 7.8, 7.8, 1.7,
ArH), 6.93 ( 1H, dd, J 8.2, 7.5, ArH), 6.84 (1H, d J 8.2, ArH), 5.07 (1H, dd, J 6.5 ,
5.3, CHOH), 3.80 (3H, s, OCH3), 2.95 (1H, br s, OH), 1.46 (3H, d, J 6.5, CHCH3);
C (100.6 MHz,CDCl3) 156.5, 133.7, 128.2, 126.1, 120.8, 110.4, 66.2 (CH), 55.3
(CH3), 23.0 (CH3). Enantiomeric excess and conversion determined by chiral GC;
(Chrompak cyclodextrin 50m x 0.25 mm x 0.25 μm column, T = 130 C, P = 15 psi,
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retention times 17.90 (2-methoxyacetophenone), S isomer 23.71 minutes, R isomer
24.77 minutes.
1-(3-Methoxyphenyl)ethanol
This compound has been reported and fully characterised.181 Colourless oil.  [α]D22
+38.1 (c 1.0, CHCl3) 96% ee (R), Lit181 [α]D22 +31.8 (c 1.1, CHCl3) 94% ee (R); H
(400 MHz, CDCl3) 7.23 (1H, dd, J 8.0, 8.1, ArH), 6.91-6.90 (2H, m, ArH), 6.78
(1H, dd, J 8.1, 2.5, ArH), 4.80 (1H, q, J 6.5 , CHOH), 3.77 (3H, s, OCH3), 2.57 (1H,
br s, OH),1.44 (3H, d, J 6.5, CHCH3); C (100.6 MHz,CDCl3) 159.7, 147.7, 129.5,
117.8, 112.8, 111.0, 70.3 (CH), 55.2 (CH3), 25.1 (CH3). Enantiomeric excess and
conversion determined by chiral GC; (Chrompak cyclodextrin 50m x 0.25 mm x
0.25 μm column, T = 130 C, P = 15 psi, retention times 18.67 (3-
methoxyacetophenone), R isomer 29.74 minutes, S isomer 31.62 minutes.
(R)-1-(4-methoxyphenyl)ethanol.
This compound has been reported and fully characterised.182 Colourless oil. [α]D22
+51.76 (c 1.2, CHCl3) 93% ee (R), lit.182 α]D24 +33.8 (c 0.54, CHCl3) 67% ee (R); H
(300 MHz, CDCl3) 7.26 (2H, d, J 8.4, ArH), 6.87-6.84 (2H, m, ArH), 4.81 (1H, q, J
6.6, CH(OH)CH3), 3.77 (3H, s, CH3O-), 2.15 (1H, br s, OH), 1.46 (3H, d, J 6.6,
CHCH3); C (100.6 MHz,CDCl3) 158.78, 138.09, 129.11, 128.86, 127.16, 126.56,
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69.72 (CH), 55.15 (CH3), 24.99 (CH3). Enantiomeric excess and conversion
determined by chiral GC; (Chrompak cyclodextrin 50 m x 0.25 mm x 0.25 μm 
column, oven 120 C, inj.: split 220 C, 100 Pa H2) retention times 41.1(4-
methoxyacetophenone), R isomer 46.56 minutes, S isomer 49.45 minutes.
(R)-1,2,3,4-Tetrahydronaphthalen-1-ol.
This compound has been reported and fully characterised.183 White solid. Mp 46-49
C,  [α]D
24 -4.9 (c 0.75, CHCl3) 95% ee, lit183 -15.0 (c -0.57, CHCl3) 53% ee; H
(300 MHz, CDCl3) 7.48-7.36 (1H, m, ArH), 7.26-7.18 (2H, m, ArH), 7.16-7.08 (1H,
m, ArH), 4.78 (1H, t, J 4.5, -CH(OH)CH2-), 2.91-2.67 (2H, m, -OH and –CHH-),
2.10-1.72 (5H, m, 3 x –CHH- and 2 x -CHH-); C (100.6 MHz,CDCl3) 138.71,
136.95, 128.81, 128.56, 127.35, 125.98, 67.99 (CH), 32.11 (CH2), 29.28 (CH2),
18.72 (CH2). Enantiomeric excess and conversion determined by chiral GC;
(Chrompak cyclodextrin 50 m x 0.25 mm x 0.25 μm column, oven 120 C, inj.: split
220 C, 100 Pa H2) retention times 41.25 (α-tetralone),  R isomer 57.65 minutes, S
isomer 55.97 minutes.
(R)-1-(4-chlorophenyl)ethanol.
This compound has been reported and fully characterised.184 Colourless oil. [α]D24 +
47.5 (c 0.5, Et2O), 92% ee (R), lit.184 [α]D26 +52.6 (c 0.56, Et2O) 95% ee (R); H
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(400 MHz, CDCl3) 7.29 (2H, dd, J 3.0, 6.5, ArH), 7.28-7.20 (2H, m, ArH), 4.85
(1H, q, J 6.5, -CH(OH)CH3), 2.11 (1H, br s, -OH), 1.50 (3H, d, J 6.5, CH3) ; C
(100.6 MHz,CDCl3) 144.28, 133.04, 228.22, 127.51, 127.10, 126.82, 69.70 (CH),
25.26 (CH3). Enantiomeric excess and conversion determined by chiral GC;
(Chrompak cyclodextrin 50m x 0.25 mm x 0.25 μm column, oven 115 C, inj.: split
220 C, 100 Pa H2) retention times 24.44 (4-chloroacetophenone), R isomer 53.47
minutes, S isomer 61.28 minutes.
(R)-3,4-Dihydro-2H-chromen-4-ol.
This compound has been reported and fully characterised.184 White solid. Mp 74-78
C. [α]D
25 + 68.25 (c 0.2, CHCl3) > 99% ee (R), lit.184 [α]D31 +61.0 (c 0.045, CHCl3)
99% ee (R);  δH (400 MHz, CDCl3) 7.27-7.24 (1H, m Ar-H ), 7.20-7.15 (1H, m Ar-H
), 6.90-6.87 (1 H, m, Ar-H), 6.82-6.79 (1 H, m, Ar-H), 4.69-4.66 (1 H, m,
CH(OH)CH2-), 4.24-4.18 (2 H, m, -CH2O-), 2.46 (1H, s, -OH), 2.09-1.91 (2H, m, -
CH2-); C (100.6 MHz,CDCl3) 154.57, 129.76, 129.68, 124.34, 120.58, 117.04,
63.16 (CH), 61.97 (CH2), 30.84 (CH2). Enantiomeric excess and conversion
determined by chiral GC; (Chrompak cyclodextrin 50m x 0.25 mm x 0.25 μm 
column, T = 115 oC, P = 15 psi, G = H2, retention times 24.54 (4-chromanone), R
isomer 42.52 minutes, S isomer 41.87 minutes.
(R)-1-phenylhexan-1-ol.
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This compound has been reported and fully characterised.185 Colourless oil.  [α]D26 –
28.6 (c 1.0, CHCl3) 91% ee (R), lit185 [α]24 D = -30.60 (c = 1.09, CHCl3) 93% ee (R)
; δH (400 MHz, CDCl3) 7.33-7.05 (5H, m, ArH), 4.47 (1H, t, J 8.7, CH), 2.38 (1H, s,
OH), 1.76-1.44 (2H, m, CH2), 1.41-1.03 (6H, m, 3 x CH2), 0.77 (3H, t, J 6.6, CH3);
C (100.6 MHz,CDCl3) 145.02, 129.01, 128.43, 128.07, 127.46, 126.55, 74.69 (CH),
39.10 (CH2), 31.78 (CH2), 25.53 (CH2), 22.6 1 (CH2), 14.08 (CH3).
Enantiomeric excess and conversion were determined by chiral GC; (Chrompak
cyclodextrin 50m x 0.25 mm x 0.25 μm column,, T = 140 oC, P = 15 psi, G = H2,
retention times 23.20 (hexanophenone), R isomer 31.97 minutes, S isomer 31.52
minutes.
1-(2-Bromophenyl) ethanol.
This compound has been reported and fully characterised.186 [α]D33 +62.9 ( c 0.42 in
CHCl3) 86.2% ee (R), lit187 [α]D25 +54.1 (c 1.18 in CHCl3) 99% ee (R); δH (300 MHz,
CDCl3) 7.58 (1 H, dd, J 7.9, 1.4, ArH), 7.50 (1 H, dd, J 7.9, 1.4, ArH), 7.36-7.31 (1
H, m, ArH), 7.14-7.09 (1 H, m, ArH), 5.22 (1 H, dq, J 6.4, 3.2, CH), 2.20 (1 H, d, J
3.2, OH), 1.47 (3 H, d, J 6.4, CH3); δC (75 MHz, CDCl3) 144.61 (C), 132.54, 128.65,
127.77, 126.62, 121.60, 69.05 (CH), 23.53 (CH3). Conversion and enantiomeric
excess were determined by chiral G.C; (Chrompak β-Cyclodextrin 50 m x 0.25 mm 
x 0.25 μm column, oven 145 °C, inj.: split 220 °C, det.: FID 220 °C, 100 Pa H2)
retention times 11.5 (2’-bromoacetophenone), R isomer 20.36 minutes, S isomer
24.31 minutes.
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1-(2-Chlorophenyl) ethanol.
This compound has been reported and fully characterised.186 [α]D26 +48.9 ( c 0.37 in
CHCl3) 87.9% ee (R), lit.186 [α]D33 +44.5 (c 0.70 in CHCl3) 70% ee (R); δH (300
MHz, CDCl3) 7.59 (1 H, dd, J 7.7, 1.8, ArH), 7.34-7.26 (2 H, m, ArH), 7.20 (1 H, dt,
J 7.7, 1.8, ArH), 5.29 (1 H, dq, J 6.4, 3.5, CH), 2.07 (1 H, d, J 3.5, OH), 1.49 (3 H, d,
J 6.4, CH3); δC (75 MHz, CDCl3) 143.02,131.52, 129.30, 128.30, 127.13, 126.35,
66.83 (CH), 23.43 (CH3). Conversion and enantiomeric excess were determined by
chiral G.C; (Chrompak β-Cyclodextrin 50 m x 0.25 mm x 0.25 μm column, oven 150 
°C, inj.: split 220 °C, det.: FID 220 °C, 100 Pa H2) retention times 6.8 (2-
chloroacetophenone), R isomer 10.5 minutes, S isomer 11.6 minutes.
1-(2-Fluorophenyl) ethanol.
This compound has been reported and fully characterised.188 [α]D28 +37.9 ( c 0.45 in
MeOH) 83.7% ee (R), lit.187 [α]D18 +44.5 (c 0.77 in MeOH) 54% ee (R); δH (300
MHz, CDCl3) 7.48 (1 H, dt, J 7.7, 1.8, ArH), 7.28-7.20 (1 H, m, ArH), 7.14 (1 H, dt,
J 7.7, 1.3, ArH), 7.04-6.98 (1 H, m, ArH), 5.23-5.15 (1 H, m, CH), 2.06 (1 H, d, J
4.2, OH), 1.51 (3 H, d, J 6.6, CH3); δC (75 MHz, CDCl3) 159.62, 132.61, 128.65,
126.56, 124.22, 64.35 CH), 23.92 (CH3); δF (300 MHz, CDCl3) -120.07 (s).
Conversion and enantiomeric excess were determined by chiral G.C; (Chrompak β-
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Cyclodextrin 50 m x 0.25 mm x 0.25 μm column, oven 120 °C, inj.: split 220 °C, 
det.: FID 220 °C, 100 Pa H2) retention times 6.4 (2-fluoroacetophenone) R isomer
12.5 minutes, S isomer 13.5 minutes.
(S)-(-)-1-(2Iodophenyl) ethanol
This compound has been reported and fully characterised.189 lit.189 [α]D24 +37.7 (c
0.93, CHCl3) 97% ee (S); δH (300 MHz, CDCl3) 7.78 (1 H, dd, J 7.7, 1.1, ArH), 7.54
(1 H, dd, J 7.7, 1.7, ArH), 7.36 (1 H, t, J 7.7, ArH), 6.95 (1 H, dt, J 7.7, 1.7, ArH),
5.04 (1 H, qd, J 6.4, 3.2, CH), 2.28 (1 H, d, J 3.2, OH), 1.43 (3 H, d, J 6.4, CH3); δC
(75 MHz, CDCl3) 147.42 (C), 139.25 (CH), 129.10 (CH), 128.68 (CH), 126.28
(CH), 97.17 (C), 73.65 (CH), 23.70 (CH3). Conversion and enantiomeric excess
were determined by chiral G.C; (Chrompak β-Cyclodextrin 50 m x 0.25 mm x 0.25 
μm column, oven 160 °C, inj.: split 220 °C, det.: FID 220 °C, 100 Pa H2) retention
times 12.4 (2’-iodoacetophenone), R isomer 18.3 minutes, S isomer 21.5 minutes.
1-(2-Methylphenyl) ethanol.
This compound has been reported and fully characterised.190 [α]D30 +56.9 ( c 0.41 in
EtOH) 93.8% e.e. (R), lit.187 [α]D20 +60.6 (c 0.71 in EtOH) 95% e.e. (R); δH (300
MHz, CDCl3) 7.47 (1 H, dd, J 7.4, 1.5, ArH), 7.24-7.08 (3 H, m, ArH), 5.06 (1 H,
dq, J 6.4, 3.3, CH), 2.31 (3 H, s, (Ar-CH3) 2.14 (1 H, d, J 3.3, OH), 1.42 (3 H, d, J
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6.4, CH3); δC (75 MHz, CDCl3) 143.79, 134.09, 130.25, 127.03, 126.26, 124.41,
66.64 (CH), 23.82 (CH3), 18.82 (CH3). Conversion and enantiomeric excess were
determined by chiral G.C; (Chrompak β-Cyclodextrin 50 m x 0.25 mm x 0.25 μm 
column, oven 125 °C, inj.: split 220 °C, det.: FID 220 °C, 100 Pa H2) retention times
8.9 (2-methylacetophenone) R isomer 18.1 minutes, S isomer 21.2 minutes.
1-(2-Trifluoromethylphenyl) ethanol.
This compound has been reported and fully characterised.191 δH (300 MHz, CDCl3)
7.79 (1 H, d, J 7.9, ArH), 7.60-7.54 (2 H, m, ArH), 7.34 (1 H, t, J 7.6, ArH), 5.33-
5.26 (1 H, m, CH), 2.40 (1 H, d, J 3.0, OH), 1.44 (3 H, d, J 6.40, CH3); δC (75 MHz,
CDCl3) 145.02 (C-CF3), 132.33 (CH), 127.27 (CH), 127.07 (CH), 126.59 (C),
125.27 (q, JCF 6.0, CH), 124.36 (q, JCF 273.9, CF3), 65.61 (CH), 25.35 (CH3); δF (300
MHz, CDCl3) -58.95 (s). Conversion and enantiomeric excess were determined by
chiral G.C; (Chrompak β-Cyclodextrin 50 m x 0.25 mm x 0.25 μm column, oven 120 
°C, inj.: split 220 °C, det.: FID 220 °C, 100 Pa H2) retention times 7.6 (2-
trifluoromethylacetophenone), R isomer 13.0 minutes, S isomer 13.8 minutes.
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5. Appendix
(S,S)-N-{1,2-Diphenyl-2-[(pyridin-2-ylmethyl)-amino]-ethyl}-4-methyl-
benzenesulfonamide (231)
Solid state structure of one of the crystallographically independent but chemically identical
molecules in the asymmetric unit of 231. The minor disordered component of the methyl
pyridyl ring has been removed for clarity.
Experimental data for 231.
There are two molecules in the asymmetric unit, eight in the unit cell. Due to the rather high
values of the thermal parameters of the pyridyl nitrogen in the methylpyridyl group (C114-
C119) a model was developed where the nitrogen was disordered over the two ortho
positions of the ring and refined to an occupancy of 7:3 C115-N119 : N115-C119.
The atoms involved in this disorder (C115, N115, N119, C119) were refined isotropically.
The methyl pyridyl group was disordered over two positions (C221-C219 and C11A-C19A)
in the other molecule. The occupancy was originally allowed to refine but then fixed at
60:40 once it settled down. AFIX 66 restraints were used to constrain these rings to a
hexagon.
The hydrogens on the amine N112 and N212 were located in a difference map and allowed
to refined with a DFIX restraint and given thermal parameters equal to1.5 times that of the
equivalent isotropic displacement parameter of the atom to which they are attached. No
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hydrogen was located for the minor component amine N12A but this was added to the
formula so as to calculate the correct density etc.
Many SIMU restraint were used to give the thermal parameters of the disordered
components reasonable values. There were 6004 Friedel pairs giving a Flack parameter of
0.003(9) and a Hooft y parameter of 0.03(15) (Olex2).
This means you can be reasonably confident in the assignment of the stereochemistry
(But you started from a know stereochemistry anyway). Some of the NHs of the
sulphonamide and amine form H bond contacts tabulated below.
Specified hydrogen bonds (with esds except fixed and riding H)
D-H H...A D...A <(DHA)
0.86 2.22 2.928(4) 139.5 N109-H109...O20A_$1
0.86 2.10 2.957(4) 173.5 N209-H209...O10B_$2
0.89(2) 2.31(12) 2.817(12) 115(10) N212_a-H212_a...N219
Symmetry operators used to generate equivalent atoms in the above contacts were
$1 -1+X,+Y,+Z
$2 1+X,+Y,+Z
There is pi stacking interaction described by the atoms used to define the mean planes, the
angle between mean planes and the closest atomic contactC102 C103 C104 C105 C106
C107 to C126 C127 C128 C129 C130 C131 is 19.50 ( 0.18 ) degreeswith the closest atomic
contact C105 - C126 3.3048 (0.0050) Angstroms.
Crystal Data
C27 H27 N3 O2 S, M = 457.58, Orthorhombic, space group P2(1)2(1)2(1)
a = 11.9961(2), b = 18.3565(3), c = 22.6663(3) A , alpha = 90 deg., beta = 90 deg., gamma =
90 deg., U = 4991.26(13) A^3 (by least squares refinement on 14229 reflection positions), T
=293(2)K, lambda = 0.71073 A, Z = 8, D(cal) = 1.218 Mg/m^3, F(000) = 1936. mu(MoK-
alpha) = 0.158 mm^-1. Crystal character:colourless block. Crystal dimensions 0.45 x 0.45 x
0.45 mm.
Data Collection and Processing.
Oxford Diffraction Gemini four-circle system with Ruby CCD area detector.
The crystal was held at 293(2) K with the Oxford Cryosystem Cryostream Cobra.
Maximum theta was 30.64 deg. The hkl ranges were -16/ 17, -25/ 26, -28/ 32. 50473
reflections measured, 14062 unique [R(int) = 0.0271]. Absorption correction by Semi-
empirical from equivalents; minimum and maximum transmission factors: 0.96; 1.00. no
crystal decay
Structure Analysis and Refinement. Systematic absences indicated space group
P2(1)2(1)2(1) and shown to be correct by successful refinement. The structure was solved
by direct methods using SHELXS (Sheldrick, 1990) (TREF) with additional light atoms
found by Fourier methods. Hydrogen atoms were added at calculated positions and refined
using a riding model with freely rotating methyl groups. Anisotropic displacement
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parameters were used for all non-H atoms; H-atoms were given isotropic displacement
parameters equal to 1.2 (or 1.5 for methyl hydrogen atoms) times the equivalent isotropic
displacement parameter of the atom to which the H-atom is attached (see above)The
absolute structure of the individual crystal chosen was checked by refinement of a delta-f"
multiplier. Absolute structure parameter x = 0.03(9). The weighting scheme was calc
w=1/[\s^2^(Fo^2^)+(0.1272P)^2^+1.6970P] where P=(Fo^2^+2Fc^2^)/3. Goodness-of-fit
on F^2 was 1.053, R1[for 10183 reflections with I>2sigma(I)] = 0.0846, wR2 = 0.2438.
Data / restraints / parameters 14062/ 92/ 602. Largest difference Fourier peak and hole 0.894
and -0.336 e.A^-3 . Refinement used SHELXL 97 (Sheldrick, 1997). Additional material
available from the Cambridge Crystallographic Data Centre comprises H-atom coordinates,
thermal parameters and the remaining bond lengths and angles.
The Oxford Diffraction Gemini XRD system was obtained through the Science City
Advanced Materials project: Creating and Characterising Next Generation Advanced
Materials, with support from Advantage West Midlands (AWM) and part funded by the
European Regional Development Fund (ERDF)
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